<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neurosci Biobehav Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurosci Biobehav Rev</journal-id>
<journal-title-group>
<journal-title>Neuroscience and Biobehavioral Reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">0149-7634</issn>
<issn pub-type="epub">1873-7528</issn>
<publisher>
<publisher-name>Pergamon Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32151655</article-id>
<article-id pub-id-type="pmc">7237884</article-id>
<article-id pub-id-type="publisher-id">S0149-7634(19)30715-8</article-id>
<article-id pub-id-type="doi">10.1016/j.neubiorev.2020.03.007</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>DNA methylation and brain structure and function across the life course: A systematic review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="aut0005">
<name>
<surname>Wheater</surname>
<given-names>Emily N.W.</given-names>
</name>
<xref ref-type="aff" rid="aff0005">a</xref>
<xref ref-type="fn" rid="fn0005">1</xref>
</contrib>
<contrib contrib-type="author" id="aut0010">
<name>
<surname>Stoye</surname>
<given-names>David Q.</given-names>
</name>
<xref ref-type="aff" rid="aff0005">a</xref>
<xref ref-type="fn" rid="fn0005">1</xref>
</contrib>
<contrib contrib-type="author" id="aut0015">
<name>
<surname>Cox</surname>
<given-names>Simon R.</given-names>
</name>
<xref ref-type="aff" rid="aff0010">b</xref>
<xref ref-type="fn" rid="fn0010">2</xref>
</contrib>
<contrib contrib-type="author" id="aut0020">
<name>
<surname>Wardlaw</surname>
<given-names>Joanna M.</given-names>
</name>
<xref ref-type="aff" rid="aff0015">c</xref>
<xref ref-type="fn" rid="fn0015">3</xref>
</contrib>
<contrib contrib-type="author" id="aut0025">
<name>
<surname>Drake</surname>
<given-names>Amanda J.</given-names>
</name>
<xref ref-type="aff" rid="aff0020">d</xref>
<xref ref-type="fn" rid="fn0005">1</xref>
</contrib>
<contrib contrib-type="author" id="aut0030">
<name>
<surname>Bastin</surname>
<given-names>Mark E.</given-names>
</name>
<xref ref-type="aff" rid="aff0015">c</xref>
<xref ref-type="fn" rid="fn0010">2</xref>
</contrib>
<contrib contrib-type="author" id="aut0035">
<name>
<surname>Boardman</surname>
<given-names>James P.</given-names>
</name>
<email>james.boardman@ed.ac.uk</email>
<xref ref-type="aff" rid="aff0005">a</xref>
<xref ref-type="aff" rid="aff0015">c</xref>
<xref ref-type="fn" rid="fn0005">1</xref>
<xref ref-type="corresp" rid="cor0005">*</xref>
</contrib>
<aff id="aff0005"><label>a</label>Medical Research Council Centre for Reproductive Health, University of Edinburgh, United Kingdom</aff>
<aff id="aff0010"><label>b</label>Department of Psychology, University of Edinburgh, United Kingdom</aff>
<aff id="aff0015"><label>c</label>Centre for Clinical Brain Sciences, University of Edinburgh, United Kingdom</aff>
<aff id="aff0020"><label>d</label>University/British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, United Kingdom</aff>
</contrib-group>
<author-notes>
<corresp id="cor0005"><label>⁎</label>Corresponding author at: Queen's Medical Research Institute (W1.26), 47 Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom. <email>james.boardman@ed.ac.uk</email></corresp>
<fn id="fn0005">
<label>1</label>
<p id="npar0005">Emily N. W. Wheater, David Q. Stoye, Amanda J. Drake, James P. Boardman: Queen’s Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom</p>
</fn>
<fn id="fn0010">
<label>2</label>
<p id="npar0010">Simon R. Cox, Mark E. Bastin: Psychology Building, 7 George Square, Edinburgh, EH8 9JZ, United Kingdom</p>
</fn>
<fn id="fn0015">
<label>3</label>
<p id="npar0015">Joanna Wardlaw: Chancellor’s Building, 49 Little France Crescent, Edinburgh, EH16 4SB, United Kingdom</p>
</fn>
</author-notes>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.-->
<pub-date pub-type="ppub">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>113</volume>
<fpage>133</fpage>
<lpage>156</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>3</day>
<month>3</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>3</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 The Authors</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p>
</license>
</permissions>
<abstract abstract-type="author-highlights" id="abs0005">
<title>Highlights</title>
<p>
<list id="lis1335" list-type="simple">
<list-item id="lsti4390">
<label>•</label>
<p id="par4390">60 studies of association between DNAm and human brain MRI were identified.</p>
</list-item>
<list-item id="lsti4395">
<label>•</label>
<p id="par4395">Differential DNAm is associated with brain structure and function throughout life.</p>
</list-item>
<list-item id="lsti4400">
<label>•</label>
<p id="par4400">There is modest consistency between DNAm and image endophenotypes.</p>
</list-item>
<list-item id="lsti4405">
<label>•</label>
<p id="par4405">Approaches for reducing heterogeneity in DNAm-MRI analyses are proposed.</p>
</list-item>
</list>
</p>
</abstract>
<abstract id="abs0010">
<p>MRI has enhanced our capacity to understand variations in brain structure and function conferred by the genome. We identified 60 studies that report associations between DNA methylation (DNAm) and human brain structure/function. Forty-three studies measured candidate loci DNAm; seventeen measured epigenome-wide DNAm. MRI features included region-of-interest and whole-brain structural, diffusion and functional imaging features. The studies report DNAm-MRI associations for: neurodevelopment and neurodevelopmental disorders; major depression and suicidality; alcohol use disorder; schizophrenia and psychosis; ageing, stroke, ataxia and neurodegeneration; post-traumatic stress disorder; and socio-emotional processing. Consistency between MRI features and differential DNAm is modest. Sources of bias: variable inclusion of comparator groups; different surrogate tissues used; variation in DNAm measurement methods; lack of control for genotype and cell-type composition; and variations in image processing. Knowledge of MRI features associated with differential DNAm may improve understanding of the role of DNAm in brain health and disease, but caution is required because conventions for linking DNAm and MRI data are not established, and clinical and methodological heterogeneity in existing literature is substantial.</p>
</abstract>
<kwd-group id="kwd0005">
<title>Keywords</title>
<kwd>DNA methylation</kwd>
<kwd>Magnetic resonance imaging</kwd>
<kwd>Brain</kwd>
<kwd>Epigenetics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="nom0005">
<title>Nomenclature</title>
<def-list>
<title>Abbreviations</title>
<def-item>
<term id="dft0005">ACR</term>
<def>
<p id="par4410">anterior corona radiata</p>
</def>
</def-item>
<def-item>
<term id="dft0010">AD</term>
<def>
<p id="par4415">alcohol dependence</p>
</def>
</def-item>
<def-item>
<term id="dft0015">AxD</term>
<def>
<p id="par4420">axial diffusivity</p>
</def>
</def-item>
<def-item>
<term id="dft0020">ADC</term>
<def>
<p id="par4425">apparent diffusion coefficient</p>
</def>
</def-item>
<def-item>
<term id="dft0025">aMCI</term>
<def>
<p id="par4430">amnesic mild cognitive impairment</p>
</def>
</def-item>
<def-item>
<term id="dft0030">BCC</term>
<def>
<p id="par4435">body of the corpus calllosum</p>
</def>
</def-item>
<def-item>
<term id="dft0035">CC</term>
<def>
<p id="par4440">corpus callosum</p>
</def>
</def-item>
<def-item>
<term id="dft0040">CLASP</term>
<def>
<p id="par4445">Constrained Laplacian-based Automated Segmentation with Proximities</p>
</def>
</def-item>
<def-item>
<term id="dft0045">CSF</term>
<def>
<p id="par4450">cerebral spinal fluid</p>
</def>
</def-item>
<def-item>
<term id="dft0050">CST</term>
<def>
<p id="par4455">corticospinal tract</p>
</def>
</def-item>
<def-item>
<term id="dft0055">DG</term>
<def>
<p id="par4460">dentate gyrus</p>
</def>
</def-item>
<def-item>
<term id="dft0060">DMR</term>
<def>
<p id="par4465">differentially methylated region</p>
</def>
</def-item>
<def-item>
<term id="dft0065">FA</term>
<def>
<p id="par4470">fractional anisotropy</p>
</def>
</def-item>
<def-item>
<term id="dft0070">FXTAS</term>
<def>
<p id="par4475">Fragile X Associated Tremor Ataxia Syndrome</p>
</def>
</def-item>
<def-item>
<term id="dft0075">GCC</term>
<def>
<p id="par4480">genu of corpus callosum</p>
</def>
</def-item>
<def-item>
<term id="dft0080">GM</term>
<def>
<p id="par4485">grey matter</p>
</def>
</def-item>
<def-item>
<term id="dft0085">HC</term>
<def>
<p id="par4490">healthy controls</p>
</def>
</def-item>
<def-item>
<term id="dft0090">HS</term>
<def>
<p id="par4495">hippocampal sclerosis</p>
</def>
</def-item>
<def-item>
<term id="dft0095">IFG</term>
<def>
<p id="par4500">inferior frontal gyrus</p>
</def>
</def-item>
<def-item>
<term id="dft0100">IT</term>
<def>
<p id="par4505">inferior temporal</p>
</def>
</def-item>
<def-item>
<term id="dft0105">MD</term>
<def>
<p id="par4510">mean diffusivity</p>
</def>
</def-item>
<def-item>
<term id="dft0110">MDD</term>
<def>
<p id="par4515">major depressive disorder</p>
</def>
</def-item>
<def-item>
<term id="dft0115">MFG</term>
<def>
<p id="par4520">middle frontal gyrus</p>
</def>
</def-item>
<def-item>
<term id="dft0120">mOFC</term>
<def>
<p id="par4525">medial orbitofrontal cortex</p>
</def>
</def-item>
<def-item>
<term id="dft0125">MRF</term>
<def>
<p id="par4530">Markov Random Field</p>
</def>
</def-item>
<def-item>
<term id="dft0130">MTLE</term>
<def>
<p id="par4535">mesial temporal lobe epilepsy</p>
</def>
</def-item>
<def-item>
<term id="dft0135">NAcc</term>
<def>
<p id="par4540">nucleus accumbens</p>
</def>
</def-item>
<def-item>
<term id="dft0140">NR</term>
<def>
<p id="par4545">not reported</p>
</def>
</def-item>
<def-item>
<term id="dft0145">PCR</term>
<def>
<p id="par4550">posterior corona radiata</p>
</def>
</def-item>
<def-item>
<term id="dft0150">PHC</term>
<def>
<p id="par4555">parahippocampal cingulum</p>
</def>
</def-item>
<def-item>
<term id="dft0155">PNT</term>
<def>
<p id="par4560">probabilistic neighbourhood tractography</p>
</def>
</def-item>
<def-item>
<term id="dft0160">PTR</term>
<def>
<p id="par4565">posterior thalamic radiation</p>
</def>
</def-item>
<def-item>
<term id="dft0165">RD</term>
<def>
<p id="par4570">radial diffusivity</p>
</def>
</def-item>
<def-item>
<term id="dft0170">RLP</term>
<def>
<p id="par4575">right lateral parietal area</p>
</def>
</def-item>
<def-item>
<term id="dft0175">RS</term>
<def>
<p id="par4580">resting state</p>
</def>
</def-item>
<def-item>
<term id="dft0180">SFG</term>
<def>
<p id="par4585">superior frontal gyrus</p>
</def>
</def-item>
<def-item>
<term id="dft0185">STG</term>
<def>
<p id="par4590">superior temporal gyrus</p>
</def>
</def-item>
<def-item>
<term id="dft0190">TBSS</term>
<def>
<p id="par4595">tract-based spatial statistics</p>
</def>
</def-item>
<def-item>
<term id="dft0195">vlPFC</term>
<def>
<p id="par4600">ventrolateral prefrontal cortex</p>
</def>
</def-item>
<def-item>
<term id="dft0200">vlThalamus</term>
<def>
<p id="par4605">ventrolateral thalamus</p>
</def>
</def-item>
<def-item>
<term id="dft0205">WB</term>
<def>
<p id="par4610">whole brain</p>
</def>
</def-item>
<def-item>
<term id="dft0210">WMH</term>
<def>
<p id="par4615">white matter hyperintensities</p>
</def>
</def-item>
</def-list>
<def-list>
<title>Gene names</title>
<def-item>
<term id="dft0215">SKA2</term>
<def>
<p id="par4620">Spindle and Kinetochore Associated Complex Subunit 2</p>
</def>
</def-item>
<def-item>
<term id="dft0220">
<italic>SLC6A4</italic>
</term>
<def>
<p id="par4625">Solute Carrier Family 6 Member 4</p>
</def>
</def-item>
<def-item>
<term id="dft0225">
<italic>BDNF</italic>
</term>
<def>
<p id="par4630">Brain Derived Neurotrophic Factor</p>
</def>
</def-item>
<def-item>
<term id="dft0230">
<italic>FKBP5</italic>
</term>
<def>
<p id="par4635">FK506 Binding Protein 51</p>
</def>
</def-item>
<def-item>
<term id="dft0235">
<italic>OXTR</italic>
</term>
<def>
<p id="par4640">Oxytocin Receptor</p>
</def>
</def-item>
<def-item>
<term id="dft0240">
<italic>NR3C1</italic>
</term>
<def>
<p id="par4645">Nuclear Receptor Subfamily 3 Group member 1</p>
</def>
</def-item>
<def-item>
<term id="dft0245">
<italic>FMR1</italic>
</term>
<def>
<p id="par4650">Fragile X Mental Retardation 1</p>
</def>
</def-item>
<def-item>
<term id="dft0250">
<italic>COMT</italic>
</term>
<def>
<p id="par4655">Catecholamine Transferase</p>
</def>
</def-item>
<def-item>
<term id="dft0255">
<italic>DAT/SLC6A3</italic>
</term>
<def>
<p id="par4660">Dopamine Transporter/Solute Carrier Family 6 Member 3</p>
</def>
</def-item>
<def-item>
<term id="dft0260">
<italic>OXT</italic>
</term>
<def>
<p id="par4665">Oxytocin/Neurophysin 1 Prepropeptide</p>
</def>
</def-item>
<def-item>
<term id="dft0265">
<italic>C9orf72</italic>
</term>
<def>
<p id="par4670">Chromosome 9 Open Reading Frame 72</p>
</def>
</def-item>
<def-item>
<term id="dft0270">
<italic>CACNA1C</italic>
</term>
<def>
<p id="par4675">Calcium Voltage-Gated Channel Subunit Alpha1 C</p>
</def>
</def-item>
<def-item>
<term id="dft0275">
<italic>DRD2</italic>
</term>
<def>
<p id="par4680">Dopamine Receptor 2</p>
</def>
</def-item>
<def-item>
<term id="dft0280">
<italic>KLF13</italic>
</term>
<def>
<p id="par4685">Kruppel Like Factor 13</p>
</def>
</def-item>
<def-item>
<term id="dft0285">
<italic>NCAPH2</italic>
</term>
<def>
<p id="par4690">Non-SMC Condensin II Complex Subunit H2</p>
</def>
</def-item>
<def-item>
<term id="dft0290">
<italic>LMF2</italic>
</term>
<def>
<p id="par4695">Lipase Maturation Factor 2</p>
</def>
</def-item>
<def-item>
<term id="dft0295">
<italic>PPM1G</italic>
</term>
<def>
<p id="par4700">Protein Phosphatase Magnesium Dependent 1 Gamma</p>
</def>
</def-item>
<def-item>
<term id="dft0300">
<italic>HTR3A</italic>
</term>
<def>
<p id="par4705">5-Hydroxytryptamine Receptor 3A</p>
</def>
</def-item>
<def-item>
<term id="dft0305">
<italic>SOD</italic>
</term>
<def>
<p id="par4710">Superoxide Dismutase</p>
</def>
</def-item>
<def-item>
<term id="dft0310">
<italic>TESC</italic>
</term>
<def>
<p id="par4715">Tescalcin</p>
</def>
</def-item>
</def-list>
</sec>
<sec id="sec0005">
<label>1</label>
<title>Introduction</title>
<p id="par4720">A growing number of studies have investigated associations between epigenetic signatures and neuroimaging markers of human disease, behaviour and cognition. This area of research is motivated by the understanding that epigenetic processes contribute to brain development, ageing and disease, and they may mediate interaction between genomic predisposition and environmental pressures that modify brain structure and function.</p>
<p id="par4725">The term epigenetics refers to a set of molecular mechanisms that modulate the function of the genome in different cell types without altering the genome itself. DNA methylation (DNAm) is one such mechanism whereby a methyl group is covalently added to cytosine residues in a Cytosine-phosphate-Guanine context (CpG). This is thought to alter the accessibility of a locus to transcriptional machinery or modifying proteins, thereby influencing gene expression. DNA methylation may also occur after an initial change in gene expression and function as a form of longer-term control (<xref ref-type="bibr" rid="bib0225">Jones, 2012</xref>).</p>
<p id="par4730">The pathogenesis of several genetic diseases with neurological phenotypes involve DNAm dysregulation. Rett syndrome is a severe neurological disorder characterised by regression of acquired skills, stereotypic movements, microcephaly, seizures, and intellectual disability. It results from a loss of function mutation in the X-linked methyl-CpG binding protein 2 gene (<italic>MECP2</italic>), which is a chromatin associated protein required for normal neuronal function throughout life. The loss of function mutation in <italic>MECP2</italic> serves to reduce the binding affinity of the MECP2 protein to methylated DNA with effects on regulation of gene expression at transcriptional and post-transcriptional levels (<xref ref-type="bibr" rid="bib0270">Lyst and Bird, 2015</xref>). Angelman syndrome is characterised by cognitive impairment, movement or balance disorder, typical abnormal behaviours, and impaired speech and language. It arises from a mutation or deletion of the maternal ubiquitin protein ligase 3A gene (<italic>UBE3A</italic>) and the neuronal tissue specific paternal imprinting of the gene that silences the paternal allele (<xref ref-type="bibr" rid="bib0355">Rangasamy et al., 2013</xref>). Fragile X syndrome arises due to CGG triplet expansion within the <italic>FMR1</italic> gene promoter which becomes hypermethylated and results in a reduction of gene expression (<xref ref-type="bibr" rid="bib0490">Wijetunge et al., 2013</xref>). In addition to these genetic neurological disorders associated with DNAm dysregulation, variation in DNAm has been implicated in the pathogenesis of a number of complex neurodevelopmental, neurological and psychiatric diseases including autism, schizophrenia, and problems associated with trauma and stress (<xref ref-type="bibr" rid="bib0085">De Rubeis et al., 2014</xref>; <xref ref-type="bibr" rid="bib0135">Grayson and Guidotti, 2013</xref>; <xref ref-type="bibr" rid="bib0245">Klengel et al., 2014</xref>; <xref ref-type="bibr" rid="bib0320">Oberlander et al., 2008</xref>; <xref ref-type="bibr" rid="bib0325">Palumbo et al., 2018</xref>).</p>
<p id="par4735">DNAm may be modifiable by environmental factors including physiological and emotional stress, child abuse, nutritional deprivation, and other lifestyle factors that operate from fetal life to old age (<xref ref-type="bibr" rid="bib0035">Cao-Lei et al., 2015</xref>; <xref ref-type="bibr" rid="bib0090">Del Blanco and Barco, 2018</xref>; <xref ref-type="bibr" rid="bib0130">Gouin et al., 2017</xref>; <xref ref-type="bibr" rid="bib0175">Heijmans et al., 2008</xref>; <xref ref-type="bibr" rid="bib0220">Joehanes et al., 2016</xref>; <xref ref-type="bibr" rid="bib0275">McGowan et al., 2009</xref>; <xref ref-type="bibr" rid="bib0335">Provenzi et al., 2018</xref>; <xref ref-type="bibr" rid="bib0460">Vidal et al., 2014</xref>). As such, it has been proposed that environmentally-induced changes in DNAm may enable short-term survival adaptation, but may also induce adaptations that contribute to impaired development of neural networks and increased risk of pathology (<xref ref-type="bibr" rid="bib0125">Gluckman et al., 2010</xref>; <xref ref-type="bibr" rid="bib0190">Hoffmann et al., 2017</xref>).</p>
<p id="par4740">Structural, diffusion and functional brain MRI enable the parsing of complex behavioural traits and diseases onto quantitative indicators of brain structure and function. Such imaging endophenotypes have been used to demonstrate the impact of common genetic variants on brain health and disease (<xref ref-type="bibr" rid="bib0100">Elliott et al., 2018</xref>), but the role of DNAm in contributing to brain structure and / or function, as opposed to being a consequence of changes in structure or function, is less certain. To obtain a comprehensive overview of the extent to which differential DNAm associates human behaviour and disease we performed a systematic review of studies that have analysed DNAm with quantitative brain MRI data. By doing so we aimed to provide a comprehensive summary of what is known about DNAm-MRI associative relationships across the life course, and to identify image features associated with differential DNAm. Finally, we captured sources of heterogeneity in the extant literature to better inform the development of methods and conventions for analysing DNAm with MRI data.</p>
</sec>
<sec id="sec0010">
<label>2</label>
<title>Materials and methods</title>
<p id="par4745">We performed a systematic literature search based on the PRISMA framework, according to a pre-registered protocol on PROSPERO (CRD42018090928).</p>
<sec id="sec0015">
<label>2.1</label>
<title>Search strategy</title>
<p id="par4750">Scopus, Web of Science, MEDLINE and EMBASE (via OVID) were searched in March 2018 to identify studies that integrated DNA methylation and human in vivo MRI (for search strategy see supplementary material). The search was composed of three OR clusters that contained terms relating to the key domains, which were combined with AND: MRI neuroimaging AND Brain AND DNA methylation. Bibliographies were searched for additional studies. There were no language restrictions on the search.</p>
</sec>
<sec id="sec0020">
<label>2.2</label>
<title>Screening and study selection</title>
<p id="par4755">Search results were imported to EndNote X8 prior to removal of duplicates and retrieval of full texts prior to import to Covidence software (<ext-link ext-link-type="uri" id="intr0005" xlink:href="https://www.covidence.org/home">https://www.covidence.org/home</ext-link>). Screening was carried out by ENWW and DQS independently and studies were included if they met the following criteria: report of primary results; recruited human participants of any age with in vivo neuroimaging and DNAm; investigated the relationship between brain imaging using MRI and epigenome-wide or loci specific DNAm. Exclusion criteria: no original data reported (reviews, abstracts, letters, and grey literature as defined by Grey Literature International Committee Guidance); no test of association between brain imaging findings and DNA methylation; analysis was carried out in animals or in post-mortem human tissue; DNAm-MRI analyses of central nervous system malignancy.</p>
</sec>
<sec id="sec0025">
<label>2.3</label>
<title>Data extraction</title>
<p id="par4760">ENWW extracted data for all included studies and DQS duplicated extraction for a subset of 25 %. Extraction included: participant characteristics, study design, method of DNAm ascertainment, MRI modality and image feature(s) of interest, and statistical method, consideration of cell sub-type composition includes cell sorting techniques or statistical methods to estimate and control for cell sub type composition and consideration of genotype or ancestry. The total number of participants per phenotypic category were estimated. Due to participant overlap in some studies, the largest study population reported was used to estimate the total number of participants.</p>
</sec>
<sec id="sec0030">
<label>2.4</label>
<title>Risk of bias assessment</title>
<p id="par4765">In the absence of a validated quality assessment tool for studies linking DNAm with MRI data, we extracted data on study characteristics that might affect risk of bias: design, presence / absence of a comparator group; DNA source; candidate or epigenome-wide approach for evaluating differential DNAm; ascertainment of cell type composition; consideration of genotype; image processing methodology; and region-of-interest versus whole brain MRI analysis, and considered their prevalence in the epigenetic-neuroimaging literature.</p>
</sec>
<sec id="sec0035">
<label>2.5</label>
<title>Data synthesis</title>
<p id="par4770">We provide a narrative synthesis structured around the type of association between DNAm and image feature, target population characteristics, tabulated, and categorised by disease.</p>
</sec>
</sec>
<sec id="sec0040">
<label>3</label>
<title>Results</title>
<sec id="sec0045">
<label>3.1</label>
<title>Overview of the literature</title>
<p id="par4775"><xref ref-type="fig" rid="fig0005">Fig. 1</xref> is the PRISMA flow chart of study identification and inclusion. Our search strategy yielded 3442 in total: 3438 resulting from the search and an additional 4 papers were identified post search and were included. After removal of duplicates and exclusions at screening, 336 articles were eligible for full text evaluation. Of the full text articles that were screened for eligibility for inclusion, 276 were removed due to lack of eligibility. In total, 60 studies were included in this review (estimated 6775 participants): 34 (57 %) included a control or comparator group. <xref ref-type="table" rid="tbl0005">Table 1</xref> summarises diseases and conditions in phenotypic categories, number of participants per category, MRI modality, and method used to analyse DNAm (epigenome wide or candidate loci). All studies report populations from resource rich settings: United States (25), United Kingdom (3), Germany (4), Switzerland (4), Germany and Switzerland (1), South Korea (7), Canada (3), Italy (2), Japan (1), China (2), Singapore (2), Republic of Ireland (2), Australia (2), Spain (1), Sweden (1).<fig id="fig0005"><label>Fig. 1</label><caption><p>PRISMA flow diagram of studies.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1"></graphic></fig><table-wrap id="tbl0005" position="float"><label>Table 1</label><caption><p>Overview of studies.</p></caption><alt-text id="at0010">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Disease or condition,<break></break>number of studies</th><th align="left">Number of participants</th><th align="left">MRI modality<break></break>(structural, functional, diffusion)</th><th align="left">Epigenetic method: Epigenome-wide (EW) or candidate (candidate loci)</th></tr></thead><tbody><tr><td align="left">Neurodevelopment and neurodevelopmental disorders<sup>†</sup><break></break>n = 8</td><td align="left">715</td><td align="left">5 sMRI<break></break>6 fMRI<break></break>2 dMRI</td><td align="left">6 EW<break></break>2 candidate (<italic>SLC6A4, FKBP5)</italic></td></tr><tr><td align="left">Major depressive disorder and suicidality<break></break>n = 11</td><td align="left">922<sup>§</sup></td><td align="left">4 sMRI<break></break>4 fMRI<break></break>2 dMRI<break></break>1 sMRI/dMRI</td><td align="left">1 EW<break></break>10 candidate (<italic>BDNF, SLC6A4, FKPB5, CACNA1C, TESC)</italic></td></tr><tr><td align="left">Alcohol use disorder<break></break>n = 4</td><td align="left">921</td><td align="left">4 fMRI</td><td align="left">0 EW<break></break>4 candidate <italic>(PPM1G, DAT/SLC6A3, DRD2)</italic></td></tr><tr><td align="left">Schizophrenia and psychosis<break></break>n=7</td><td align="left">456<sup>§</sup></td><td align="left">2 sMRI<break></break>4 fMRI<break></break>1 sMRI/fMRI</td><td align="left">5 EW<break></break>3 candidate (<italic>OXTR, BDNF, COMT)</italic></td></tr><tr><td align="left">Ageing, stroke, ataxia and neurodegeneration<break></break>n = 8</td><td align="left">1456<sup>§</sup></td><td align="left">5 sMRI<break></break>2 dMRI<break></break>1 sMRI/dMRI</td><td align="left">3 EW<break></break>5 candidate <italic>(C9orf72, FMR1, SOD, NCAPH2/LMF2)</italic></td></tr><tr><td align="left">Post-traumatic stress disorder<break></break>n=7</td><td align="left">450<sup>§</sup></td><td align="left">3 sMRI<break></break>3 fMRI<break></break>1 dMRI</td><td align="left">1 EW<break></break>6 candidate <italic>(SKA2, NR3C1, HTR3A, BDNF, FKBP5)</italic></td></tr><tr><td align="left">Miscellaneous<sup>‡</sup><break></break>n = 15</td><td align="left">1855</td><td align="left">3 sMRI<break></break>10 fMRI<break></break>2 sMRI/fMRI</td><td align="left">1 EW<break></break>14 candidate <italic>(COMT, OXTR, NR3C1, SLC6A4, OXT, FKBP5, KLF13, BDNF)</italic></td></tr></tbody></table><table-wrap-foot><fn id="spar0015"><p><sup>†</sup>Includes studies of typical development, twin birth weight discordance, <italic>BDNF</italic> Val66 Met polymorphism, preterm birth, early life stress, attention deficit hyperactivity disorder, medial temporal lobe epilepsy.</p></fn><fn id="spar0020"><p><sup>‡</sup>Healthy adults, emotion processing, social anxiety disorder, Cushing’s syndrome.</p></fn><fn id="spar0025"><p><sup>§</sup>Estimate due to possible sample overlap within phenotypic category.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec0050">
<label>3.2</label>
<title>DNA methylation</title>
<p id="par4780">All studies used surrogate tissues to probe methylation status: blood (n = 46); saliva (n = 12); one study reported using both blood and saliva, and one reported using blood/saliva/buccal cells (<xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref>; <xref ref-type="bibr" rid="bib0315">Nikolova et al., 2014</xref>). The majority of studies did not report adjustments for cell type composition of samples used to estimate DNAm (n = 48).</p>
<p id="par4785">Forty-three studies used a candidate gene analysis approach and 17 performed an epigenome-wide association study (EWAS). The majority of included studies that used a candidate gene approach measured methylation using bisulfite pyrosequencing (n = 36). Three studies measured methylation at a candidate gene using the EpiTYPER® system (<xref ref-type="bibr" rid="bib0150">Haas et al., 2016</xref>; <xref ref-type="bibr" rid="bib0405">Shelton et al., 2017</xref>, <xref ref-type="bibr" rid="bib0400">2016</xref>). One study carried out a restriction enzyme digest and sequencing to measure DNAm at a candidate site (<xref ref-type="bibr" rid="bib0280">McMillan et al., 2015</xref>). Three studies measured DNAm using Illumina 450k arrays, and used the output to inform candidate gene DNAm-MRI analyses (<xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>; <xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>; <xref ref-type="bibr" rid="bib0480">Wiemerslage et al., 2017</xref>). Overall nineteen candidate loci were studied. <italic>SLC6A4</italic> (Na+/Cl- Dependent Serotonin Transporter) was the gene of interest in 11 studies; <italic>BDNF</italic> (member of nerve growth factor family), <italic>FKBP5</italic> (member of the immunophilin family) and <italic>OXTR</italic> (oxytocin receptor) were selected as candidate genes in four studies; <italic>NR3C1</italic> (glucocorticoid receptor) in three studies; <italic>FMR1</italic> (FMRP Translational Regulator 1), <italic>COMT</italic> (enzyme involved in catecholamine degradation) and <italic>DAT/SLC6A3</italic> (Na<sup>+</sup>/K<sup>+</sup> dependent dopamine transporter) in two studies. The following genes were selected candidates in one study: <italic>OXT</italic> (encodes oxytocin and neurophysin 1 precursor protein)<italic>, C9orf72</italic> (thought to be a transcriptional regulator in the brain), <italic>CACNA1C</italic> (voltage gated calcium channel), <italic>DRD2</italic> (dopamine receptor), <italic>KLF13</italic> (transcription regulator), <italic>NCAPH2/LMF2</italic> (encoding both a non-SMC subunit of the condensin II complex and a lipase maturation factor protein from the same locus), <italic>PPM1G</italic> (member of the PP2C family of Ser/Thr protein phosphatases), <italic>HTR3A</italic> (member of the ligand-gated ion channel receptor superfamily), <italic>SKA2</italic> (Spindle And Kinetochore Associated Complex Subunit 2), <italic>SOD</italic> (superoxide dismutase) and <italic>TESC</italic> (tescalcin – regulates cell pH by controlling H+/Na + exchange across the plasma membrane).</p>
<p id="par4790">All of the EWAS studies (n = 17) used Illumina Infinium arrays to measure DNAm: Illumina HumanMethylation27 (n = 6), Illumina 450k (n = 10), and Illumina EPIC (n = 1). These arrays measure methylation at 27 578, &gt;450 000 and &gt;850 000 CpG sites, respectively. Five studies investigated DNAm age, a method that uses a subset of CpG sites associated with age to investigate age and age acceleration (<xref ref-type="bibr" rid="bib0060">Chouliaras et al., 2018</xref>; <xref ref-type="bibr" rid="bib0080">Davis et al., 2017</xref>; <xref ref-type="bibr" rid="bib0185">Hodgson et al., 2017</xref>; <xref ref-type="bibr" rid="bib0350">Raina et al., 2017</xref>; <xref ref-type="bibr" rid="bib0495">Wolf et al., 2016</xref>).</p>
<p id="par4795">Of studies which report DNAm at candidate genes, two reported that the sample used to measure DNAm was mononuclear blood cells (lymphocytes and monocytes) (<xref ref-type="bibr" rid="bib0060">Chouliaras et al., 2018</xref>; <xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref>). None of the studies that measured DNAm by bisulfite pyrosequencing reported correction for cell type composition. 12 of the 20 studies which used Illumina arrays performed a correction for cell type composition. Only one study reported direct counting of cell types included in their samples (<xref ref-type="bibr" rid="bib0115">Freytag et al., 2017</xref>).</p>
</sec>
<sec id="sec0055">
<label>3.3</label>
<title>Magnetic resonance imaging</title>
<sec id="sec0060">
<label>3.3.1</label>
<title>MRI modalities</title>
<p id="par4800">The majority of studies used 3 T MRI scanners (n = 42); five studies used 1.5 T scanners; five included participants scanned at 1.5 T and 3 T scanners; and eight studies did not report field strength. Many included studies carried out functional MRI (n = 29), of which three studies also carried out structural analysis. Structural MRI, to investigate volumes, cortical morphology, and conventional clinical MRI measures, was used in 26 studies. Diffusion MRI to measure properties of white matter microstructure was used in nine studies, and MR angiography was used in one.</p>
</sec>
<sec id="sec0065">
<label>3.3.2</label>
<title>MRI features associated with DNAm across studies</title>
<p id="par4805"><xref ref-type="table" rid="tbl0010">Table 2</xref> shows 10 MRI features that are associated with differential DNAm in two or more studies. The image features are: hippocampal volume (n = 11); hippocampal functional connectivity/activity (n = 4); amygdala functional connectivity/activity (n = 9); PFC functional connectivity/activity (n = 8); regional FA measures (n = 6); cortical thickness (n = 6); regional diffusion metrics (AxD/MD/RD) (n = 5); global FA (n = 2); and cortical volume (n = 2). For most of these, differential DNAm occurred at different loci. However, amygdala functional connectivity/activity was associated with differential DNAm in <italic>SLC6A4</italic> in six studies, and <italic>OXTR</italic> in two studies. PFC connectivity/activity was associated with DNAm in <italic>BDNF</italic> in two studies. Hippocampal volume was associated with <italic>FKBP5</italic> DNAm in two studies. Activation within the prefrontal cortex in working memory tasks were associated with <italic>COMT</italic> DNAm in two studies. The studies all employed a candidate gene approach to DNAm analysis and directions of association were mixed across the studies.<table-wrap id="tbl0010" position="float"><label>Table 2</label><caption><p>Associations between image features and DNAm.</p></caption><alt-text id="at0015">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Image Feature<break></break>(number of studies)</th><th align="left">Differential DNAm: gene or feature</th></tr></thead><tbody><tr><td align="left">Global fractional anisotropy (n = 2)</td><td align="left">DNAm age (Horvath)<break></break>DNAm age (Hannum)</td></tr><tr><td align="left">Regional fractional anisotropy (n = 6)</td><td align="left"></td></tr><tr><td align="left"><list id="lis0005" list-type="simple"><list-item id="lsti0005"><label>•</label><p id="par0005">Corpus callosum</p></list-item></list></td><td align="left"><italic>SLC6A4</italic><break></break><italic>FMR1</italic><break></break>DNAm age (Hannum)</td></tr><tr><td align="left"><list id="lis0010" list-type="simple"><list-item id="lsti0010"><label>•</label><p id="par0010">Ventrolateral thalamus</p></list-item><list-item id="lsti0015"><label>•</label><p id="par0015">Right anterior corona radiata</p></list-item><list-item id="lsti0020"><label>•</label><p id="par0020">Right parahippocampal cingulum</p></list-item></list></td><td align="left"><italic>SMOC2</italic><break></break><italic>BDNF</italic><break></break><italic>TESC</italic></td></tr><tr><td align="left">Regional radial, mean or axial diffusivity (n = 5)<list id="lis0015" list-type="simple"><list-item id="lsti0025"><label>•</label><p id="par0025">Inferior and middle cerebellar peduncle</p></list-item><list-item id="lsti0030"><label>•</label><p id="par0030">Corpus Callosum</p></list-item><list-item id="lsti0035"><label>•</label><p id="par0035">Right anterior corona radiata</p></list-item><list-item id="lsti0040"><label>•</label><p id="par0040">Right parahippocampal cingulum</p></list-item></list></td><td align="left"><italic>FMR1</italic><break></break>DNAm age (Hannum)<break></break><italic>SLC6A4</italic><break></break><italic>BDNF</italic><break></break><italic>TESC</italic></td></tr><tr><td align="left">Amygdala functional connectivity<break></break>(n = 9)</td><td align="left"><italic>SLC6A4</italic><break></break><italic>SLC6A4</italic><break></break><italic>SLC6A4</italic><break></break><italic>SLC6A3/DAT</italic><break></break><italic>SLC6A4</italic><break></break><italic>OXTR</italic><break></break><italic>OXTR</italic><break></break><italic>SLC6A4</italic><break></break><italic>SLC6A4</italic></td></tr><tr><td align="left">Hippocampal functional connectivity<break></break>(n = 4)</td><td align="left"><italic>SLC6A4</italic><break></break>Cluster of genes identified through EWAS (<xref ref-type="bibr" rid="bib0475">Wang et al., 2017</xref>)*<break></break>Cluster of genes identified through EWAS (<xref ref-type="bibr" rid="bib0200">Hu et al., 2018</xref>)*<break></break><italic>BDNF</italic></td></tr><tr><td align="left">Prefrontal cortex functional connectivity<break></break>(n = 8)</td><td align="left"><italic>FKBP5</italic><break></break><italic>MB-COMT</italic><break></break><italic>BDNF</italic><break></break><italic>NR3C1</italic><break></break><italic>HTR3A</italic><break></break><italic>COMT</italic><break></break><italic>SLC6A4</italic><break></break><italic>BDNF</italic></td></tr><tr><td align="left">Hippocampal volume<break></break>(n = 11)</td><td align="left"><italic>BDNF</italic><break></break><italic>SLC6A4</italic><break></break><italic>TESC</italic><break></break>DNAm age (Horvath)<break></break>Cluster of genes identified through EWAS (<xref ref-type="bibr" rid="bib0170">Hass et al., 2015</xref>)*<break></break><italic>OXTR</italic><break></break>DNAm age (Hannum)<break></break><italic>FKBP5</italic><break></break><italic>NR3C1-1F</italic><break></break><italic>SLC6A4</italic><break></break><italic>FKBP5</italic></td></tr><tr><td align="left">Cortical volume<break></break>(n = 2)</td><td align="left">Cluster of genes identified through EWAS (<xref ref-type="bibr" rid="bib0040">Casey et al., 2017</xref>)*<break></break>Cluster of genes identified through EWAS (<xref ref-type="bibr" rid="bib0255">Liu et al., 2015</xref>)*</td></tr><tr><td align="left">Cortical thickness<break></break>(n = 6)</td><td align="left"><italic>SLC6A4</italic><break></break><italic>BDNF</italic><break></break><italic>FKBP5</italic><break></break><italic>FMR1</italic><break></break><italic>SKA2</italic><break></break>Independent component of DNAm (<xref ref-type="bibr" rid="bib0115">Freytag et al., 2017</xref>)</td></tr><tr><td align="left">PFC (volume/thickness)<break></break>(n = 2)</td><td align="left"><italic>OXTR</italic><break></break><italic>SKA2</italic></td></tr></tbody></table><table-wrap-foot><fn><p>*See <xref ref-type="table" rid="tbl0015">Table 3</xref>, <xref ref-type="table" rid="tbl0020">Table 4</xref>, <xref ref-type="table" rid="tbl0025">Table 5</xref>, <xref ref-type="table" rid="tbl0030">Table 6</xref>, <xref ref-type="table" rid="tbl0035">Table 7</xref>, <xref ref-type="table" rid="tbl0040">Table 8</xref>, <xref ref-type="table" rid="tbl0045">Table 9</xref> for list of genes included in clusters identified by EWAS.</p></fn></table-wrap-foot></table-wrap></p>
<p id="par4810">Six studies tested an association between <italic>SLC6A4</italic> methylation and amygdala reactivity. Four out of five studies that reported associations between <italic>SLC6A4</italic> methylation and the emotional face processing task assessed by fMRI in response to threat stimuli found positive associations with amygdala reactivity and connectivity (<xref ref-type="bibr" rid="bib0210">Ismaylova et al., 2018</xref>; <xref ref-type="bibr" rid="bib0315">Nikolova et al., 2014</xref>; <xref ref-type="bibr" rid="bib0395">Schneider et al., 2018</xref>; <xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref>). One study investigated resting state functional connectivity and reported a positive association between <italic>SLC6A4</italic> methylation and amygdala coupling with the salience network (<xref ref-type="bibr" rid="bib0295">Muehlhan et al., 2015</xref>). However, in a further study that investigated <italic>SLC6A4</italic> methylation and brain activity in the context of both resting state connectivity and the emotional face processing task, there were no significant associations reported with regard to the amygdala either with regards to whole brain analysis or amygdala region-of-interest analysis (<xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref>). The sixth study that reported an association between <italic>SLC6A4</italic> and amygdala connectivity was also task-based fMRI, and used a visual emotional attention shifting paradigm (<xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref>). These papers assessed DNAm within the promoter region of the <italic>SLC6A4</italic> gene, with the exception of <xref ref-type="bibr" rid="bib0395">Schneider et al., 2018</xref>, where a retrotransposon element, AluJb, was studied.</p>
<p id="par4815">Two studies reported significant associations between <italic>OXTR</italic> methylation and amygdala connectivity (<xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref>; <xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>). Each study used a different fMRI task paradigm: the first used a task employing words involving social phobia relevant verbal stimuli in a cohort of patients with social anxiety disorder (<xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>); and the second used an emotional face- matching block-design task in a group of healthy study participants (<xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref>). Both studies measured DNAm in blood but each targeted a different region of the <italic>OXTR</italic> gene in bisulfite sequencing. <xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref> targeted exon 3 of the <italic>OXTR</italic> gene due to previous work demonstrating an association between methylation in this region and social cognition (<xref ref-type="bibr" rid="bib0445">Unternaehrer et al., 2012</xref>; <xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>). <xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref> targeted a single CpG site at position -934 relative to the transcription start site, where methylation had previously been associated with autism spectrum disorder (<xref ref-type="bibr" rid="bib0140">Gregory et al., 2009</xref>; <xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref>). The directions of associations reported in these two studies were mixed, and may be explained by the variations in study design and participant characteristics.</p>
<p id="par4820">Two studies reported significant associations between <italic>BDNF</italic> methylation and PFC functional connectivity (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>; <xref ref-type="bibr" rid="bib0455">Ursini et al., 2016</xref>). Moser et al. performed DNAm-MRI analysis in a combined group of analysis of study participants with PTSD, sub-threshold PTSD and healthy control women, and assessed neural response to a Modified Crowell Procedure (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>). The second study reported <italic>BDNF</italic> DNAm associations with PFC activity during a working memory task in a healthy group of study participants (<xref ref-type="bibr" rid="bib0455">Ursini et al., 2016</xref>). Both of these studies measured DNAm at different regions of the <italic>BDNF</italic> gene. <xref ref-type="bibr" rid="bib0455">Ursini et al., 2016</xref> measured <italic>BDNF</italic> DNAm in blood at a region containing the rs6265 SNP, which lies in a coding region of the gene, which may interact with environmental factors to modulate risk for schizophrenia, while <xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref> measured <italic>BDNF</italic> promoter DNAm in saliva, where methylation has been associated with trauma associated psychiatric disease in children (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>; <xref ref-type="bibr" rid="bib0455">Ursini et al., 2016</xref>). The directions of associations reported in these studies were mixed.</p>
<p id="par4825">Two studies reported associations between <italic>FKBP5</italic> methylation and hippocampal volume (<xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref>; <xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref>). In study participants with childhood trauma related PTSD there was a negative correlation between <italic>FKBP5</italic> methylation in blood and right hippocampal head volume (<xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref>). In patients with Cushing’s syndrome there was a positive association between <italic>FKBP5</italic> methylation in blood and bilateral hippocampal volume (<xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref>). Both of these studies measured DNAm at glucocorticoid responsive regions of the <italic>FKBP5</italic> gene, but report significant associations in different regions. <xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref> reported significant associations with intron 7, while <xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref> reports a significant association with a CpG site within intron 2 (<xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref>; <xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref>).</p>
<p id="par4830">Two studies reported associations between <italic>COMT</italic> DNAm and PFC activation during working memory tasks (<xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref>; <xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>). The two studies assessed brain activity during different working memory tasks: the <italic>n</italic>-back task (<xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref>); and the Sternberg Item Recognition task (<xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>). The <italic>COMT</italic> gene encodes two isoforms of the catechol-O-methyltransferase enzyme: one soluble and one membrane bound, each with their own promoters, with the membrane bound isoform being the form most commonly found in the brain. Positive associations between <italic>MB-COMT</italic> promoter DNAm in blood and activity in the left dlPFC and vlPFC (Broca’s area 45) during the Sternberg Item Recognition task were found in a group of participants including healthy controls and schizophrenia patients (<xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>). In the second study of healthy participants significant negative associations were reported between methylation at <italic>COMT</italic> rs4680 SNP in blood and activity in the bilateral PFC (BA 45/14 and BA47) during the <italic>n</italic>-back task in participants homozygous for the Val/Val allele at the rs4680 <italic>COMT</italic> SNP (<xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref>). The difference in direction of associations reported by these two studies may be explained by the variations in study design and participant characteristics.</p>
</sec>
</sec>
<sec id="sec0070">
<label>3.4</label>
<title>Associations between DNAm and MRI features categorised by phenotype</title>
<sec id="sec0075">
<label>3.4.1</label>
<title>Neurodevelopment and neurodevelopmental disorders</title>
<p id="par4835"><xref ref-type="table" rid="tbl0015">Table 3</xref> summarises eight studies that focused on neurodevelopment: typical development; the impact of early life stress on young adulthood; <italic>BDNF</italic> polymorphism in early life; ADHD; preterm brain injury; hippocampal sclerosis in mesial temporal lobe epilepsy; birthweight discordance between twins and its impact on cortical anatomy. Four of the eight studies included a comparison group, and four were case series. Two studies report data from the Growing up towards Healthy Outcomes in Singapore (GUSTO) cohort study (<xref ref-type="bibr" rid="bib0045">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>).<table-wrap id="tbl0015" position="float"><label>Table 3</label><caption><p>Neurodevelopment and neurodevelopmental disorders.</p></caption><alt-text id="at0020">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0020" list-type="simple"><list-item id="lsti0045"><label>•</label><p id="par0045">Condition</p></list-item><list-item id="lsti0050"><label>•</label><p id="par0050">Cases (male); controls (male)</p></list-item><list-item id="lsti0055"><label>•</label><p id="par0055">Age</p></list-item></list></th><th align="left"><list id="lis0025" list-type="simple"><list-item id="lsti0060"><label>•</label><p id="par0060">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti0065"><label>•</label><p id="par0065">Tissue sampled</p></list-item><list-item id="lsti0070"><label>•</label><p id="par0070">Correction for cell sub-type distribution</p></list-item><list-item id="lsti0075"><label>•</label><p id="par0075">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0030" list-type="simple"><list-item id="lsti0080"><label>•</label><p id="par0080">MRI field strength</p></list-item><list-item id="lsti0085"><label>•</label><p id="par0085">Modality</p></list-item><list-item id="lsti0090"><label>•</label><p id="par0090">Image feature(s)</p></list-item><list-item id="lsti0095"><label>•</label><p id="par0095">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left"><xref ref-type="bibr" rid="bib0045">Chen et al., 2015</xref><break></break>Singapore †</td><td align="left"><list id="lis0035" list-type="simple"><list-item id="lsti0100"><label>•</label><p id="par0100"><italic>BDNF</italic> Val66 Met polymorphism in GUSTO study</p></list-item><list-item id="lsti0105"><label>•</label><p id="par0105">237 cases (133 M)</p></list-item><list-item id="lsti0110"><label>•</label><p id="par0110">Mean gestational age 38.7 weeks</p></list-item></list></td><td align="left"><list id="lis0040" list-type="simple"><list-item id="lsti0115"><label>•</label><p id="par0115">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0120"><label>•</label><p id="par0120">Umbilical cord blood</p></list-item><list-item id="lsti0125"><label>•</label><p id="par0125">Cell type composition: NR</p></list-item><list-item id="lsti0130"><label>•</label><p id="par0130">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0045" list-type="simple"><list-item id="lsti0135"><label>•</label><p id="par0135">1.5 T</p></list-item><list-item id="lsti0140"><label>•</label><p id="par0140">Structural, T2</p></list-item><list-item id="lsti0145"><label>•</label><p id="par0145">Volume of total brain and 18 ROIs</p></list-item><list-item id="lsti0150"><label>•</label><p id="par0150">MRF model segmentation</p></list-item></list></td><td align="left"><list id="lis0050" list-type="simple"><list-item id="lsti0155"><label>•</label><p id="par0155">19 % of total variable CpGs were significantly associated with the volume of the left hippocampus for Val/Val neonates.</p></list-item><list-item id="lsti0160"><label>•</label><p id="par0160">5% of total variable CpGs were associated with left hippocampal volume in the Met/Val genotype group</p></list-item><list-item id="lsti0165"><label>•</label><p id="par0165">3% of total variable CpGs were significant in the Met/Met genotype group.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0330">Park et al., 2015</xref><break></break>South Korea</td><td align="left"><list id="lis0055" list-type="simple"><list-item id="lsti0170"><label>•</label><p id="par0170">ADHD</p></list-item><list-item id="lsti0175"><label>•</label><p id="par0175">102 participants (77 M)</p></list-item><list-item id="lsti0180"><label>•</label><p id="par0180">Mean age 8.9 years</p></list-item></list></td><td align="left"><list id="lis0060" list-type="simple"><list-item id="lsti0185"><label>•</label><p id="par0185">Candidate: <italic>SLC6A4</italic> - promoter (185bp region)</p></list-item><list-item id="lsti0190"><label>•</label><p id="par0190">Blood</p></list-item><list-item id="lsti0195"><label>•</label><p id="par0195">Cell type composition: NR</p></list-item><list-item id="lsti0200"><label>•</label><p id="par0200">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0065" list-type="simple"><list-item id="lsti0205"><label>•</label><p id="par0205">3 T</p></list-item><list-item id="lsti0210"><label>•</label><p id="par0210">Structural, T1</p></list-item><list-item id="lsti0215"><label>•</label><p id="par0215">Cortical thickness</p></list-item><list-item id="lsti0220"><label>•</label><p id="par0220">CLASP algorithm (<xref ref-type="bibr" rid="bib0230">Kim et al., 2005</xref>)</p></list-item></list></td><td align="left"><list id="lis0070" list-type="simple"><list-item id="lsti0225"><label>•</label><p id="par0225">Negative association between DNAm of <italic>SLC6A4</italic> CpGs 5-8 in the promoter region and cortical thickness in the right STG, middle occipital gyrus, lingual gyrus, inferior occipital gyrus, precentral gyrus, MTG, cuneus, and cingulate gyrus.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0425">Sparrow et al., 2016</xref><break></break>United Kingdom</td><td align="left"><list id="lis0075" list-type="simple"><list-item id="lsti0230"><label>•</label><p id="par0230">Preterm birth</p></list-item><list-item id="lsti0235"><label>•</label><p id="par0235">36 preterm infants (&lt;32 weeks’ gestation); 36 term controls</p></list-item><list-item id="lsti0240"><label>•</label><p id="par0240">Mean age at assessment: 39.7 weeks for controls and; 40.0 weeks for cases</p></list-item></list></td><td align="left"><list id="lis0080" list-type="simple"><list-item id="lsti0245"><label>•</label><p id="par0245">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0250"><label>•</label><p id="par0250">Saliva</p></list-item><list-item id="lsti0255"><label>•</label><p id="par0255">Cell type composition: no</p></list-item><list-item id="lsti0260"><label>•</label><p id="par0260">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0085" list-type="simple"><list-item id="lsti0265"><label>•</label><p id="par0265">3 T</p></list-item><list-item id="lsti0270"><label>•</label><p id="par0270">Diffusion</p></list-item><list-item id="lsti0275"><label>•</label><p id="par0275">Tract shape in 8 major tracts.</p></list-item><list-item id="lsti0280"><label>•</label><p id="par0280">Probabilistic Neighbourhood Tractography (PNT)</p></list-item></list></td><td align="left"><list id="lis0090" list-type="simple"><list-item id="lsti0285"><label>•</label><p id="par0285">95 % of the variance in the preterm methylome was explained by 23 principal components; the 6<sup>th</sup> principal component explained 2.9 % of the variance of DNAm data in the preterm group and was associated with right CST topology.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0040">Casey et al., 2017</xref><break></break>Canada</td><td align="left"><list id="lis0095" list-type="simple"><list-item id="lsti0290"><label>•</label><p id="par0290">Cortical anatomy in monozygotic twin cohort</p></list-item><list-item id="lsti0295"><label>•</label><p id="par0295">52 twin pairs (22 M)</p></list-item><list-item id="lsti0300"><label>•</label><p id="par0300">Mean age 15.7 years</p></list-item></list></td><td align="left"><list id="lis0100" list-type="simple"><list-item id="lsti0305"><label>•</label><p id="par0305">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0310"><label>•</label><p id="par0310">Saliva</p></list-item><list-item id="lsti0315"><label>•</label><p id="par0315">Cell type composition: yes</p></list-item><list-item id="lsti0320"><label>•</label><p id="par0320">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0105" list-type="simple"><list-item id="lsti0325"><label>•</label><p id="par0325">3 T</p></list-item><list-item id="lsti0330"><label>•</label><p id="par0330">Structural, T1</p></list-item><list-item id="lsti0335"><label>•</label><p id="par0335">Cortical thickness, surface area, volume</p></list-item><list-item id="lsti0340"><label>•</label><p id="par0340">CIVET automated analysis pipeline</p></list-item></list></td><td align="left"><list id="lis0110" list-type="simple"><list-item id="lsti0345"><label>•</label><p id="par0345">23 probes mediate the relationship between birthweight discordance and cortical volume, including annotated probes found in 13 genes: <italic>PRPF3, RELN, EXOC2, LEFTY2, CAST, SNK1G2, TRIM5, ABR, TNF, C6orf10, FREM2, GABPA</italic> and <italic>EFNA5</italic>; 15 probes mediate the relationship between birthweight discordance and cortical surface area, including annotated probes found in 9 genes: <italic>TMCO3, TRIM15, KDM2A, EPDR1, PARP14, PBLD, RELN, ACACA</italic> and <italic>CASZ1.</italic></p></list-item><list-item id="lsti0350"><label>•</label><p id="par0350">No probes significantly mediated the relationship between birthweight discordance and cortical thickness discordance.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0260">Long et al., 2017</xref><break></break>China<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0115" list-type="simple"><list-item id="lsti0355"><label>•</label><p id="par0355">HS in MTLE</p></list-item><list-item id="lsti0360"><label>•</label><p id="par0360">Cases n = 30 (18 M); controls n = 30 (18 M)</p></list-item><list-item id="lsti0365"><label>•</label><p id="par0365">Cases mean 25.3 years; controls mean 28.2 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0120" list-type="simple"><list-item id="lsti0370"><label>•</label><p id="par0370">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0375"><label>•</label><p id="par0375">Blood</p></list-item><list-item id="lsti0380"><label>•</label><p id="par0380">Cell type composition: NR</p></list-item><list-item id="lsti0385"><label>•</label><p id="par0385">Consideration of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0125" list-type="simple"><list-item id="lsti0390"><label>•</label><p id="par0390">Image acquisition: NR</p></list-item><list-item id="lsti0395"><label>•</label><p id="par0395">Hippocampal sclerosis on conventional MRI</p></list-item></list><hr/></td><td align="left">Subgroup analysis: MTLE patients with (n = 9) or without HS (n = 14).</td></tr><tr><td align="left"><list id="lis0130" list-type="simple"><list-item id="lsti0400"><label>•</label><p id="par0400">From top 10 differentially methylated probes: DNAm in <italic>SLC12A7, SRC</italic>, <italic>PLIN5</italic> had a positive association with HS; DNAm in <italic>PCNT, CEACAM21, PCGF3, BAT2</italic> displayed a negative association with HS.</p></list-item><list-item id="lsti0405"><label>•</label><p id="par0405">Genes from top 10 positively associated with HS: <italic>RASAL3</italic>, <italic>PFDN6:WDR46</italic>, <italic>UBN1:GLYR1</italic>, <italic>TRIM49</italic>, <italic>ACVR1B</italic>.</p></list-item><list-item id="lsti0410"><label>•</label><p id="par0410">Genes from the top 10 negatively associated with HS: <italic>SPIRE2</italic>, <italic>NKD1</italic>, <italic>TNFRSF11B</italic></p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0165">Harms et al., 2017</xref><break></break>United States</td><td align="left"><list id="lis0135" list-type="simple"><list-item id="lsti0415"><label>•</label><p id="par0415">Early life stress exposure on adult outcome</p></list-item><list-item id="lsti0420"><label>•</label><p id="par0420">33 participants (15 M)</p></list-item><list-item id="lsti0425"><label>•</label><p id="par0425">Mean age 20.5 years</p></list-item></list></td><td align="left"><list id="lis0140" list-type="simple"><list-item id="lsti0430"><label>•</label><p id="par0430">Candidate: <italic>FKBP5</italic> - CpG sites in intron 7, 5, and 2</p></list-item><list-item id="lsti0435"><label>•</label><p id="par0435">Saliva</p></list-item><list-item id="lsti0440"><label>•</label><p id="par0440">Cell type composition: NR</p></list-item><list-item id="lsti0445"><label>•</label><p id="par0445">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0145" list-type="simple"><list-item id="lsti0450"><label>•</label><p id="par0450">3 T</p></list-item><list-item id="lsti0455"><label>•</label><p id="par0455">fMRI task: go-no go task</p></list-item><list-item id="lsti0460"><label>•</label><p id="par0460">dlPFC activation</p></list-item><list-item id="lsti0465"><label>•</label><p id="par0465">Analysis of Functional NeuroImages</p></list-item></list></td><td align="left"><list id="lis0150" list-type="simple"><list-item id="lsti0470"><label>•</label><p id="par0470">Negative association between DNAm of intron 5 of FKBP5 and activation in the dlPFC in the go no-go task.</p></list-item><list-item id="lsti0475"><label>•</label><p id="par0475">CpG8 of intron 5 mediates the relationship between childhood stress and dlPFC activation.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0050">Chen et al., 2018</xref><break></break>United States<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0155" list-type="simple"><list-item id="lsti0480"><label>•</label><p id="par0480">ADHD</p></list-item><list-item id="lsti0485"><label>•</label><p id="par0485">15 monozygotic twin pairs (12 M), discordant for ADHD</p></list-item><list-item id="lsti0490"><label>•</label><p id="par0490">Mean 9.7 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0160" list-type="simple"><list-item id="lsti0495"><label>•</label><p id="par0495">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0500"><label>•</label><p id="par0500">Blood</p></list-item><list-item id="lsti0505"><label>•</label><p id="par0505">Cell type composition: yes</p></list-item><list-item id="lsti0510"><label>•</label><p id="par0510">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0165" list-type="simple"><list-item id="lsti0515"><label>•</label><p id="par0515">1.5 T</p></list-item><list-item id="lsti0520"><label>•</label><p id="par0520">Structural, T1</p></list-item><list-item id="lsti0525"><label>•</label><p id="par0525">Cerebral cortex, cerebellum, caudate, putamen, thalamus volumes</p></list-item><list-item id="lsti0530"><label>•</label><p id="par0530">FreeSurfer</p></list-item></list><hr/></td><td align="left">Subset of 14 MZ twins:</td></tr><tr><td align="left">Of the 67 genes with intrapair probe DNAm which associated with volume discordance in the cerebellum, 49 were negatively associated. Of the 48 genes associated with the striatum, 38 were negatively associated, while of the 78 associated with the thalamus 44 were negatively associated.</td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref><break></break>Singapore †</td><td align="left"><list id="lis0170" list-type="simple"><list-item id="lsti0535"><label>•</label><p id="par0535">GUSTO birth cohort</p></list-item><list-item id="lsti0540"><label>•</label><p id="par0540">114 participants</p></list-item><list-item id="lsti0545"><label>•</label><p id="par0545">7-10 days post birth</p></list-item></list></td><td align="left"><list id="lis0175" list-type="simple"><list-item id="lsti0550"><label>•</label><p id="par0550">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti0555"><label>•</label><p id="par0555">Umbilical cord blood</p></list-item><list-item id="lsti0560"><label>•</label><p id="par0560">Cell type composition: yes</p></list-item><list-item id="lsti0565"><label>•</label><p id="par0565">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0180" list-type="simple"><list-item id="lsti0570"><label>•</label><p id="par0570">1.5 T,</p></list-item><list-item id="lsti0575"><label>•</label><p id="par0575">Diffusion</p></list-item><list-item id="lsti0580"><label>•</label><p id="par0580">FA</p></list-item><list-item id="lsti0585"><label>•</label><p id="par0585">Voxel based comparison of FA maps</p></list-item></list></td><td align="left">EWAS a significant association between probe cg19641625 in the <italic>SMOC2</italic> gene locus, with FA in the left vlThalamus.</td></tr></tbody></table><table-wrap-foot><fn><p><sup>†</sup> Overlapping cohorts (GUSTO study).</p></fn></table-wrap-foot></table-wrap></p>
<p id="par4840">Two studies used a candidate gene approach and both reported positive associations, but between different MRI features and different genes: the first between DNAm at the <italic>SLC6A4</italic> promoter and cortical thickness in an uncontrolled case series of 102 children with ADHD (<xref ref-type="bibr" rid="bib0330">Park et al., 2015</xref>); and the second between DNAm at <italic>FKBP5</italic> introns and dlPFC activation during the go no-go task in a case series of young adults with a history of early life stress exposure (<xref ref-type="bibr" rid="bib0165">Harms et al., 2017</xref>). The remaining six studies used the Illumina 450k array to measure DNAm, and all reported significant associations between DNAm at multiple loci and features including fractional anisotropy (FA), sub-cortical ROI volumes, cortical thickness, volume and surface area (<xref ref-type="bibr" rid="bib0040">Casey et al., 2017</xref>; <xref ref-type="bibr" rid="bib0045">Chen et al., 2015</xref>, <xref ref-type="bibr" rid="bib0050">2018</xref>; <xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>; <xref ref-type="bibr" rid="bib0260">Long et al., 2017</xref>; <xref ref-type="bibr" rid="bib0425">Sparrow et al., 2016</xref>). Two studies reported associations between DNAm at <italic>SMOC2</italic> and MRI brain imaging features (<xref ref-type="bibr" rid="bib0050">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>). <xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref> performed an EWAS in neonates and report an association between DNAm at this gene and FA in the left ventrolateral thalamus (<xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>). <xref ref-type="bibr" rid="bib0050">Chen et al., 2018</xref> reported differential methylation and discordance in twin pairs discordant for ADHD diagnosis, and identified six probes associated with the <italic>SMOC2</italic> gene which were differentially methylated and were associated with differences in striatum (among 48 probes that were differentially methylated with regard to striatum volume) (Chen et al., 2018). <italic>SMOC2</italic> encodes SPARC-related modular calcium binding protein 2.</p>
<p id="par4845">Two studies reported an association between neonatal water diffusion properties and DNAm (<xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>; <xref ref-type="bibr" rid="bib0425">Sparrow et al., 2016</xref>). In a case control study of preterm infants and term born controls principal component analysis of saliva DNAm identified a component that was associated with shape of the right corticospinal tract (<xref ref-type="bibr" rid="bib0425">Sparrow et al., 2016</xref>); and in neonates from the GUSTO cohort study there was an association between umbilical cord blood DNAm at the <italic>SMOC2</italic> gene and FA in the left ventrolateral thalamus (<xref ref-type="bibr" rid="bib0145">Guillaume et al., 2018</xref>).</p>
</sec>
<sec id="sec0080">
<label>3.4.2</label>
<title>Major depressive disorder (MDD) and suicidality</title>
<p id="par4850"><xref ref-type="table" rid="tbl0020">Table 4</xref> describes 10 studies of MDD and 1 of suicidality. Seven studies had overlapping participants: five have some overlapping participants from an outpatient psychiatric clinic of Korea University Anam Hospital and community controls (<xref ref-type="bibr" rid="bib0055">Choi et al., 2015</xref>; <xref ref-type="bibr" rid="bib0155">Han et al., 2017a</xref>, <xref ref-type="bibr" rid="bib0160">b</xref>; <xref ref-type="bibr" rid="bib0305">Na et al., 2016</xref>; <xref ref-type="bibr" rid="bib0500">Won et al., 2016</xref>); and two other studies had overlapping participants (<xref ref-type="bibr" rid="bib0025">Booij et al., 2015</xref>; <xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref>). Nine studies included a comparator group and 2 were case series of individuals with familial risk for MDD.<table-wrap id="tbl0020" position="float"><label>Table 4</label><caption><p>Major depressive disorder and suicidality.</p></caption><alt-text id="at0025">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0185" list-type="simple"><list-item id="lsti0590"><label>•</label><p id="par0590">Condition</p></list-item><list-item id="lsti0595"><label>•</label><p id="par0595">Cases (male); controls (male)</p></list-item><list-item id="lsti0600"><label>•</label><p id="par0600">Age</p></list-item></list></th><th align="left"><list id="lis0190" list-type="simple"><list-item id="lsti0605"><label>•</label><p id="par0605">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti0610"><label>•</label><p id="par0610">Tissue sampled</p></list-item><list-item id="lsti0615"><label>•</label><p id="par0615">Correction for cell sub-type distribution</p></list-item><list-item id="lsti0620"><label>•</label><p id="par0620">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0195" list-type="simple"><list-item id="lsti0625"><label>•</label><p id="par0625">MRI field strength</p></list-item><list-item id="lsti0630"><label>•</label><p id="par0630">Modality</p></list-item><list-item id="lsti0635"><label>•</label><p id="par0635">Image feature(s)</p></list-item><list-item id="lsti0640"><label>•</label><p id="par0640">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left"><xref ref-type="bibr" rid="bib0055">Choi et al., 2015</xref><break></break>South Korea †</td><td align="left"><list id="lis0200" list-type="simple"><list-item id="lsti0645"><label>•</label><p id="par0645">MDD</p></list-item><list-item id="lsti0650"><label>•</label><p id="par0650">Cases, n = 60 (13 M); controls, n = 53 (17 M)</p></list-item><list-item id="lsti0655"><label>•</label><p id="par0655">Cases, mean 41.9 years; controls, mean 41.2 years</p></list-item></list></td><td align="left"><list id="lis0205" list-type="simple"><list-item id="lsti0660"><label>•</label><p id="par0660">Candidate: <italic>BDNF-</italic> 4 CpGs in the promoter region</p></list-item><list-item id="lsti0665"><label>•</label><p id="par0665">Blood</p></list-item><list-item id="lsti0670"><label>•</label><p id="par0670">Cell type composition: NR</p></list-item><list-item id="lsti0675"><label>•</label><p id="par0675">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0210" list-type="simple"><list-item id="lsti0680"><label>•</label><p id="par0680">3 T</p></list-item><list-item id="lsti0685"><label>•</label><p id="par0685">Diffusion</p></list-item><list-item id="lsti0690"><label>•</label><p id="par0690">FA/RD/AxD of 7 white matter tracts</p></list-item><list-item id="lsti0695"><label>•</label><p id="par0695">Tract Based Spatial Statistics (TBSS)</p></list-item></list></td><td align="left"><list id="lis0215" list-type="simple"><list-item id="lsti0700"><label>•</label><p id="par0700">Cases: negative association between DNAm of CpG4 and FA of the right ACR, AxD of right ACR is negatively associated with <italic>BDNF</italic> DNAm. RD was not significantly associated with <italic>BDNF</italic> DNAm.</p></list-item><list-item id="lsti0705"><label>•</label><p id="par0705">Controls: no significant positive associations.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0025">Booij et al., 2015</xref><break></break>Republic of Ireland ‡</td><td align="left"><list id="lis0220" list-type="simple"><list-item id="lsti0710"><label>•</label><p id="par0710">MDD</p></list-item><list-item id="lsti0715"><label>•</label><p id="par0715">Cases, n = 33 (10 M); controls, n = 36 (15 M)</p></list-item><list-item id="lsti0720"><label>•</label><p id="par0720">Cases, mean 40.3 years; controls, mean 35.3 years</p></list-item></list></td><td align="left"><list id="lis0225" list-type="simple"><list-item id="lsti0725"><label>•</label><p id="par0725">Candidate: <italic>SLC6A4-</italic> CpGs 5-15 found 214–625 bp upstream of the gene promoter</p></list-item><list-item id="lsti0730"><label>•</label><p id="par0730">Blood</p></list-item><list-item id="lsti0735"><label>•</label><p id="par0735">Cell type composition: NR</p></list-item><list-item id="lsti0740"><label>•</label><p id="par0740">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0230" list-type="simple"><list-item id="lsti0745"><label>•</label><p id="par0745">3 T</p></list-item><list-item id="lsti0750"><label>•</label><p id="par0750">Structural, T1</p></list-item><list-item id="lsti0755"><label>•</label><p id="par0755">Whole hippocampal and sub-hippocampal volumes</p></list-item><list-item id="lsti0760"><label>•</label><p id="par0760">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0235" list-type="simple"><list-item id="lsti0765"><label>•</label><p id="par0765">Whole group: negative predictive value of hippocampal volume and sub-volumes (CA2/3 and DG, and CA1) and <italic>SLC6A4</italic> DNAm (average and site specific – CpG 5&amp;6, CpG 11&amp;12)</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref><break></break>Republic of Ireland ‡</td><td align="left"><list id="lis0240" list-type="simple"><list-item id="lsti0770"><label>•</label><p id="par0770">MDD</p></list-item><list-item id="lsti0775"><label>•</label><p id="par0775">Cases, n = 25(7 M); controls, n = 35(13 M)</p></list-item><list-item id="lsti0780"><label>•</label><p id="par0780">Cases, mean 41.6 years; controls, mean 35.6</p></list-item></list></td><td align="left"><list id="lis0245" list-type="simple"><list-item id="lsti0785"><label>•</label><p id="par0785">Candidate: <italic>SLC6A4-</italic>promoter</p></list-item><list-item id="lsti0790"><label>•</label><p id="par0790">Blood</p></list-item><list-item id="lsti0795"><label>•</label><p id="par0795">Cell type composition: NR</p></list-item><list-item id="lsti0800"><label>•</label><p id="par0800">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0250" list-type="simple"><list-item id="lsti0805"><label>•</label><p id="par0805">3 T</p></list-item><list-item id="lsti0810"><label>•</label><p id="par0810">fMRI task: Visual emotional attention shifting</p></list-item><list-item id="lsti0815"><label>•</label><p id="par0815">Whole brain</p></list-item><list-item id="lsti0820"><label>•</label><p id="par0820">SPM8</p></list-item></list></td><td align="left"><list id="lis0255" list-type="simple"><list-item id="lsti0825"><label>•</label><p id="par0825">Whole group: when shifting from emotional valence to geometric properties there is a negative association between DNAm and activation in the right Rolandic operculum and insula, right superior temporal lobe, and pons; when shifting from negative to neutral emotional valence, there is positive association between DNAm and activation in the left anterior insula and inferior frontal operculum</p></list-item><list-item id="lsti0830"><label>•</label><p id="par0830">Controls: When looking at emotionally negative stimuli versus neutral stimuli, there was a positive association between DNAm and more activation in the bilateral hippocampus, left inferior operculum, fusiform gyrus and amygdala regions.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0305">Na et al., 2016</xref><break></break>South Korea †</td><td align="left"><list id="lis0260" list-type="simple"><list-item id="lsti0835"><label>•</label><p id="par0835">MDD</p></list-item><list-item id="lsti0840"><label>•</label><p id="par0840">Cases, n = 65 (11 M); controls, n = 65 (15 M)</p></list-item><list-item id="lsti0845"><label>•</label><p id="par0845">Cases, mean 42.5 years; controls mean 40.3 years</p></list-item></list></td><td align="left"><list id="lis0265" list-type="simple"><list-item id="lsti0850"><label>•</label><p id="par0850">Candidate: <italic>BDNF</italic> - 4 CpGs in the promoter region</p></list-item><list-item id="lsti0855"><label>•</label><p id="par0855">Blood</p></list-item><list-item id="lsti0860"><label>•</label><p id="par0860">Cell type composition: NR</p></list-item><list-item id="lsti0865"><label>•</label><p id="par0865">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0270" list-type="simple"><list-item id="lsti0870"><label>•</label><p id="par0870">3 T</p></list-item><list-item id="lsti0875"><label>•</label><p id="par0875">Structural, T1</p></list-item><list-item id="lsti0880"><label>•</label><p id="par0880">Cortical thickness</p></list-item><list-item id="lsti0885"><label>•</label><p id="par0885">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0275" list-type="simple"><list-item id="lsti0890"><label>•</label><p id="par0890">Cases: negative association between CpG2/4 and cortical thickness in the right rostral middle frontal, mOFC cortical thicknesses and left lingual, STG and SFG cortices. Negative association between CpG2 and cortical thickness in the right IT and pericalcarine and left rostral middle frontal cortices. Negative association between CpG4 and cortical thickness in the right cuneus, precuneus and post central cortices and left frontal pole cortices.</p></list-item><list-item id="lsti0895"><label>•</label><p id="par0895">Controls: no significant associations found.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0500">Won et al., 2016</xref><break></break>South Korea †</td><td align="left"><list id="lis0280" list-type="simple"><list-item id="lsti0900"><label>•</label><p id="par0900">MDD</p></list-item><list-item id="lsti0905"><label>•</label><p id="par0905">Cases, n = 35 (10 M); controls, n = 49 (15 M)</p></list-item><list-item id="lsti0910"><label>•</label><p id="par0910">Cases, mean 40.3 years; controls mean 41.1 years</p></list-item></list></td><td align="left"><list id="lis0285" list-type="simple"><list-item id="lsti0915"><label>•</label><p id="par0915">Candidate: <italic>SLC6A4-</italic>5 CpGs in the promoter</p></list-item><list-item id="lsti0920"><label>•</label><p id="par0920">Blood</p></list-item><list-item id="lsti0925"><label>•</label><p id="par0925">Cell type composition: NR</p></list-item><list-item id="lsti0930"><label>•</label><p id="par0930">Consideration of genotype NR</p></list-item></list></td><td align="left"><list id="lis0290" list-type="simple"><list-item id="lsti0935"><label>•</label><p id="par0935">3 T</p></list-item><list-item id="lsti0940"><label>•</label><p id="par0940">Diffusion</p></list-item><list-item id="lsti0945"><label>•</label><p id="par0945">FA/MD/AxD/RD</p></list-item><list-item id="lsti0950"><label>•</label><p id="par0950">TBSS</p></list-item></list></td><td align="left"><list id="lis0295" list-type="simple"><list-item id="lsti0955"><label>•</label><p id="par0955">Cases: negative association between <italic>SLC6A4</italic> DNAm and FA/AxD in the BCC (medication naïve).</p></list-item><list-item id="lsti0960"><label>•</label><p id="par0960">Controls: negative association between <italic>SLC6A4</italic> DNAm and GCC FA, and positive association with RD.</p></list-item><list-item id="lsti0965"><label>•</label><p id="par0965">Associations between BCC FA/AxD and CpG3 DNAm are higher in the cases compared to controls.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0155">Han et al., 2017a</xref><break></break>South Korea †</td><td align="left"><list id="lis0300" list-type="simple"><list-item id="lsti0970"><label>•</label><p id="par0970">MDD</p></list-item><list-item id="lsti0975"><label>•</label><p id="par0975">Cases, n = 114 (24 M); controls, n = 88 (27 M)</p></list-item><list-item id="lsti0980"><label>•</label><p id="par0980">Cases, mean 43.5 years; controls, mean 39.9 years</p></list-item></list></td><td align="left"><list id="lis0305" list-type="simple"><list-item id="lsti0985"><label>•</label><p id="par0985">Candidate: <italic>FKBP5</italic> - intron 7 rs1360780, 2 CpGs investigated</p></list-item><list-item id="lsti0990"><label>•</label><p id="par0990">Blood</p></list-item><list-item id="lsti0995"><label>•</label><p id="par0995">Cell type composition: NR</p></list-item><list-item id="lsti1000"><label>•</label><p id="par1000">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0310" list-type="simple"><list-item id="lsti1005"><label>•</label><p id="par1005">3 T</p></list-item><list-item id="lsti1010"><label>•</label><p id="par1010">Structural, T1</p></list-item><list-item id="lsti1015"><label>•</label><p id="par1015">GM volumes/cortical thickness of 14 cortical/subcortical regions</p></list-item><list-item id="lsti1020"><label>•</label><p id="par1020">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0315" list-type="simple"><list-item id="lsti1025"><label>•</label><p id="par1025"><italic>FKBP5</italic> C homozygote group (patients and controls) (n = 118): positive association between DNAm of CpG1 and cortical thickness in the right transverse frontopolar gyrus.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0235">Kim et al., 2017</xref><break></break>South Korea</td><td align="left"><list id="lis0320" list-type="simple"><list-item id="lsti1030"><label>•</label><p id="par1030">Suicidality</p></list-item><list-item id="lsti1035"><label>•</label><p id="par1035">Cases (suicide attempters), n = 14 (1 M), controls, n = 22 (9 M)</p></list-item><list-item id="lsti1040"><label>•</label><p id="par1040">Cases, mean 31.9 years, controls, 33.6 years</p></list-item></list></td><td align="left"><list id="lis0325" list-type="simple"><list-item id="lsti1045"><label>•</label><p id="par1045">Candidate: <italic>CACNA1C</italic> - 11 CpG sites in DMR in a transcription factor binding site</p></list-item><list-item id="lsti1050"><label>•</label><p id="par1050">Blood</p></list-item><list-item id="lsti1055"><label>•</label><p id="par1055">Cell type composition: NR</p></list-item><list-item id="lsti1060"><label>•</label><p id="par1060">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0330" list-type="simple"><list-item id="lsti1065"><label>•</label><p id="par1065">3 T</p></list-item><list-item id="lsti1070"><label>•</label><p id="par1070">fMRI task: participants shown pictures of facial emotion and objects relating to suicidal means</p></list-item><list-item id="lsti1075"><label>•</label><p id="par1075">Activation in 4 left hemisphere regions</p></list-item><list-item id="lsti1080"><label>•</label><p id="par1080">SPM5</p></list-item></list></td><td align="left"><list id="lis0335" list-type="simple"><list-item id="lsti1085"><label>•</label><p id="par1085">Cases: in knife vs neutral landscape contrast positive association between CpG4/6 DNAm and brain activation in the left thalamus, MFG, IFG.</p></list-item><list-item id="lsti1090"><label>•</label><p id="par1090">Controls: positive association between CpG6 DNAm and activation in the left MFG and IFG.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0160">Han et al., 2017b</xref><break></break>South Korea †</td><td align="left"><list id="lis0340" list-type="simple"><list-item id="lsti1095"><label>•</label><p id="par1095">MDD</p></list-item><list-item id="lsti1100"><label>•</label><p id="par1100">Cases, n = 84 (13 M); controls, n = 61(17 M)</p></list-item><list-item id="lsti1105"><label>•</label><p id="par1105">Cases, mean 43.4 years; controls, mean 38.6 years</p></list-item></list></td><td align="left"><list id="lis0345" list-type="simple"><list-item id="lsti1110"><label>•</label><p id="par1110">Candidate: <italic>TESC-</italic>rs7294919 locus</p></list-item><list-item id="lsti1115"><label>•</label><p id="par1115">Blood</p></list-item><list-item id="lsti1120"><label>•</label><p id="par1120">Cell type composition: NR</p></list-item><list-item id="lsti1125"><label>•</label><p id="par1125">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0350" list-type="simple"><list-item id="lsti1130"><label>•</label><p id="par1130">3 T</p></list-item><list-item id="lsti1135"><label>•</label><p id="par1135">Diffusion</p></list-item><list-item id="lsti1140"><label>•</label><p id="par1140">Structural</p></list-item><list-item id="lsti1145"><label>•</label><p id="par1145">Diffusion parameters of the PHC</p></list-item><list-item id="lsti1150"><label>•</label><p id="par1150">Hippocampal subfield volumes</p></list-item><list-item id="lsti1155"><label>•</label><p id="par1155">Global PNT</p></list-item></list></td><td align="left"><list id="lis0355" list-type="simple"><list-item id="lsti1160"><label>•</label><p id="par1160">Cases: negative association of FA and positive association of RD with CpG3 DNAm in right PHC.</p></list-item><list-item id="lsti1165"><label>•</label><p id="par1165">Controls: no significant associations.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref><break></break>United States</td><td align="left"><list id="lis0360" list-type="simple"><list-item id="lsti1170"><label>•</label><p id="par1170">Family history of depression</p></list-item><list-item id="lsti1175"><label>•</label><p id="par1175">Cases n = 94 (51 M); controls n = 89(46 M);</p></list-item><list-item id="lsti1180"><label>•</label><p id="par1180">Wave 1, mean 13.5 years; wave 2, mean 15.6 years</p></list-item></list></td><td align="left"><list id="lis0365" list-type="simple"><list-item id="lsti1185"><label>•</label><p id="par1185">Candidate: <italic>SLC6A4</italic> - 20 CpG sites in promoter region</p></list-item><list-item id="lsti1190"><label>•</label><p id="par1190">Blood</p></list-item><list-item id="lsti1195"><label>•</label><p id="par1195">Cell type composition: NR</p></list-item><list-item id="lsti1200"><label>•</label><p id="par1200">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0370" list-type="simple"><list-item id="lsti1205"><label>•</label><p id="par1205">3 T</p></list-item><list-item id="lsti1210"><label>•</label><p id="par1210">fMRI task: emotional face processing</p></list-item><list-item id="lsti1215"><label>•</label><p id="par1215">Amygdala reactivity</p></list-item><list-item id="lsti1220"><label>•</label><p id="par1220">SPM8</p></list-item></list></td><td align="left"><list id="lis0375" list-type="simple"><list-item id="lsti1225"><label>•</label><p id="par1225">Subgroup (n = 87), longitudinal analysis: <italic>SLC6A4</italic> promoter DNAm increases over time is associated with increases in left centromedial amygdala reactivity when participants viewed faces with fearful expressions in contrast to geometric shapes.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0080">Davis et al., 2017</xref><break></break>United States<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0380" list-type="simple"><list-item id="lsti1230"><label>•</label><p id="par1230">High/low familial MDD risk among females</p></list-item><list-item id="lsti1235"><label>•</label><p id="par1235">High risk, n = 24; low risk, n = 22</p></list-item><list-item id="lsti1240"><label>•</label><p id="par1240">High risk, mean 12.9 years; low risk, mean 12.1 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0385" list-type="simple"><list-item id="lsti1245"><label>•</label><p id="par1245">Epigenome-wide: Illumina EPIC, Horvath DNAm age</p></list-item><list-item id="lsti1250"><label>•</label><p id="par1250">Saliva</p></list-item><list-item id="lsti1255"><label>•</label><p id="par1255">Cell type composition: yes</p></list-item><list-item id="lsti1260"><label>•</label><p id="par1260">Correction of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0390" list-type="simple"><list-item id="lsti1265"><label>•</label><p id="par1265">1.5 T/3 T</p></list-item><list-item id="lsti1270"><label>•</label><p id="par1270">Structural, T1</p></list-item><list-item id="lsti1275"><label>•</label><p id="par1275">Hippocampal and amygdala volumes</p></list-item><list-item id="lsti1280"><label>•</label><p id="par1280">FreeSurfer</p></list-item></list><hr/></td><td align="left">Whole group analysis:</td></tr><tr><td align="left"><list id="lis0395" list-type="simple"><list-item id="lsti1285"><label>•</label><p id="par1285">Negative associations between DNAm age residual and left hippocampal volume.</p></list-item><list-item id="lsti1290"><label>•</label><p id="par1290">Accelerated DNAm age mediates the effect of cortisol on left hippocampal volume.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0395">Schneider et al., 2018</xref><break></break>Germany</td><td align="left"><list id="lis0400" list-type="simple"><list-item id="lsti1295"><label>•</label><p id="par1295">MDD</p></list-item><list-item id="lsti1300"><label>•</label><p id="par1300">Cases, n = 137 (57 M); controls, n = 189 (83 M)</p></list-item><list-item id="lsti1305"><label>•</label><p id="par1305">Cases, mean 37.4 years; controls, mean 35.6 years</p></list-item></list></td><td align="left"><list id="lis0405" list-type="simple"><list-item id="lsti1310"><label>•</label><p id="par1310">Candidate: <italic>SLC6A4</italic> - AluJb element</p></list-item><list-item id="lsti1315"><label>•</label><p id="par1315">Blood</p></list-item><list-item id="lsti1320"><label>•</label><p id="par1320">Cell type composition: NR</p></list-item><list-item id="lsti1325"><label>•</label><p id="par1325">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0410" list-type="simple"><list-item id="lsti1330"><label>•</label><p id="par1330">3 T</p></list-item><list-item id="lsti1335"><label>•</label><p id="par1335">fMRI task: emotional face processing (threat/fearful faces)</p></list-item><list-item id="lsti1340"><label>•</label><p id="par1340">Amygdala reactivity</p></list-item><list-item id="lsti1345"><label>•</label><p id="par1345">SPM8</p></list-item></list></td><td align="left"><list id="lis0415" list-type="simple"><list-item id="lsti1350"><label>•</label><p id="par1350">Whole group analysis: Significant interaction of amygdala activity with DNAm and diagnosis.</p></list-item><list-item id="lsti1355"><label>•</label><p id="par1355">Cases: positive association between AluJb DNAm and activity in the right amygdala. No effect of DNAm on bilateral amygdala reactivity</p></list-item><list-item id="lsti1360"><label>•</label><p id="par1360">Controls: no significant associations</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="spar0055"><p><sup>†</sup> Overlapping cohorts.</p></fn><fn id="spar0060"><p><sup>‡</sup> Overlapping cohorts.</p></fn></table-wrap-foot></table-wrap></p>
<p id="par4855">Ten of eleven studies used a candidate gene approach based on blood samples and one carried out EWAS on salivary DNA. Five candidate genes were studied in the context of MDD: <italic>SLC6A4</italic> (n = 5), <italic>BDNF</italic> (n = 2), <italic>TESC</italic> (n = 1), <italic>FKBP5</italic> (n = 1) and <italic>CACNA1C</italic> (n = 1). The single EWAS study reported an association between DNAm age and hippocampal volume, noting that DNAm mediated the effect of cortisol on hippocampal volume (<xref ref-type="bibr" rid="bib0080">Davis et al., 2017</xref>).</p>
<p id="par4860">All four fMRI studies were task based. Two used the emotional face processing paradigm to investigate amygdala reactivity in relation to the <italic>SLC6A4</italic>AluJb element or its promoter, and both report significant correlations between activation and <italic>SLC6A4</italic> DNAm among cases (<xref ref-type="bibr" rid="bib0395">Schneider et al., 2018</xref>; <xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref>). Another study reported a correlation between DNAm at the <italic>SLC6A4</italic> and limbic system activation during a visual emotional attention shifting task in an analysis which pooled MDD cases and controls (<xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref>). Together these studies suggest that <italic>SLC6A4</italic> methylation positively correlates with limbic system reactivity in response to threat or negative emotional stimuli. However, these studies measured and reported <italic>SLC6A4</italic> methylation at different sites, and analysed them differently. For example, Frodl et al. used a summary mean measure calculated from 11 CpG sites in the promoter, Swartz et al. calculated a residualised change score from 20 CpG sites, and Schneider et al. calculated mean methylation at the AluJb element of the promoter from 6 CpG sites (<xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref>; <xref ref-type="bibr" rid="bib0395">Schneider et al., 2018</xref>; <xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref>). The fourth fMRI study investigated brain responses to images that were associated with suicidal means in relation to DNAm in the <italic>CACNA1C</italic> transcription factor binding site, and reported differential brain activation in association with DNAm at two CpGs (<xref ref-type="bibr" rid="bib0235">Kim et al., 2017</xref>).</p>
</sec>
<sec id="sec0085">
<label>3.4.3</label>
<title>Alcohol use disorder</title>
<p id="par4865"><xref ref-type="table" rid="tbl0025">Table 5</xref> summarises 4 studies of alcohol use disorder, all of which investigated DNAm in candidate genes in relation to task-based fMRI. Two were case-control study designs and two were uncontrolled case series. Three candidate genes were assessed: <italic>DRD2</italic>, <italic>SLC6A3/DAT</italic> and <italic>PPM1G</italic>. Three different tasks were used: testing impulse control, reactivity to alcohol cues and processing of reward/punishment cues. Three of these studies measured DNAm in blood, and one in saliva. Three of the four studies reported positive correlations between functional activation in limbic system structures and DNAm among participants with alcohol use disorder (<xref ref-type="bibr" rid="bib0020">Bidwell et al., 2018</xref>; <xref ref-type="bibr" rid="bib0370">Ruggeri et al., 2015</xref>; <xref ref-type="bibr" rid="bib0485">Wiers et al., 2015</xref>). The remaining study found no significant correlations in the alcohol dependent cases, but did find negative correlations in functional activation in the nucleus accumbens and methylation at the <italic>SLC6A3</italic> promoter in the context of a monetary incentive delay task (<xref ref-type="bibr" rid="bib0300">Muench et al., 2018</xref><italic>)</italic>.<table-wrap id="tbl0025" position="float"><label>Table 5</label><caption><p>Alcohol use disorder.</p></caption><alt-text id="at0030">Table 5</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0420" list-type="simple"><list-item id="lsti1365"><label>•</label><p id="par1365">Condition</p></list-item><list-item id="lsti1370"><label>•</label><p id="par1370">Cases (male); controls (male)</p></list-item><list-item id="lsti1375"><label>•</label><p id="par1375">Age</p></list-item></list></th><th align="left"><list id="lis0425" list-type="simple"><list-item id="lsti1380"><label>•</label><p id="par1380">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti1385"><label>•</label><p id="par1385">Tissue sampled</p></list-item><list-item id="lsti1390"><label>•</label><p id="par1390">Correction for cell sub-type distribution</p></list-item><list-item id="lsti1395"><label>•</label><p id="par1395">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0430" list-type="simple"><list-item id="lsti1400"><label>•</label><p id="par1400">MRI field strength</p></list-item><list-item id="lsti1405"><label>•</label><p id="par1405">Modality</p></list-item><list-item id="lsti1410"><label>•</label><p id="par1410">Image feature(s)</p></list-item><list-item id="lsti1415"><label>•</label><p id="par1415">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0370">Ruggeri et al., 2015</xref><break></break>United Kingdom<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0435" list-type="simple"><list-item id="lsti1420"><label>•</label><p id="par1420">Alcohol exposure (IMAGEN cohort)</p></list-item><list-item id="lsti1425"><label>•</label><p id="par1425">n = 499(222 M)</p></list-item><list-item id="lsti1430"><label>•</label><p id="par1430">Mean age 14 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0440" list-type="simple"><list-item id="lsti1435"><label>•</label><p id="par1435">Candidate: <italic>PPM1G</italic> - 3’ UTR</p></list-item><list-item id="lsti1440"><label>•</label><p id="par1440">Blood</p></list-item><list-item id="lsti1445"><label>•</label><p id="par1445">Cell type composition: NR</p></list-item><list-item id="lsti1450"><label>•</label><p id="par1450">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0445" list-type="simple"><list-item id="lsti1455"><label>•</label><p id="par1455">3 T</p></list-item><list-item id="lsti1460"><label>•</label><p id="par1460">fMRI task: stop signal task - impulse control</p></list-item><list-item id="lsti1465"><label>•</label><p id="par1465">BOLD responses in 2 ROIs</p></list-item><list-item id="lsti1470"><label>•</label><p id="par1470">MarsBaR (SPM8)</p></list-item></list><hr/></td><td align="left">Subset of whole sample (n = 393)</td></tr><tr><td align="left"><list id="lis0450" list-type="simple"><list-item id="lsti1475"><label>•</label><p id="par1475">Positive association between <italic>PPM1G</italic> DNAm and BOLD response in the right subthalamic nucleus in the stop success versus go success contrast</p></list-item><list-item id="lsti1480"><label>•</label><p id="par1480">No association with right IFG activation</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0485">Wiers et al., 2015</xref><break></break>United States</td><td align="left"><list id="lis0455" list-type="simple"><list-item id="lsti1485"><label>•</label><p id="par1485">Alcohol dependence</p></list-item><list-item id="lsti1490"><label>•</label><p id="par1490">Cases n = 38 (M); controls, n = 17 (M)</p></list-item><list-item id="lsti1495"><label>•</label><p id="par1495">Cases, mean age 44.4 years; controls, mean 42.7 years</p></list-item></list></td><td align="left"><list id="lis0460" list-type="simple"><list-item id="lsti1500"><label>•</label><p id="par1500">Candidate: <italic>SLC6A3/DAT -</italic> 12 CpG sites in promoter region (-1037 to -829)</p></list-item><list-item id="lsti1505"><label>•</label><p id="par1505">Blood</p></list-item><list-item id="lsti1510"><label>•</label><p id="par1510">Cell type composition: NR</p></list-item><list-item id="lsti1515"><label>•</label><p id="par1515">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0465" list-type="simple"><list-item id="lsti1520"><label>•</label><p id="par1520">3 T</p></list-item><list-item id="lsti1525"><label>•</label><p id="par1525">fMRI task: cue reactivity task, alcohol elicited response</p></list-item><list-item id="lsti1530"><label>•</label><p id="par1530">Reactivity in 4 ROIs</p></list-item><list-item id="lsti1535"><label>•</label><p id="par1535">MarsBaR (SPM8)</p></list-item></list></td><td align="left"><list id="lis0470" list-type="simple"><list-item id="lsti1540"><label>•</label><p id="par1540">Cases: positive association between alcohol elicited amygdala reactivity (in contrast to soft drink) and <italic>DAT</italic> DNAm found only in cases with low depression scores (n = 29)</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0020">Bidwell et al., 2018</xref><break></break>United States</td><td align="left"><list id="lis0475" list-type="simple"><list-item id="lsti1545"><label>•</label><p id="par1545">Alcohol dependence</p></list-item><list-item id="lsti1550"><label>•</label><p id="par1550">383 (238 M)</p></list-item><list-item id="lsti1555"><label>•</label><p id="par1555">Mean age 30.1 years (range 21–56)</p></list-item></list></td><td align="left"><list id="lis0480" list-type="simple"><list-item id="lsti1560"><label>•</label><p id="par1560">Candidate: <italic>DRD2</italic> - 6 CpGs in promoter region (-126 to -189)</p></list-item><list-item id="lsti1565"><label>•</label><p id="par1565">Saliva</p></list-item><list-item id="lsti1570"><label>•</label><p id="par1570">Cell type composition: NR</p></list-item><list-item id="lsti1575"><label>•</label><p id="par1575">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0485" list-type="simple"><list-item id="lsti1580"><label>•</label><p id="par1580">3 T</p></list-item><list-item id="lsti1585"><label>•</label><p id="par1585">fMRI task: cue reactivity task, alcohol elicited response</p></list-item><list-item id="lsti1590"><label>•</label><p id="par1590">BOLD contrasts of 10 ROIs and WB analysis</p></list-item><list-item id="lsti1595"><label>•</label><p id="par1595">SPM8</p></list-item></list></td><td align="left"><list id="lis0490" list-type="simple"><list-item id="lsti1600"><label>•</label><p id="par1600">ROI analysis: Positive association between DRD2 DNAm and alcohol elicited activation in striatum: right NAcc, bilateral putamen and bilateral caudate.</p></list-item><list-item id="lsti1605"><label>•</label><p id="par1605">WB analysis: positive associations between DRD2 DNAm and alcohol elicited response in: left superior temporal, middle temporal, insula, postcentral, supramarginal, putamen regions.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0300">Muench et al., 2018</xref><break></break>United States</td><td align="left"><list id="lis0495" list-type="simple"><list-item id="lsti1610"><label>•</label><p id="par1610">Alcohol dependence</p></list-item><list-item id="lsti1615"><label>•</label><p id="par1615">Cases, n = 45(35 M); controls, n = 45 (22 M)</p></list-item><list-item id="lsti1620"><label>•</label><p id="par1620">Cases: mean 43.3 years; controls: 36.2 years</p></list-item></list></td><td align="left"><list id="lis0500" list-type="simple"><list-item id="lsti1625"><label>•</label><p id="par1625">Candidate: <italic>SLC6A3/DAT-</italic>48 CpGs</p></list-item><list-item id="lsti1630"><label>•</label><p id="par1630">Blood</p></list-item><list-item id="lsti1635"><label>•</label><p id="par1635">Cell type composition: NR</p></list-item><list-item id="lsti1640"><label>•</label><p id="par1640">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0505" list-type="simple"><list-item id="lsti1645"><label>•</label><p id="par1645">3 T</p></list-item><list-item id="lsti1650"><label>•</label><p id="par1650">fMRI task: Monetary incentive delay task</p></list-item><list-item id="lsti1655"><label>•</label><p id="par1655">BOLD responses in bilateral NAcc</p></list-item><list-item id="lsti1660"><label>•</label><p id="par1660">AFNI</p></list-item></list></td><td align="left"><list id="lis0510" list-type="simple"><list-item id="lsti1665"><label>•</label><p id="par1665">Cases: no significant associations</p></list-item><list-item id="lsti1670"><label>•</label><p id="par1670">Controls: negative association between SLC6A3 promoter DNAm and NAcc activation during the anticipation of both high and low monetary loss. The effects were driven by 2 CpGs located at positions -1,001 and -993 from the TSS in the promoter of <italic>SLC6A3</italic>.</p></list-item></list></td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="sec0090">
<label>3.4.4</label>
<title>Schizophrenia and psychosis</title>
<p id="par4870"><xref ref-type="table" rid="tbl0030">Table 6</xref> summarises seven studies of schizophrenia and psychosis, all of which included a comparator group. Six of the included studies use data from participants in the Mind Clinical Imaging Consortium (MCIC) all of whom have MRI, DNAm and SNP data available (<xref ref-type="bibr" rid="bib0095">Deng et al., 2016</xref>; <xref ref-type="bibr" rid="bib0170">Hass et al., 2015</xref>; <xref ref-type="bibr" rid="bib0200">Hu et al., 2018</xref>; <xref ref-type="bibr" rid="bib0255">Liu et al., 2015</xref>; <xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>; <xref ref-type="bibr" rid="bib0475">Wang et al., 2017</xref>).<table-wrap id="tbl0030" position="float"><label>Table 6</label><caption><p>Schizophrenia and psychosis.</p></caption><alt-text id="at0035">Table 6</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0515" list-type="simple"><list-item id="lsti1675"><label>•</label><p id="par1675">Condition</p></list-item><list-item id="lsti1680"><label>•</label><p id="par1680">Cases (male); controls (male)</p></list-item><list-item id="lsti1685"><label>•</label><p id="par1685">Age</p></list-item></list></th><th align="left"><list id="lis0520" list-type="simple"><list-item id="lsti1690"><label>•</label><p id="par1690">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti1695"><label>•</label><p id="par1695">Tissue sampled</p></list-item><list-item id="lsti1700"><label>•</label><p id="par1700">Correction for cell sub-type distribution</p></list-item><list-item id="lsti1705"><label>•</label><p id="par1705">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0525" list-type="simple"><list-item id="lsti1710"><label>•</label><p id="par1710">MRI field strength</p></list-item><list-item id="lsti1715"><label>•</label><p id="par1715">Modality</p></list-item><list-item id="lsti1720"><label>•</label><p id="par1720">Image feature(s)</p></list-item><list-item id="lsti1725"><label>•</label><p id="par1725">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref><break></break>United States †<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0530" list-type="simple"><list-item id="lsti1730"><label>•</label><p id="par1730">Schizophrenia or schizophreniform disorder</p></list-item><list-item id="lsti1735"><label>•</label><p id="par1735">Cases, n = 82(62 M); controls, n = 102(62 M)</p></list-item><list-item id="lsti1740"><label>•</label><p id="par1740">Cases, mean 33.8 years; controls 32.7 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0535" list-type="simple"><list-item id="lsti1745"><label>•</label><p id="par1745">Candidate: <italic>MB-COMT</italic> - 864bp upstream from TSS of membrane bound isoform of <italic>COMT</italic></p></list-item><list-item id="lsti1750"><label>•</label><p id="par1750">Blood</p></list-item><list-item id="lsti1755"><label>•</label><p id="par1755">Cell type composition: NR</p></list-item><list-item id="lsti1760"><label>•</label><p id="par1760">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0540" list-type="simple"><list-item id="lsti1765"><label>•</label><p id="par1765">1.5 T and 3 T</p></list-item><list-item id="lsti1770"><label>•</label><p id="par1770">fMRI task: Sternberg item recognition paradigm - working memory task.</p></list-item><list-item id="lsti1775"><label>•</label><p id="par1775">BOLD response in dlPFC and exploratory whole brain analysis</p></list-item><list-item id="lsti1780"><label>•</label><p id="par1780">fMRIB (FSL)</p></list-item></list><hr/></td><td align="left">Whole group:</td></tr><tr><td align="left"><list id="lis0545" list-type="simple"><list-item id="lsti1785"><label>•</label><p id="par1785">ROI analysis: positive association between <italic>MB-COMT</italic> promoter DNAm and left dlPFC activation;</p></list-item><list-item id="lsti1790"><label>•</label><p id="par1790">Whole brain analysis: positive association between <italic>MB-COMT</italic> promoter methylation and left dlPFC and vlPFC (BA45), left premotor and primary sensory cortex. No effect in R dlPFC.</p></list-item></list>No effect of diagnosis.</td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="3" valign="middle"><xref ref-type="bibr" rid="bib0255">Liu et al., 2015</xref><break></break>United States †<hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis0550" list-type="simple"><list-item id="lsti1795"><label>•</label><p id="par1795">Schizophrenia, schizophreniform or schizoaffective disorder</p></list-item><list-item id="lsti1800"><label>•</label><p id="par1800">Cases, n = 94; controls, n = 106</p></list-item><list-item id="lsti1805"><label>•</label><p id="par1805">Cases, mean 34.7 years; controls, mean 32.5 years</p></list-item></list><hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis0555" list-type="simple"><list-item id="lsti1810"><label>•</label><p id="par1810">Epigenome-wide: Illumina Infinium HumanMethylation27 Array</p></list-item><list-item id="lsti1815"><label>•</label><p id="par1815">Blood</p></list-item><list-item id="lsti1820"><label>•</label><p id="par1820">Cell type composition: NR</p></list-item><list-item id="lsti1825"><label>•</label><p id="par1825">Consideration of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis0560" list-type="simple"><list-item id="lsti1830"><label>•</label><p id="par1830">1.5 T and 3 T</p></list-item><list-item id="lsti1835"><label>•</label><p id="par1835">Structural, T1</p></list-item><list-item id="lsti1840"><label>•</label><p id="par1840">Volumes of cortical and subcortical regions</p></list-item><list-item id="lsti1845"><label>•</label><p id="par1845">FreeSurfer</p></list-item></list><hr/></td><td align="left"><list id="lis0565" list-type="simple"><list-item id="lsti1850"><label>•</label><p id="par1850">Negative association between the 7<sup>th</sup> DNAm component and the 1<sup>st</sup> brain volume component:</p></list-item></list></td></tr><tr><td align="left">Brain volume component - left cerebellar cortex, right cerebellar cortex</td></tr><tr><td align="left">Methylation component - <italic>C1orf65, MCCC1, EPHA3, CDX1, RAET1L, LR8, STMN2, GATA4, NALP6, KCNK10, ADRA1D, NPDC1, MCHR1</italic></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0170">Hass et al., 2015</xref><break></break>United States †</td><td align="left"><list id="lis0570" list-type="simple"><list-item id="lsti1855"><label>•</label><p id="par1855">Schizophrenia</p></list-item><list-item id="lsti1860"><label>•</label><p id="par1860">Cases, n = 103 (75 M); Controls, n = 111(71 M)</p></list-item><list-item id="lsti1865"><label>•</label><p id="par1865">Cases: mean 34.6 years; controls, mean 32.1 years</p></list-item></list></td><td align="left"><list id="lis0575" list-type="simple"><list-item id="lsti1870"><label>•</label><p id="par1870">Epigenome-wide: Illumina Infinium HumanMethylation27 Array</p></list-item><list-item id="lsti1875"><label>•</label><p id="par1875">Blood</p></list-item><list-item id="lsti1880"><label>•</label><p id="par1880">Cell type composition: yes</p></list-item><list-item id="lsti1885"><label>•</label><p id="par1885">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0580" list-type="simple"><list-item id="lsti1890"><label>•</label><p id="par1890">1.5 T and 3 T</p></list-item><list-item id="lsti1895"><label>•</label><p id="par1895">Structural, T1</p></list-item><list-item id="lsti1900"><label>•</label><p id="par1900">fMRI: Sternberg Item Recognition Paradigm - working memory task.</p></list-item><list-item id="lsti1905"><label>•</label><p id="par1905">Hippocampal volume, STG thickness</p></list-item><list-item id="lsti1910"><label>•</label><p id="par1910">Working memory load dependent neural activity (percentage BOLD signal change) in the dlPFC</p></list-item><list-item id="lsti1915"><label>•</label><p id="par1915">FreeSurfer</p></list-item><list-item id="lsti1920"><label>•</label><p id="par1920">fMRIB (FSL)</p></list-item></list></td><td align="left"><list id="lis0585" list-type="simple"><list-item id="lsti1925"><label>•</label><p id="par1925">Alterations in the DNAm state of genes within the hsa-miR-219a-5p targets are associated with hippocampal volume changes (has-miR-219a-5p target gene set: <italic>KIAA0182, PKNOX1, TRAF7, CBFA2T3, EPHA4, MKNK2, DDAH1, ESR1, AKAP13, PHACTR2, SLC31A1, KBTBD8, ADD2, ERGIC1, RBM24, KIAA0240, NEK6, THRB, SCN5A, TGFBR2, FZD4, SEMA4G)</italic></p></list-item><list-item id="lsti1930"><label>•</label><p id="par1930">STG thickness: miR-513 gene set sig enriched (NES = 1.7636) with an FDR q value of 0.2404 (based on positive association between DNAm data and phenotype)</p></list-item><list-item id="lsti1935"><label>•</label><p id="par1935">None of the predicted miRNA target gene sets was significantly enriched in association with working-memory load-dependent neural activity in the dlPFC.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0095">Deng et al., 2016</xref><break></break>United States †</td><td align="left"><list id="lis0590" list-type="simple"><list-item id="lsti1940"><label>•</label><p id="par1940">Schizophrenia</p></list-item><list-item id="lsti1945"><label>•</label><p id="par1945">Case, n = 80(60 M); Controls, n = 104 (66 M)</p></list-item><list-item id="lsti1950"><label>•</label><p id="par1950">Cases, mean 34 years; controls, mean 32 years</p></list-item></list></td><td align="left"><list id="lis0595" list-type="simple"><list-item id="lsti1955"><label>•</label><p id="par1955">Epigenome-wide: Illumina Infinium HumanMethylation27 Array</p></list-item><list-item id="lsti1960"><label>•</label><p id="par1960">Tissue sampled: blood</p></list-item><list-item id="lsti1965"><label>•</label><p id="par1965">Cell type composition: NR</p></list-item><list-item id="lsti1970"><label>•</label><p id="par1970">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0600" list-type="simple"><list-item id="lsti1975"><label>•</label><p id="par1975">NR</p></list-item><list-item id="lsti1980"><label>•</label><p id="par1980">fMRI</p></list-item><list-item id="lsti1985"><label>•</label><p id="par1985">NR</p></list-item><list-item id="lsti1990"><label>•</label><p id="par1990">NR</p></list-item></list></td><td align="left"><list id="lis0605" list-type="simple"><list-item id="lsti1995"><label>•</label><p id="par1995">Small concordance between fMRI data and DNAm data.</p></list-item><list-item id="lsti2000"><label>•</label><p id="par2000">Prediction accuracy of schizophrenia cases was improved by incorporating the two data types versus prediction models using one or the other.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0365">Rubin et al., 2016</xref><break></break>United States</td><td align="left"><list id="lis0610" list-type="simple"><list-item id="lsti2005"><label>•</label><p id="par2005">Schizophrenia and Bipolar disorder</p></list-item><list-item id="lsti2010"><label>•</label><p id="par2010">Case, n = 167(75 M); controls, n = 75(37 M)</p></list-item><list-item id="lsti2015"><label>•</label><p id="par2015">Age</p></list-item></list>Schizophrenia: Women (n = 22): mean 39 years; Men (n = 35): mean 22 years<break></break>Schizoaffective disorder: Women (n = 19) mean 37 years; Men (n = 15) mean 38 years<break></break>Bipolar disorder: Women (n = 51) mean 36 years; Men (n = 25) mean 26 years<break></break>Controls: Women (n = 38) mean 36 years; Men (n = 37) mean 39 years</td><td align="left"><list id="lis0615" list-type="simple"><list-item id="lsti2020"><label>•</label><p id="par2020">Candidate: <italic>OXTR</italic> - methylation measured at a site 934bp upstream of TSS</p></list-item><list-item id="lsti2025"><label>•</label><p id="par2025">Blood</p></list-item><list-item id="lsti2030"><label>•</label><p id="par2030">Cell type composition: NR</p></list-item><list-item id="lsti2035"><label>•</label><p id="par2035">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0620" list-type="simple"><list-item id="lsti2040"><label>•</label><p id="par2040">3 T</p></list-item><list-item id="lsti2045"><label>•</label><p id="par2045">Structural, T1</p></list-item><list-item id="lsti2050"><label>•</label><p id="par2050">Volumes of prefrontal regions and temporal limbic regions</p></list-item><list-item id="lsti2055"><label>•</label><p id="par2055">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0625" list-type="simple"><list-item id="lsti2060"><label>•</label><p id="par2060">Schizophrenia: positive association between OXTR DNAm and volumes of the left OFC, and right fusiform gyrus and negative association with the right hippocampus.</p></list-item><list-item id="lsti2065"><label>•</label><p id="par2065">Bipolar disorder: positive association between DNAm and right parahippocampal gyrus volume.</p></list-item><list-item id="lsti2070"><label>•</label><p id="par2070">Schizoaffective disorder (men): Negative association between <italic>OXTR</italic> DNAm and left MFG volume.</p></list-item><list-item id="lsti2075"><label>•</label><p id="par2075">Controls: negative association between <italic>OXTR</italic> DNAm and left amygdala, right MFG and IFG volumes.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0475">Wang et al., 2017</xref><break></break>United States †</td><td align="left"><list id="lis0630" list-type="simple"><list-item id="lsti2080"><label>•</label><p id="par2080">Schizophrenia</p></list-item><list-item id="lsti2085"><label>•</label><p id="par2085">Cases, n = 80(60 M); Controls, n = 104 (66 M)</p></list-item><list-item id="lsti2090"><label>•</label><p id="par2090">Cases: mean 34 years; controls mean 32 years</p></list-item></list></td><td align="left"><list id="lis0635" list-type="simple"><list-item id="lsti2095"><label>•</label><p id="par2095">Epigenome-wide: Illumina Infinium HumanMethylation27 Array</p></list-item><list-item id="lsti2100"><label>•</label><p id="par2100">Blood</p></list-item><list-item id="lsti2105"><label>•</label><p id="par2105">Cell type composition: NR</p></list-item><list-item id="lsti2110"><label>•</label><p id="par2110">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0640" list-type="simple"><list-item id="lsti2115"><label>•</label><p id="par2115">NR</p></list-item><list-item id="lsti2120"><label>•</label><p id="par2120">fMRI</p></list-item><list-item id="lsti2125"><label>•</label><p id="par2125">NR</p></list-item><list-item id="lsti2130"><label>•</label><p id="par2130">NR</p></list-item></list></td><td align="left"><list id="lis0645" list-type="simple"><list-item id="lsti2135"><label>•</label><p id="par2135">Positive association between fMRI and DNAm modules in cases.</p></list-item><list-item id="lsti2140"><label>•</label><p id="par2140">Associations in controls do not reach statistical significance.</p></list-item><list-item id="lsti2145"><label>•</label><p id="par2145">DNAm module: <italic>ANKRD15, ATP6V0A4, C1orf116, C1orf172, C21orf56, CCNA1, CREB3L3, FLJ11017, HOXA4, HTN3, KIF27, LDHD, PAGE5, PDIA2, RCBTB2, RPL26L1, TMEM100</italic></p></list-item><list-item id="lsti2150"><label>•</label><p id="par2150">fMRI module: midcingulate area, parahippocampal gyrus, postcentral gyrus, supramarginal gyrus, angular gyrus, precuneus, superior temporal gyrus</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0200">Hu et al., 2018</xref><break></break>United States †</td><td align="left"><list id="lis0650" list-type="simple"><list-item id="lsti2155"><label>•</label><p id="par2155">Schizophrenia</p></list-item><list-item id="lsti2160"><label>•</label><p id="par2160">Cases, n = 79; controls, n = 104</p></list-item><list-item id="lsti2165"><label>•</label><p id="par2165">Age: NR</p></list-item></list></td><td align="left"><list id="lis0655" list-type="simple"><list-item id="lsti2170"><label>•</label><p id="par2170">Epigenome-wide: Illumina Infinium HumanMethylation27 Array</p></list-item><list-item id="lsti2175"><label>•</label><p id="par2175">Blood</p></list-item><list-item id="lsti2180"><label>•</label><p id="par2180">Cell type composition: NR</p></list-item><list-item id="lsti2185"><label>•</label><p id="par2185">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0660" list-type="simple"><list-item id="lsti2190"><label>•</label><p id="par2190">Field Strength: NR</p></list-item><list-item id="lsti2195"><label>•</label><p id="par2195">fMRI task: Sensorimotor task</p></list-item><list-item id="lsti2200"><label>•</label><p id="par2200">NR</p></list-item><list-item id="lsti2205"><label>•</label><p id="par2205">NR</p></list-item></list></td><td align="left"><list id="lis0665" list-type="simple"><list-item id="lsti2210"><label>•</label><p id="par2210">Positive association between DNAm and fMRI data</p></list-item><list-item id="lsti2215"><label>•</label><p id="par2215">DNAm: 31 CpG sites that correspond to 30 genes</p></list-item><list-item id="lsti2220"><label>•</label><p id="par2220">fMRI (7 ROIs): left inferior frontal gyrus (pars triangularis), left hippocampus, right inferior occipital gyrus, bilateral fusiform gyrus, right middle temporal gyrus, left inferior temporal gyrus</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn><p><sup>†</sup> Mind Clinical Imaging Consortium.</p></fn></table-wrap-foot></table-wrap></p>
<p id="par4875">The majority of these studies measured blood DNAm on the Illumina HumanMethylation27 array (n = 4), and one study carried out a candidate gene analysis on blood <italic>MB-COMT</italic> DNAm. Five of these used the Illumina HumanMethylation27 array, and two carried out bisulfite pyrosequencing of two genes: <italic>OXTR</italic> and <italic>MB-COMT</italic>. fMRI was the most commonly used modality (n = 5), followed by sMRI (n = 3). Of these, one study used both modalities. fMRI tasks included: a sensorimotor task and the Sternberg Item Recognition Paradigm for working memory (<xref ref-type="bibr" rid="bib0200">Hu et al., 2018</xref>; <xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>). Two studies did not report the fMRI paradigm (<xref ref-type="bibr" rid="bib0095">Deng et al., 2016</xref>; <xref ref-type="bibr" rid="bib0475">Wang et al., 2017</xref>).</p>
</sec>
<sec id="sec0095">
<label>3.4.5</label>
<title>Ageing, stroke, ataxia and neurodegeneration</title>
<p id="par4880"><xref ref-type="table" rid="tbl0035">Table 7</xref> summarises eight studies that investigated aspects of ageing, including healthy ageing, Alzheimer’s disease, minor cognitive impairment, stroke, WMH burden and <italic>C9orf72</italic> expansion and Fragile X Associated Tremor Ataxia Syndrome (FXTAS).<table-wrap id="tbl0035" position="float"><label>Table 7</label><caption><p>Ageing, stroke, ataxia and neurodegeneration.</p></caption><alt-text id="at0040">Table 7</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0670" list-type="simple"><list-item id="lsti2225"><label>•</label><p id="par2225">Condition</p></list-item><list-item id="lsti2230"><label>•</label><p id="par2230">Cases (male); controls (male)</p></list-item><list-item id="lsti2235"><label>•</label><p id="par2235">Age</p></list-item></list></th><th align="left"><list id="lis0675" list-type="simple"><list-item id="lsti2240"><label>•</label><p id="par2240">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti2245"><label>•</label><p id="par2245">Tissue sampled</p></list-item><list-item id="lsti2250"><label>•</label><p id="par2250">Correction for cell sub-type distribution</p></list-item><list-item id="lsti2255"><label>•</label><p id="par2255">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0680" list-type="simple"><list-item id="lsti2260"><label>•</label><p id="par2260">MRI field strength</p></list-item><list-item id="lsti2265"><label>•</label><p id="par2265">Modality</p></list-item><list-item id="lsti2270"><label>•</label><p id="par2270">Image feature(s)</p></list-item><list-item id="lsti2275"><label>•</label><p id="par2275">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left"><xref ref-type="bibr" rid="bib0280">McMillan et al., 2015</xref><break></break>United States</td><td align="left"><list id="lis0685" list-type="simple"><list-item id="lsti2280"><label>•</label><p id="par2280"><italic>C9orf72</italic> expansion</p></list-item><list-item id="lsti2285"><label>•</label><p id="par2285">Cases, n = 20; Controls, n = 25</p></list-item><list-item id="lsti2290"><label>•</label><p id="par2290">Cases: mean 61.9 years; controls: mean 6138 years</p></list-item></list></td><td align="left"><list id="lis0690" list-type="simple"><list-item id="lsti2295"><label>•</label><p id="par2295">Candidate: <italic>C9orf72</italic></p></list-item><list-item id="lsti2300"><label>•</label><p id="par2300">Blood</p></list-item><list-item id="lsti2305"><label>•</label><p id="par2305">Cell type composition: NR</p></list-item><list-item id="lsti2310"><label>•</label><p id="par2310">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0695" list-type="simple"><list-item id="lsti2315"><label>•</label><p id="par2315">3 T</p></list-item><list-item id="lsti2320"><label>•</label><p id="par2320">Structural, T1</p></list-item><list-item id="lsti2325"><label>•</label><p id="par2325">Grey matter density</p></list-item><list-item id="lsti2330"><label>•</label><p id="par2330">Randomise (FSL)</p></list-item></list></td><td align="left"><list id="lis0700" list-type="simple"><list-item id="lsti2335"><label>•</label><p id="par2335"><italic>C9orf72</italic> expansion group: positive association between <italic>C9orf72</italic> DNAm and grey matter density in the right hippocampus and thalamus and left premotor cortex.</p></list-item><list-item id="lsti2340"><label>•</label><p id="par2340">Longitudinal analysis (n = 11): GM atrophy progresses more rapidly over time with decreased <italic>C9orf72</italic> DNAm in patients with <italic>C9orf72</italic> expansion</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0400">Shelton et al., 2016</xref><break></break>Australia †</td><td align="left"><list id="lis0705" list-type="simple"><list-item id="lsti2345"><label>•</label><p id="par2345">Fragile X associated tremor ataxia syndrome (FXTAS)</p></list-item><list-item id="lsti2350"><label>•</label><p id="par2350">Cases, n = 19 F; controls, n = 17F</p></list-item><list-item id="lsti2355"><label>•</label><p id="par2355">Cases: mean 39.4 years; controls, mean 39.8 years</p></list-item></list></td><td align="left"><list id="lis0710" list-type="simple"><list-item id="lsti2360"><label>•</label><p id="par2360">Candidate: FMR1 - exon 1 CpG1 and CpG2; intron 1 CpG6/7, CpG8/9; CpG10-12</p></list-item><list-item id="lsti2365"><label>•</label><p id="par2365">Blood</p></list-item><list-item id="lsti2370"><label>•</label><p id="par2370">Cell type composition: NR</p></list-item><list-item id="lsti2375"><label>•</label><p id="par2375">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0715" list-type="simple"><list-item id="lsti2380"><label>•</label><p id="par2380">3 T</p></list-item><list-item id="lsti2385"><label>•</label><p id="par2385">Structural, T1</p></list-item><list-item id="lsti2390"><label>•</label><p id="par2390">Regional cortical thickness from bilateral MFG and SFG and inferior parietal gyrus</p></list-item><list-item id="lsti2395"><label>•</label><p id="par2395">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0720" list-type="simple"><list-item id="lsti2400"><label>•</label><p id="par2400">Premutation group: positive associations between methylation of <italic>FMR1</italic> CpG6/7 or CpG1 or CpG10-12 and of cortical thickness in the left inferior parietal gyrus, middle frontal gyrus, and right middle frontal gyrus, superior frontal gyrus. Negative association between methylation in the intronic region with white matter hyperintensities.</p></list-item><list-item id="lsti2405"><label>•</label><p id="par2405">Controls: negative associations between FMR1 DNAm at CpGs 2, 6/7, 10–12 and cortical thickness in frontal lobe regions: left middle frontal gyrus and right superior frontal gyrus</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0505">Zhou et al., 2016</xref><break></break>China</td><td align="left"><list id="lis0725" list-type="simple"><list-item id="lsti2410"><label>•</label><p id="par2410">Cerebral infarction</p></list-item><list-item id="lsti2415"><label>•</label><p id="par2415">Cases, n = 83(45 M); controls, n = 94(52 M)</p></list-item><list-item id="lsti2420"><label>•</label><p id="par2420">Cases: mean 61.6 years; controls: mean 61.6 years</p></list-item></list></td><td align="left"><list id="lis0730" list-type="simple"><list-item id="lsti2425"><label>•</label><p id="par2425">Candidate: Extracellular <italic>SOD</italic></p></list-item><list-item id="lsti2430"><label>•</label><p id="par2430">Blood</p></list-item><list-item id="lsti2435"><label>•</label><p id="par2435">Cell type composition: NR</p></list-item><list-item id="lsti2440"><label>•</label><p id="par2440">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0735" list-type="simple"><list-item id="lsti2445"><label>•</label><p id="par2445">Field strength: NR</p></list-item><list-item id="lsti2450"><label>•</label><p id="par2450">MR Angiography</p></list-item><list-item id="lsti2455"><label>•</label><p id="par2455">Area of cerebral infarction; cerebral arteriosclerosis</p></list-item><list-item id="lsti2460"><label>•</label><p id="par2460">Analysis: NR</p></list-item></list></td><td align="left"><list id="lis0740" list-type="simple"><list-item id="lsti2465"><label>•</label><p id="par2465">Dependence between large/small area of cerebral infarction and extent of extracellular <italic>SOD</italic> DNAm.</p></list-item><list-item id="lsti2470"><label>•</label><p id="par2470">Negative but non-significant association between arteriosclerosis severity and extracellular <italic>SOD</italic> DNAm</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0410">Shinagawa et al., 2016</xref><break></break>Japan</td><td align="left"><list id="lis0745" list-type="simple"><list-item id="lsti2475"><label>•</label><p id="par2475">Alzheimer’s/aMCI</p></list-item><list-item id="lsti2480"><label>•</label><p id="par2480">Cases 58(27 M): AD, n = 30; aMCI n = 28</p></list-item><list-item id="lsti2485"><label>•</label><p id="par2485">Cases, mean 71.9 years</p></list-item></list></td><td align="left"><list id="lis0750" list-type="simple"><list-item id="lsti2490"><label>•</label><p id="par2490">Candidate: <italic>NCAPH2/LMF2</italic> promoter – representative CpG site</p></list-item><list-item id="lsti2495"><label>•</label><p id="par2495">Blood</p></list-item><list-item id="lsti2500"><label>•</label><p id="par2500">Cell type composition: NR</p></list-item><list-item id="lsti2505"><label>•</label><p id="par2505">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0755" list-type="simple"><list-item id="lsti2510"><label>•</label><p id="par2510">1.5 T</p></list-item><list-item id="lsti2515"><label>•</label><p id="par2515">Structural, T1</p></list-item><list-item id="lsti2520"><label>•</label><p id="par2520">VBM Grey matter/ VSRAD Z-score (hippocampal atrophy grade)</p></list-item><list-item id="lsti2525"><label>•</label><p id="par2525">SPM8, DARTEL/VSRAD</p></list-item></list></td><td align="left"><list id="lis0760" list-type="simple"><list-item id="lsti2530"><label>•</label><p id="par2530">Extent of grey matter atrophy non-significant for associations with NCAPH/LMF2 promoter DNAm.</p></list-item><list-item id="lsti2535"><label>•</label><p id="par2535">Positive association between DNAm of <italic>NCAPH2/LMF2</italic> and severity of hippocampal atrophy.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0185">Hodgson et al., 2017</xref><break></break>United States<hr/></td><td align="left"><list id="lis0765" list-type="simple"><list-item id="lsti2540"><label>•</label><p id="par2540">Ageing</p></list-item><list-item id="lsti2545"><label>•</label><p id="par2545">N = 376</p></list-item></list></td><td align="left" rowspan="2" valign="middle"><list id="lis0770" list-type="simple"><list-item id="lsti2550"><label>•</label><p id="par2550">Epigenome-wide: Illumina 450 array, Horvath DNAm age</p></list-item><list-item id="lsti2555"><label>•</label><p id="par2555">Blood</p></list-item><list-item id="lsti2560"><label>•</label><p id="par2560">Cell type composition: yes</p></list-item><list-item id="lsti2565"><label>•</label><p id="par2565">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0775" list-type="simple"><list-item id="lsti2570"><label>•</label><p id="par2570">3 T</p></list-item><list-item id="lsti2575"><label>•</label><p id="par2575">Diffusion</p></list-item><list-item id="lsti2580"><label>•</label><p id="par2580">FA</p></list-item><list-item id="lsti2585"><label>•</label><p id="par2585">TBSS</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0780" list-type="simple"><list-item id="lsti2590"><label>•</label><p id="par2590">Negative association of FA with epigenetic age acceleration.</p></list-item></list><hr/></td></tr><tr><td align="left"><list id="lis0785" list-type="simple"><list-item id="lsti2595"><label>•</label><p id="par2595">Mean age 45.5 years</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0350">Raina et al., 2017</xref><break></break>United States</td><td align="left"><list id="lis0790" list-type="simple"><list-item id="lsti2600"><label>•</label><p id="par2600">Cerebral white matter hyperintensities</p></list-item><list-item id="lsti2605"><label>•</label><p id="par2605">N = 713(257 M)</p></list-item><list-item id="lsti2610"><label>•</label><p id="par2610">Mean age at MRI was 61.8 years; mean age at DNA sampling 59.3 years</p></list-item></list></td><td align="left"><list id="lis0795" list-type="simple"><list-item id="lsti2615"><label>•</label><p id="par2615">Epigenome-wide; Illumina 450k array, Hannum/Horvath DNAm age</p></list-item><list-item id="lsti2620"><label>•</label><p id="par2620">Blood</p></list-item><list-item id="lsti2625"><label>•</label><p id="par2625">Cell type composition: yes</p></list-item><list-item id="lsti2630"><label>•</label><p id="par2630">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0800" list-type="simple"><list-item id="lsti2635"><label>•</label><p id="par2635">1.5 T</p></list-item><list-item id="lsti2640"><label>•</label><p id="par2640">Structural, T1/T2</p></list-item><list-item id="lsti2645"><label>•</label><p id="par2645">White matter hyperintensities</p></list-item><list-item id="lsti2650"><label>•</label><p id="par2650">Non-automated counting</p></list-item></list></td><td align="left"><list id="lis0805" list-type="simple"><list-item id="lsti2655"><label>•</label><p id="par2655">Positive association between WMH burden and DNAm age acceleration: high WMH burden category was associated with DNAm age acceleration, whereas low WMH burden was not.</p></list-item><list-item id="lsti2660"><label>•</label><p id="par2660">No individual probe reached significance in any analysis.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0405">Shelton et al., 2017</xref><break></break>Australia †</td><td align="left"><list id="lis0810" list-type="simple"><list-item id="lsti2665"><label>•</label><p id="par2665">FXTAS</p></list-item><list-item id="lsti2670"><label>•</label><p id="par2670">Cases n = 20 F; controls, n = 20 F</p></list-item><list-item id="lsti2675"><label>•</label><p id="par2675">Cases mean 40.1 years; controls mean 39.1 years</p></list-item></list></td><td align="left"><list id="lis0815" list-type="simple"><list-item id="lsti2680"><label>•</label><p id="par2680">Candidate: <italic>FMR1</italic> – exon 1 CpG1 and CpG2; intron 1 CpG6/7, CpG8/9; CpG10-12</p></list-item><list-item id="lsti2685"><label>•</label><p id="par2685">Blood</p></list-item><list-item id="lsti2690"><label>•</label><p id="par2690">Cell type composition: NR</p></list-item><list-item id="lsti2695"><label>•</label><p id="par2695">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0820" list-type="simple"><list-item id="lsti2700"><label>•</label><p id="par2700">3 T</p></list-item><list-item id="lsti2705"><label>•</label><p id="par2705">Diffusion</p></list-item><list-item id="lsti2710"><label>•</label><p id="par2710">FA, MD in ROIs</p></list-item><list-item id="lsti2715"><label>•</label><p id="par2715">TBSS (FSL)</p></list-item></list></td><td align="left"><list id="lis0825" list-type="simple"><list-item id="lsti2720"><label>•</label><p id="par2720">Premutation group: negative association between inferior and middle cerebellar peduncle’s MD and CpG1</p></list-item><list-item id="lsti2725"><label>•</label><p id="par2725">Control: negative association between BCC FA and CpG6/7</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0060">Chouliaras et al., 2018</xref><break></break>United Kingdom</td><td align="left"><list id="lis0830" list-type="simple"><list-item id="lsti2730"><label>•</label><p id="par2730">N = 47(39 M)</p></list-item><list-item id="lsti2735"><label>•</label><p id="par2735">Cognitively intact, mean 72.8 years; cognitively impaired, mean 72.3 years (s.d. 6.02)</p></list-item></list></td><td align="left"><list id="lis0835" list-type="simple"><list-item id="lsti2740"><label>•</label><p id="par2740">Epigenome-wide: Illumina 450k array, Horvath/Hannum DNAm age</p></list-item><list-item id="lsti2745"><label>•</label><p id="par2745">Blood</p></list-item><list-item id="lsti2750"><label>•</label><p id="par2750">Cell type composition: yes</p></list-item><list-item id="lsti2755"><label>•</label><p id="par2755">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0840" list-type="simple"><list-item id="lsti2760"><label>•</label><p id="par2760">3 T</p></list-item><list-item id="lsti2765"><label>•</label><p id="par2765">Structural, T1/</p></list-item><list-item id="lsti2770"><label>•</label><p id="par2770">Diffusion</p></list-item><list-item id="lsti2775"><label>•</label><p id="par2775">total brain, hippocampal, CSF, GM volumes, WMH</p></list-item><list-item id="lsti2780"><label>•</label><p id="par2780">FA, MD</p></list-item><list-item id="lsti2785"><label>•</label><p id="par2785">Voxel wise statistical analysis, BIANCA (WMH detection)/ FSL</p></list-item></list></td><td align="left"><list id="lis0845" list-type="simple"><list-item id="lsti2790"><label>•</label><p id="par2790">No associations were observed between the Horvath epigenetic clock and any of the imaging variables tested</p></list-item><list-item id="lsti2795"><label>•</label><p id="par2795">Candidate gene testing did not find any associations that survived correction for multiple comparisons.</p></list-item><list-item id="lsti2800"><label>•</label><p id="par2800">Negative association between global MD and Hannum age, and positive association between global FA and Hannum age.</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn><p><sup>†</sup> Overlapping cohort.</p></fn></table-wrap-foot></table-wrap></p>
<p id="par4885">Imaging modalities used were as follows: dMRI (n = 2), sMRI (n = 5) d/sMRI (n = 1). All studies used blood samples to measure DNAm. Five studies carried out candidate gene analysis and three measured DNAm in an epigenome-wide manner. The candidate genes studied were: <italic>C9orf72</italic> (n = 1), <italic>NCAPH2/LMF2</italic> (n = 1), <italic>FMR1</italic> (n = 2), <italic>SOD</italic> (n = 1). Two studies carried out a longitudinal analysis as well as a cross-sectional analysis (<xref ref-type="bibr" rid="bib0280">McMillan et al., 2015</xref>; <xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref>). One of these showed, in a group of 11 <italic>C9orf72</italic> expansion patients, that there was more rapid grey matter atrophy in the right hippocampus, right thalamus and left middle frontal cortex where there was decreased methylation in the expansion region (<xref ref-type="bibr" rid="bib0280">McMillan et al., 2015</xref>). The other found in 87 study participants that increases in <italic>SLC6A4</italic> promoter methylation corresponded to increases in amygdala reactivity in response to threat related stimuli in task-based fMRI (<xref ref-type="bibr" rid="bib0435">Swartz et al., 2017</xref>). Two studies that investigated associations between <italic>FMR1</italic> methylation and brain imaging in women with FXTAS had overlapping participants (<xref ref-type="bibr" rid="bib0405">Shelton et al., 2017</xref>, <xref ref-type="bibr" rid="bib0400">2016</xref>). The three EWAS studies investigated DNAm age in relation to its associations with brain imaging features (<xref ref-type="bibr" rid="bib0060">Chouliaras et al., 2018</xref>; <xref ref-type="bibr" rid="bib0185">Hodgson et al., 2017</xref>; <xref ref-type="bibr" rid="bib0350">Raina et al., 2017</xref>). Two of these three studies investigated dMRI: one found a negative association of FA with epigenetic age acceleration, while the other found a negative association between global mean diffusivity (MD) and Hannum age and a positive association between FA and Hannum age (<xref ref-type="bibr" rid="bib0060">Chouliaras et al., 2018</xref>; <xref ref-type="bibr" rid="bib0185">Hodgson et al., 2017</xref>). In an analysis with sMRI a positive association was found between WMH burden category and DNAm age acceleration (<xref ref-type="bibr" rid="bib0350">Raina et al., 2017</xref>).</p>
</sec>
<sec id="sec0100">
<label>3.4.6</label>
<title>Post-traumatic stress disorder</title>
<p id="par4890"><xref ref-type="table" rid="tbl0040">Table 8</xref> summarises seven studies that were carried out in participants with PTSD (<xref ref-type="table" rid="tbl0030">Table 6</xref>). Several studies had overlapping participants. Three studies report associations in an overlapping group of participants: PTSD cases and non-PTSD controls, where the case population was mothers who have experienced interpersonal violence (IPV) (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>; <xref ref-type="bibr" rid="bib0390">Schechter et al., 2017</xref>, <xref ref-type="bibr" rid="bib0385">2015</xref>). Two further studies had overlapping participants – a cohort of trauma exposed veterans (<xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>; <xref ref-type="bibr" rid="bib0495">Wolf et al., 2016</xref>). An additional group of veterans was also studied in relation to PTSD (<xref ref-type="bibr" rid="bib0285">McNerney et al., 2018</xref>). A further study recruited women who had experienced early life trauma to investigate associations between DNAm and sMRI features (<xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref>). Five candidate genes were studied: <italic>NR3C1</italic> (n = 2), <italic>SKA2</italic> (n = 1), <italic>BDNF</italic> (n = 1), <italic>FKBP5</italic> (n = 1), <italic>5HT3A</italic> (n = 1). All three modalities were employed to investigate neuroimaging features: dMRI (n = 1), sMRI (n = 3), fMRI (n = 3). Overlap in study populations lay between two studies which measured DNAm using the Illumina 450k array (<xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>; <xref ref-type="bibr" rid="bib0495">Wolf et al., 2016</xref>). <xref ref-type="bibr" rid="bib0495">Wolf et al. (2016)</xref> carried out analysis of DNAm age while <xref ref-type="bibr" rid="bib0380">Sadeh et al. (2016)</xref> carried out a candidate gene analysis of <italic>SKA2</italic> (<xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>; <xref ref-type="bibr" rid="bib0495">Wolf et al., 2016</xref>). <xref ref-type="bibr" rid="bib0285">McNerney et al. (2018)</xref> measured DNAm at the <italic>NR3C1</italic> gene using bisulfite pyrosequencing (<xref ref-type="bibr" rid="bib0285">McNerney et al., 2018</xref>). All three of the articles investigating a population of mothers who have experienced IPV studied candidate genes: <italic>NR3C1, BDNF</italic> and <italic>5HT3A</italic> (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>; <xref ref-type="bibr" rid="bib0390">Schechter et al., 2017</xref>, <xref ref-type="bibr" rid="bib0385">2015</xref>). All three used fMRI, with two using the same task (Modified Crowell procedure), and one using a unique task video stimulus depicting neutral, menacing, and male-female prosocial interactions (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>). The two studies that reported on IPV PTSD mothers in relation to the modified Crowell procedure showed positive associations between DNAm at <italic>NR3C1</italic> and <italic>BDNF</italic> and cluster activation in vmPFC OFC posterior cingulate cortex (<xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref>; <xref ref-type="bibr" rid="bib0385">Schechter et al., 2015</xref>).<table-wrap id="tbl0040" position="float"><label>Table 8</label><caption><p>Post-traumatic stress disorder.</p></caption><alt-text id="at0045">Table 8</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis0850" list-type="simple"><list-item id="lsti2805"><label>•</label><p id="par2805">Condition</p></list-item><list-item id="lsti2810"><label>•</label><p id="par2810">Cases (male); controls (male)</p></list-item><list-item id="lsti2815"><label>•</label><p id="par2815">Age</p></list-item></list></th><th align="left"><list id="lis0855" list-type="simple"><list-item id="lsti2820"><label>•</label><p id="par2820">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti2825"><label>•</label><p id="par2825">Tissue sampled</p></list-item><list-item id="lsti2830"><label>•</label><p id="par2830">Correction for cell sub-type distribution</p></list-item><list-item id="lsti2835"><label>•</label><p id="par2835">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis0860" list-type="simple"><list-item id="lsti2840"><label>•</label><p id="par2840">MRI field strength</p></list-item><list-item id="lsti2845"><label>•</label><p id="par2845">Modality</p></list-item><list-item id="lsti2850"><label>•</label><p id="par2850">Image feature(s)</p></list-item></list>Analysis method</th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left"><xref ref-type="bibr" rid="bib0240">Klengel et al., 2013</xref><break></break>United States</td><td align="left"><list id="lis0865" list-type="simple"><list-item id="lsti2855"><label>•</label><p id="par2855">Childhood trauma related PTSD</p></list-item><list-item id="lsti2860"><label>•</label><p id="par2860">Cases n = 56(F)</p></list-item><list-item id="lsti2865"><label>•</label><p id="par2865">Cases, mean age 28.5 mean years</p></list-item></list></td><td align="left"><list id="lis0870" list-type="simple"><list-item id="lsti2870"><label>•</label><p id="par2870">Candidate: <italic>FKBP5</italic> - 4 intronic regions, CpG island of TSS and a region upstream of the TSS</p></list-item><list-item id="lsti2875"><label>•</label><p id="par2875">Blood</p></list-item><list-item id="lsti2880"><label>•</label><p id="par2880">Cell type composition: NR</p></list-item><list-item id="lsti2885"><label>•</label><p id="par2885">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0875" list-type="simple"><list-item id="lsti2890"><label>•</label><p id="par2890">3 T</p></list-item><list-item id="lsti2895"><label>•</label><p id="par2895">Structural, T1</p></list-item><list-item id="lsti2900"><label>•</label><p id="par2900">Amygdala/Hippocampal volume</p></list-item><list-item id="lsti2905"><label>•</label><p id="par2905">Amygdala and hippocampal segmentation (<xref ref-type="bibr" rid="bib0340">Pruessner et al., 2000</xref>)</p></list-item></list></td><td align="left"><list id="lis0880" list-type="simple"><list-item id="lsti2910"><label>•</label><p id="par2910">Negative association between FKBP5 (mean at intron 7 bin 2) DNAm and right hippocampal head volume in a subset of the cohort (n = 34).</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0290">Moser et al., 2015</xref><break></break>Switzerland †<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0885" list-type="simple"><list-item id="lsti2915"><label>•</label><p id="par2915">Inter-personal violence related PTSD</p></list-item><list-item id="lsti2920"><label>•</label><p id="par2920">Controls, n = 20 F; Subthreshold PTSD, n = 8 F; IPV-PTSD diagnosis, n = 18 F</p></list-item><list-item id="lsti2925"><label>•</label><p id="par2925">Age - (sample of 68 mothers with saliva): Mean 34.3 years (s.d. 5.8 years)</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0890" list-type="simple"><list-item id="lsti2930"><label>•</label><p id="par2930">Candidate: <italic>BDNF</italic> - mean methylation of 4 CpGs found in exon IV</p></list-item><list-item id="lsti2935"><label>•</label><p id="par2935">Saliva</p></list-item><list-item id="lsti2940"><label>•</label><p id="par2940">Cell type composition: NR</p></list-item><list-item id="lsti2945"><label>•</label><p id="par2945">Consideration of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0895" list-type="simple"><list-item id="lsti2950"><label>•</label><p id="par2950">3 T</p></list-item><list-item id="lsti2955"><label>•</label><p id="par2955">fMRI task: Modified Crowell Procedure</p></list-item><list-item id="lsti2960"><label>•</label><p id="par2960">Contrast of brain activity when mothers watched their own and unfamiliar children during scenes of separation vs play</p></list-item><list-item id="lsti2965"><label>•</label><p id="par2965">SPM8</p></list-item></list><hr/></td><td align="left">Whole group analysis:</td></tr><tr><td align="left"><list id="lis0900" list-type="simple"><list-item id="lsti2970"><label>•</label><p id="par2970">Positive associations between <italic>BDNF</italic> promoter mean methylation and DNAm and cluster activation in the following clusters: in left vmPFC, OFC, sgACC; right vmPFC, OFC; posterior cingulate cortex.</p></list-item><list-item id="lsti2975"><label>•</label><p id="par2975">Negative associations between <italic>BDNF</italic> promoter mean methylation and cluster activation in the following clusters: right hippocampus, right parahippocampal gyrus, right fusiform gyrus; left precuneus; right precuneus; left cerebellum; right STG.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0385">Schechter et al., 2015</xref><break></break>Switzerland †<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0905" list-type="simple"><list-item id="lsti2980"><label>•</label><p id="par2980">Inter-personal violence related PTSD</p></list-item><list-item id="lsti2985"><label>•</label><p id="par2985">Cases, n = 28; controls n = 17</p></list-item><list-item id="lsti2990"><label>•</label><p id="par2990">Cases, median 35.1 years; controls, median 35.5 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0910" list-type="simple"><list-item id="lsti2995"><label>•</label><p id="par2995">Candidate: <italic>NR3C1</italic> – mean methylation of 13 CpGs</p></list-item><list-item id="lsti3000"><label>•</label><p id="par3000">Saliva</p></list-item><list-item id="lsti3005"><label>•</label><p id="par3005">Cell type composition: NR</p></list-item><list-item id="lsti3010"><label>•</label><p id="par3010">Consideration of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0915" list-type="simple"><list-item id="lsti3015"><label>•</label><p id="par3015">3 T</p></list-item><list-item id="lsti3020"><label>•</label><p id="par3020">fMRI task: Modified Crowell Procedure</p></list-item><list-item id="lsti3025"><label>•</label><p id="par3025">Batch programming based on SPM8</p></list-item></list><hr/></td><td align="left">Whole group analysis:</td></tr><tr><td align="left"><list id="lis0920" list-type="simple"><list-item id="lsti3030"><label>•</label><p id="par3030">Positive associations between DNAm of <italic>NRC31</italic> and cluster activation in vmPFC OFC, right gyrus rectus; left dlPFC; left dlPFC, left precentral gyrus; dmPFC; left precuneus, posterior cingulate cortex</p></list-item><list-item id="lsti3035"><label>•</label><p id="par3035">Spearman’s correlations between each of the 13 CpG sites and neural activity in prefrontal cortex regions during separation vs. play did not reach statistical significance</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref><break></break>United States ‡</td><td align="left"><list id="lis0925" list-type="simple"><list-item id="lsti3040"><label>•</label><p id="par3040">PTSD</p></list-item><list-item id="lsti3045"><label>•</label><p id="par3045">Cases: a subset (n = 145) of cohort size n = 200(182 M)</p></list-item><list-item id="lsti3050"><label>•</label><p id="par3050">Mean 31.8 years</p></list-item></list></td><td align="left"><list id="lis0930" list-type="simple"><list-item id="lsti3055"><label>•</label><p id="par3055">Candidate: <italic>SKA2</italic>– 3’ UTR. (Illumina probe cg13989295)</p></list-item><list-item id="lsti3060"><label>•</label><p id="par3060">Illumina 450 array</p></list-item><list-item id="lsti3065"><label>•</label><p id="par3065">Blood</p></list-item></list><list id="lis0935" list-type="simple"><list-item id="lsti3070"><label>•</label><p id="par3070">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis0940" list-type="simple"><list-item id="lsti3075"><label>•</label><p id="par3075">3 T</p></list-item><list-item id="lsti3080"><label>•</label><p id="par3080">Structural, T1</p></list-item><list-item id="lsti3085"><label>•</label><p id="par3085">Cortical thicknesses</p></list-item><list-item id="lsti3090"><label>•</label><p id="par3090">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis0945" list-type="simple"><list-item id="lsti3095"><label>•</label><p id="par3095">Negative associations between <italic>SKA2</italic> DNAm and cortical thickness in prefrontal regions: left frontal pole, SFG and rostral middle frontal gyrus; right frontal pole, SFG, and right OFC/IFG pars orbitalis and rostral MFG.</p></list-item><list-item id="lsti3100"><label>•</label><p id="par3100">Mediation was significant for right OFC and rostral MFG cluster, and for left prefrontal cluster. Mediation effect not significant for the right frontal pole/SFG cluster, though direction of association was consistent.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0495">Wolf et al., 2016</xref><break></break>United States ‡<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0950" list-type="simple"><list-item id="lsti3105"><label>•</label><p id="par3105">PTSD</p></list-item><list-item id="lsti3110"><label>•</label><p id="par3110">Cases, n = 281(247 M)</p></list-item><list-item id="lsti3115"><label>•</label><p id="par3115">Cases, mean age 31.9 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0955" list-type="simple"><list-item id="lsti3120"><label>•</label><p id="par3120">Epigenome-wide: Illumina 450 array, Horvath/Hannum DNAm age Blood</p></list-item><list-item id="lsti3125"><label>•</label><p id="par3125">Cell type composition: yes</p></list-item><list-item id="lsti3130"><label>•</label><p id="par3130">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis0960" list-type="simple"><list-item id="lsti3135"><label>•</label><p id="par3135">3 T</p></list-item><list-item id="lsti3140"><label>•</label><p id="par3140">Diffusion</p></list-item><list-item id="lsti3145"><label>•</label><p id="par3145">FA/RD/MD/AxD in right frontal cortex, left frontal cortex, genu of corpus callosum</p></list-item><list-item id="lsti3150"><label>•</label><p id="par3150">FreeSurfer/TBSS</p></list-item></list><hr/></td><td align="left">Subset (n = 241):</td></tr><tr><td align="left"><list id="lis0965" list-type="simple"><list-item id="lsti3155"><label>•</label><p id="par3155">Accelerated Hannum DNAm age associated with decreased FA, increased RD and MD in genu of corpus callosum</p></list-item><list-item id="lsti3160"><label>•</label><p id="par3160">Positive association between DNAm age acceleration and RD and MD in genu of corpus callosum</p></list-item><list-item id="lsti3165"><label>•</label><p id="par3165">Negative association between DNAn age acceleration and FA in the genu of corpus callosum.</p></list-item><list-item id="lsti3170"><label>•</label><p id="par3170">No associations found with Horvath DNAm age.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0390">Schechter et al., 2017</xref><break></break>Switzerland †</td><td align="left"><list id="lis0970" list-type="simple"><list-item id="lsti3175"><label>•</label><p id="par3175">Inter-personal violence related PTSD</p></list-item><list-item id="lsti3180"><label>•</label><p id="par3180">Cases, n = 18 F; controls, n = 17F</p></list-item><list-item id="lsti3185"><label>•</label><p id="par3185">Cases, mean age 33.5 years; controls, mean 35.6 years</p></list-item></list></td><td align="left"><list id="lis0975" list-type="simple"><list-item id="lsti3190"><label>•</label><p id="par3190">Candidate: serotonin receptor 3A methylation (<italic>HTR3A</italic>) – 7 CpG sites in the promoter region</p></list-item><list-item id="lsti3195"><label>•</label><p id="par3195">Saliva</p></list-item><list-item id="lsti3200"><label>•</label><p id="par3200">Cell type composition: NR</p></list-item><list-item id="lsti3205"><label>•</label><p id="par3205">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis0980" list-type="simple"><list-item id="lsti3210"><label>•</label><p id="par3210">Field strength: NR</p></list-item><list-item id="lsti3215"><label>•</label><p id="par3215">fMRI task: video stimuli depicting neutral, menacing, and male-female prosocial interactions.</p></list-item><list-item id="lsti3220"><label>•</label><p id="par3220">Neural activity in maternal brain regions association with emotion regulation</p></list-item><list-item id="lsti3225"><label>•</label><p id="par3225">Batch programming based on SPM8</p></list-item></list></td><td align="left"><list id="lis0985" list-type="simple"><list-item id="lsti3230"><label>•</label><p id="par3230">Negative association between DNAm at CpG 2 III site and neural activity in response to menacing vs prosocial stimuli: dorsomedial PFC, dACC, bilateral dorsolateral prefrontal gyrus, left prefrontal gyrus, left temporal pole, left STG, left MTG; posterior cingulate cortex; left cuneus, V1; cerebellum; right brainstem.</p></list-item><list-item id="lsti3235"><label>•</label><p id="par3235">Negative association between DNAm at <italic>5HT3A</italic> CpG 2 III site and neural activity in response to menacing vs neutral stimuli: dmPFC, left dlPFC, left temporal pole, left middle temporal gyrus.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0285">Mcnerney et al., 2018</xref><break></break>United States</td><td align="left"><list id="lis0990" list-type="simple"><list-item id="lsti3240"><label>•</label><p id="par3240">Veterans risk of meeting PTSD diagnostic criteria</p></list-item><list-item id="lsti3245"><label>•</label><p id="par3245">Cases, n = 67 (59 M)</p></list-item><list-item id="lsti3250"><label>•</label><p id="par3250">Cases, mean 46 years</p></list-item></list></td><td align="left"><list id="lis0995" list-type="simple"><list-item id="lsti3255"><label>•</label><p id="par3255">Candidate: <italic>NR3C1-1F</italic> – promoter binding sites for transcription factor NGF1A</p></list-item><list-item id="lsti3260"><label>•</label><p id="par3260">Saliva</p></list-item><list-item id="lsti3265"><label>•</label><p id="par3265">Cell type composition: NR</p></list-item><list-item id="lsti3270"><label>•</label><p id="par3270">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1000" list-type="simple"><list-item id="lsti3275"><label>•</label><p id="par3275">3 T</p></list-item><list-item id="lsti3280"><label>•</label><p id="par3280">Structural, FSPGR</p></list-item><list-item id="lsti3285"><label>•</label><p id="par3285">Intracranial volume and hippocampal volume</p></list-item><list-item id="lsti3290"><label>•</label><p id="par3290">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis1005" list-type="simple"><list-item id="lsti3295"><label>•</label><p id="par3295">Positive associations between hippocampal volume and DNAm of <italic>NR3C1</italic> gene in low scorers on the PTSD checklist (Civilian version 4; PCL-C), unlikely to meet PTSD diagnostic criteria).</p></list-item><list-item id="lsti3300"><label>•</label><p id="par3300">Associations were not significant for those who scored highly on the PCL-C.</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn id="spar0095"><p><sup>†</sup> Overlapping cohort.</p></fn><fn id="spar0100"><p><sup>‡</sup> Overlapping cohort.</p></fn></table-wrap-foot></table-wrap></p>
</sec>
<sec id="sec0105">
<label>3.4.7</label>
<title>Miscellaneous: healthy adults, socio-emotional processing, Cushing’s syndrome</title>
<p id="par4895">Two of the included studies in this section investigated patient populations, and the remainder reported healthy participants. One case-control study investigated DNAm-MRI in Cushing’s Syndrome patients, and another case series study investigated social anxiety disorder (<xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref>; <xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>). Both studies discovered significant correlations between DNAm and neuroimaging findings. Fourteen studies in this section adopt a candidate gene analysis approach, with 1 being epigenome-wide (<xref ref-type="table" rid="tbl0045">Table 9</xref>). The candidate genes studied were: <italic>COMT</italic> (n = 1)<italic>, OXTR</italic> (n = 3)<italic>, NR3C1</italic> (n = 1)<italic>, SLC6A4</italic> (n = 5)<italic>, OXT</italic> (n = 1)<italic>, FKBP5</italic> (n = 1)<italic>, KLF13</italic> (n = 1), <italic>BDNF</italic> (n = 1). DNAm was measured in the following tissues: saliva (n = 3); blood (n = 10); blood/saliva/buccal (n = 1); saliva and blood (n = 1). Two MRI modalities are represented in this section: sMRI (n = 3), and fMRI (n = 10), and two studies used both modalities (s/fMRI (n = 2). fMRI tasks included: N back task, social phobia associated verbal stimuli, emotional perspective, emotional attribution, social perception, emotional face processing, responses to high calorie versus low calorie foods.<table-wrap id="tbl0045" position="float"><label>Table 9</label><caption><p>Miscellaneous: healthy adults, emotion processing, social anxiety disorder, Cushing’s syndrome.</p></caption><alt-text id="at0050">Table 9</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Author, Country</th><th align="left">Sample characteristics<list id="lis1010" list-type="simple"><list-item id="lsti3305"><label>•</label><p id="par3305">Condition</p></list-item><list-item id="lsti3310"><label>•</label><p id="par3310">Cases (male); controls (male)</p></list-item><list-item id="lsti3315"><label>•</label><p id="par3315">Age</p></list-item></list></th><th align="left"><list id="lis1015" list-type="simple"><list-item id="lsti3320"><label>•</label><p id="par3320">Epigenome-wide/candidate, platform</p></list-item><list-item id="lsti3325"><label>•</label><p id="par3325">Tissue sampled</p></list-item><list-item id="lsti3330"><label>•</label><p id="par3330">Correction for cell sub-type distribution</p></list-item><list-item id="lsti3335"><label>•</label><p id="par3335">Consideration of genotype</p></list-item></list></th><th align="left"><list id="lis1020" list-type="simple"><list-item id="lsti3340"><label>•</label><p id="par3340">MRI field strength</p></list-item><list-item id="lsti3345"><label>•</label><p id="par3345">Modality</p></list-item><list-item id="lsti3350"><label>•</label><p id="par3350">Image feature(s)</p></list-item><list-item id="lsti3355"><label>•</label><p id="par3355">Analysis method</p></list-item></list></th><th align="left">Main Findings</th></tr></thead><tbody><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref><break></break>Italy<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1025" list-type="simple"><list-item id="lsti3360"><label>•</label><p id="par3360">Healthy participants</p></list-item><list-item id="lsti3365"><label>•</label><p id="par3365">Cases, n = 84(32 M)</p></list-item><list-item id="lsti3370"><label>•</label><p id="par3370">Cases, mean age 25.9 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1030" list-type="simple"><list-item id="lsti3375"><label>•</label><p id="par3375">Candidate: <italic>COMT-</italic> rs4680 (C2) and gene promoter (3 CpGs in the promoter)</p></list-item><list-item id="lsti3380"><label>•</label><p id="par3380">Peripheral blood mononuclear cells</p></list-item><list-item id="lsti3385"><label>•</label><p id="par3385">Cell type composition: NR</p></list-item><list-item id="lsti3390"><label>•</label><p id="par3390">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1035" list-type="simple"><list-item id="lsti3395"><label>•</label><p id="par3395">3 T</p></list-item><list-item id="lsti3400"><label>•</label><p id="par3400">fMRI task: N-back task–working memory</p></list-item><list-item id="lsti3405"><label>•</label><p id="par3405">BOLD responses in the bilateral prefrontal cortex</p></list-item><list-item id="lsti3410"><label>•</label><p id="par3410">SPM5</p></list-item></list><hr/></td><td align="left">Val/Val genotype:</td></tr><tr><td align="left"><list id="lis1040" list-type="simple"><list-item id="lsti3415"><label>•</label><p id="par3415">Negative association between C2 DNAm and bilateral PFC (BA 45/13 and BA47) activity during task</p></list-item><list-item id="lsti3420"><label>•</label><p id="par3420">Increased stress and lower C2 DNAm related to greater activity in bilateral PFC (BA10/47; BA44/45) during working memory task</p></list-item><list-item id="lsti3425"><label>•</label><p id="par3425">No significant relationship was found between DNAm of sites in the COMT promoter or in LINE-1 and working memory related PFC activity in any other genotype group or in the whole sample.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0215">Jack et al., 2012</xref><break></break>United States</td><td align="left"><list id="lis1045" list-type="simple"><list-item id="lsti3430"><label>•</label><p id="par3430">Healthy participants</p></list-item><list-item id="lsti3435"><label>•</label><p id="par3435">Cases, n = 42(23 M)</p></list-item><list-item id="lsti3440"><label>•</label><p id="par3440">Cases, mean age 21.9 years</p></list-item></list></td><td align="left"><list id="lis1050" list-type="simple"><list-item id="lsti3445"><label>•</label><p id="par3445">Candidate: <italic>OXTR</italic>- coding strand including site -934</p></list-item><list-item id="lsti3450"><label>•</label><p id="par3450">Blood (mononuclear cells)</p></list-item><list-item id="lsti3455"><label>•</label><p id="par3455">Cell type composition: NR</p></list-item><list-item id="lsti3460"><label>•</label><p id="par3460">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1055" list-type="simple"><list-item id="lsti3465"><label>•</label><p id="par3465">3 T</p></list-item><list-item id="lsti3470"><label>•</label><p id="par3470">fMRI task: social perception task (animacy versus random movement)</p></list-item><list-item id="lsti3475"><label>•</label><p id="par3475">whole brain: BOLD activity</p></list-item><list-item id="lsti3480"><label>•</label><p id="par3480">FSL (FEAT)</p></list-item></list></td><td align="left"><list id="lis1060" list-type="simple"><list-item id="lsti3485"><label>•</label><p id="par3485"><italic>OXTR</italic> DNAm positively associated with activity in left STG, supramarginal gyrus, and right dACC.</p></list-item><list-item id="lsti3490"><label>•</label><p id="par3490">Controlling for sex: <italic>OXTR</italic> DNAm positively associated with activity in the left STG and right dACC. No difference between men and women.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0465">Vukojevic et al., 2014</xref><break></break>Switzerland</td><td align="left"><list id="lis1065" list-type="simple"><list-item id="lsti3495"><label>•</label><p id="par3495">Healthy participants</p></list-item><list-item id="lsti3500"><label>•</label><p id="par3500">Cases, n = 72(25 M)</p></list-item><list-item id="lsti3505"><label>•</label><p id="par3505">Cases, median age 23 years</p></list-item></list></td><td align="left"><list id="lis1070" list-type="simple"><list-item id="lsti3510"><label>•</label><p id="par3510">Candidate: <italic>NR3C1</italic> - CpG3</p></list-item><list-item id="lsti3515"><label>•</label><p id="par3515">Saliva</p></list-item><list-item id="lsti3520"><label>•</label><p id="par3520">Cell type composition: NR</p></list-item><list-item id="lsti3525"><label>•</label><p id="par3525">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1075" list-type="simple"><list-item id="lsti3530"><label>•</label><p id="par3530">3 T</p></list-item><list-item id="lsti3535"><label>•</label><p id="par3535">fMRI task: N-back task–working memory task</p></list-item><list-item id="lsti3540"><label>•</label><p id="par3540">Brain activation</p></list-item><list-item id="lsti3545"><label>•</label><p id="par3545">SPM8</p></list-item></list></td><td align="left"><list id="lis1080" list-type="simple"><list-item id="lsti3550"><label>•</label><p id="par3550">Women: no significant associations between <italic>NR3C1</italic> CpG3 DNAm and brain activation during fMRI task.</p></list-item><list-item id="lsti3555"><label>•</label><p id="par3555">Men: positive associations between DNAm at <italic>NR3C1</italic> CpG3 and brain activity related to successful recognition of previously seen pictures: right hemisphere pars orbitalis, right hemisphere pars triangularis of the inferior frontal gyrus; near superior temporal cortex; left hemisphere cuneus, left hemisphere pericalcarine; near superior frontal cortex.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0315">Nikolova et al., 2014</xref><break></break>United States</td><td align="left"><list id="lis1085" list-type="simple"><list-item id="lsti3560"><label>•</label><p id="par3560">Healthy participants, Discovery set n = 80(38 M); replication set: 96 (48 M)</p></list-item><list-item id="lsti3565"><label>•</label><p id="par3565">Discovery set mean age 19.7 years; replication set 13.6 years</p></list-item></list></td><td align="left"><list id="lis1090" list-type="simple"><list-item id="lsti3570"><label>•</label><p id="par3570">Candidate: <italic>SLC6A4-</italic> 20 CpG sites in promoter region</p></list-item><list-item id="lsti3575"><label>•</label><p id="par3575">Discovery: saliva</p></list-item><list-item id="lsti3580"><label>•</label><p id="par3580">Replication: blood</p></list-item><list-item id="lsti3585"><label>•</label><p id="par3585">Cell type composition: NR</p></list-item><list-item id="lsti3590"><label>•</label><p id="par3590">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis1095" list-type="simple"><list-item id="lsti3595"><label>•</label><p id="par3595">3 T</p></list-item><list-item id="lsti3600"><label>•</label><p id="par3600">fMRI task: emotional faces processing</p></list-item><list-item id="lsti3605"><label>•</label><p id="par3605">BOLD - amygdala reactivity to threat (angry/fearful faces vs shapes).</p></list-item><list-item id="lsti3610"><label>•</label><p id="par3610">SPM8</p></list-item></list></td><td align="left"><list id="lis1100" list-type="simple"><list-item id="lsti3615"><label>•</label><p id="par3615">Positive association between <italic>SLC6A4</italic> DNAm and left amygdala reactivity in response to threat stimuli; right amygdala did not reach statistical significance.</p></list-item><list-item id="lsti3620"><label>•</label><p id="par3620">The CpG with the strongest association across both hemispheres is CpG14.</p></list-item><list-item id="lsti3625"><label>•</label><p id="par3625">Findings consistent in discovery and replication sets</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0075">Dannlowski et al., 2014</xref><break></break>Germany</td><td align="left"><list id="lis1105" list-type="simple"><list-item id="lsti3630"><label>•</label><p id="par3630">Healthy participants</p></list-item><list-item id="lsti3635"><label>•</label><p id="par3635">Cases, n = 189(90 M)</p></list-item><list-item id="lsti3640"><label>•</label><p id="par3640">Two independent samples: sample 1 n = 94(42 M); sample 2 n = 95(46 M)</p></list-item><list-item id="lsti3645"><label>•</label><p id="par3645">Sample 1 mean age 36.9 years; sample 2 mean age 34.2 years</p></list-item></list></td><td align="left"><list id="lis1110" list-type="simple"><list-item id="lsti3650"><label>•</label><p id="par3650">Candidate: <italic>SLC6A4</italic> AluJb element – mean methylation of 8 investigated sites</p></list-item><list-item id="lsti3655"><label>•</label><p id="par3655">Blood</p></list-item><list-item id="lsti3660"><label>•</label><p id="par3660">Cell type composition: NR</p></list-item><list-item id="lsti3665"><label>•</label><p id="par3665">Genotype: yes</p></list-item></list></td><td align="left"><list id="lis1115" list-type="simple"><list-item id="lsti3670"><label>•</label><p id="par3670">Field strength: NR</p></list-item><list-item id="lsti3675"><label>•</label><p id="par3675">Structural, T1</p></list-item><list-item id="lsti3680"><label>•</label><p id="par3680">VBM-ROI volumes: hippocampus, anterior cingulate cortex, amygdala</p></list-item><list-item id="lsti3685"><label>•</label><p id="par3685">VBM – whole brain.</p></list-item><list-item id="lsti3690"><label>•</label><p id="par3690">VBM8/SPM8</p></list-item></list></td><td align="left"><list id="lis1120" list-type="simple"><list-item id="lsti3695"><label>•</label><p id="par3695">Positive association between AluJb DNAm in the <italic>SLC6A4</italic> gene and bilateral hippocampal grey matter volume in ROI analysis in both samples. In sample 1 peak coordinates cluster extended into the bilateral amygdala. This was not the case in sample 2, but was the case in the combined sample.</p></list-item><list-item id="lsti3700"><label>•</label><p id="par3700">Whole brain analysis: positive association clusters where a positive association is also found: bilateral insula, right putamen, amygdala and caudate, and left superior occipital gyrus, bilateral hippocampus.</p></list-item><list-item id="lsti3705"><label>•</label><p id="par3705">No areas showed a negative association between DNAm rates and grey matter volume.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref><break></break>United States</td><td align="left"><list id="lis1125" list-type="simple"><list-item id="lsti3710"><label>•</label><p id="par3710">Healthy participants</p></list-item><list-item id="lsti3715"><label>•</label><p id="par3715">Cases, n = 98(42 M)</p></list-item><list-item id="lsti3720"><label>•</label><p id="par3720">Cases, mean age 22.8 years</p></list-item></list></td><td align="left"><list id="lis1130" list-type="simple"><list-item id="lsti3725"><label>•</label><p id="par3725">Candidate: <italic>OXTR-</italic> CpG site at position -934 relative to TSS</p></list-item><list-item id="lsti3730"><label>•</label><p id="par3730">Peripheral blood mononuclear cells</p></list-item><list-item id="lsti3735"><label>•</label><p id="par3735">Cell type composition: NR</p></list-item><list-item id="lsti3740"><label>•</label><p id="par3740">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1135" list-type="simple"><list-item id="lsti3745"><label>•</label><p id="par3745">3 T</p></list-item><list-item id="lsti3750"><label>•</label><p id="par3750">fMRI task: emotional face matching task.</p></list-item><list-item id="lsti3755"><label>•</label><p id="par3755">BOLD - ROI analysis</p></list-item><list-item id="lsti3760"><label>•</label><p id="par3760">PPI/FEAT (FSL)</p></list-item></list></td><td align="left"><list id="lis1140" list-type="simple"><list-item id="lsti3765"><label>•</label><p id="par3765">Positive association between <italic>OXTR</italic> DNAm and BOLD in the left amygdala in Faces versus Ovals. No association in right amygdala.</p></list-item><list-item id="lsti3770"><label>•</label><p id="par3770">Higher <italic>OXTR</italic> DNAm predicted decreased levels of functional connectivity on tasks involving affect appraisal and emotion regulation between right amygdala and brain regions involved in emotional regulation including insular cortex, cingulate cortex, orbitofrontal cortex as well as regions associated with face perception e.g fusiform gyrus. Left amygdala showed no significant voxels.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref><break></break>Germany</td><td align="left"><list id="lis1145" list-type="simple"><list-item id="lsti3775"><label>•</label><p id="par3775">Social anxiety disorder</p></list-item><list-item id="lsti3780"><label>•</label><p id="par3780">Cases, n = 25(F)</p></list-item><list-item id="lsti3785"><label>•</label><p id="par3785">Cases, mean age 28.8 years</p></list-item></list></td><td align="left"><list id="lis1150" list-type="simple"><list-item id="lsti3790"><label>•</label><p id="par3790">Candidate: <italic>OXTR-</italic> exon 3</p></list-item><list-item id="lsti3795"><label>•</label><p id="par3795">Blood</p></list-item><list-item id="lsti3800"><label>•</label><p id="par3800">Cell type composition: NR</p></list-item><list-item id="lsti3805"><label>•</label><p id="par3805">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis1155" list-type="simple"><list-item id="lsti3810"><label>•</label><p id="par3810">3 T</p></list-item><list-item id="lsti3815"><label>•</label><p id="par3815">fMRI task: social phobia related verbal stimuli</p></list-item><list-item id="lsti3820"><label>•</label><p id="par3820">Amygdala responsiveness</p></list-item><list-item id="lsti3825"><label>•</label><p id="par3825">SPM8</p></list-item></list></td><td align="left"><list id="lis1160" list-type="simple"><list-item id="lsti3830"><label>•</label><p id="par3830">In SAD patients (n = 25 F): negative association between <italic>OXTR</italic> DNAm and amygdala responsiveness in social phobia vs negative words or neutral words.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0295">Muehlhan et al., 2015</xref><break></break>Germany<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1165" list-type="simple"><list-item id="lsti3835"><label>•</label><p id="par3835">Healthy participants</p></list-item><list-item id="lsti3840"><label>•</label><p id="par3840">Cases, n = 74(45 M)</p></list-item><list-item id="lsti3845"><label>•</label><p id="par3845">Cases (male), mean age 23.6 years; cases (female), mean age 23.2 years</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1170" list-type="simple"><list-item id="lsti3850"><label>•</label><p id="par3850">Candidate: <italic>SLC6A4</italic>- mean methylation score at the promoter</p></list-item><list-item id="lsti3855"><label>•</label><p id="par3855">Blood</p></list-item><list-item id="lsti3860"><label>•</label><p id="par3860">Cell type composition: NR</p></list-item><list-item id="lsti3865"><label>•</label><p id="par3865">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1175" list-type="simple"><list-item id="lsti3870"><label>•</label><p id="par3870">3 T</p></list-item><list-item id="lsti3875"><label>•</label><p id="par3875">fMRI: resting state</p></list-item><list-item id="lsti3880"><label>•</label><p id="par3880">SPM12</p></list-item></list><hr/></td><td align="left">Positive associations between <italic>SLC6A4</italic> DNAm and amygdala RS functional coupling with nodes of the salience network:</td></tr><tr><td align="left"><list id="lis1180" list-type="simple"><list-item id="lsti3885"><label>•</label><p id="par3885">Right amygdala: right SMA and left dACC, left putamen and left insula, right IFG, right putamen, right insula</p></list-item><list-item id="lsti3890"><label>•</label><p id="par3890">Left amygdala: right dACC, left ACC, left SMA</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="2" valign="middle"><xref ref-type="bibr" rid="bib0455">Ursini et al., 2016</xref><break></break>Italy<hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1185" list-type="simple"><list-item id="lsti3895"><label>•</label><p id="par3895">Healthy participants</p></list-item><list-item id="lsti3900"><label>•</label><p id="par3900">Cases, n = 141</p></list-item><list-item id="lsti3905"><label>•</label><p id="par3905">Age: NR</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1190" list-type="simple"><list-item id="lsti3910"><label>•</label><p id="par3910">Candidate: <italic>BDNF</italic> - rs6265 methylation status</p></list-item><list-item id="lsti3915"><label>•</label><p id="par3915">Blood</p></list-item><list-item id="lsti3920"><label>•</label><p id="par3920">Cell type composition: NR</p></list-item><list-item id="lsti3925"><label>•</label><p id="par3925">Consideration of genotype: yes</p></list-item></list><hr/></td><td align="left" rowspan="2" valign="middle"><list id="lis1195" list-type="simple"><list-item id="lsti3930"><label>•</label><p id="par3930">3 T</p></list-item><list-item id="lsti3935"><label>•</label><p id="par3935">fMRI task: N-back task, working memory</p></list-item><list-item id="lsti3940"><label>•</label><p id="par3940">SPM8</p></list-item></list><hr/></td><td align="left">Analysis carried out in 141 healthy subjects:</td></tr><tr><td align="left"><list id="lis1200" list-type="simple"><list-item id="lsti3945"><label>•</label><p id="par3945">Positive association between <italic>BDNF</italic> rs6265 DNAm and left prefrontal activity</p></list-item><list-item id="lsti3950"><label>•</label><p id="par3950">Val/Val genotype: greater DNAm is associated with reduced activity in the PFC (BA46) subjects with hypoxia related obstetric complications (assessed using the McNeil-Sjöström Scale) compared to those without.</p></list-item><list-item id="lsti3955"><label>•</label><p id="par3955">Val/Met genotype: lower DNAm is associated with reduced activity in the prefrontal cortex (BA46) in subjects with hypoxia related obstetric complications compared to those without.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0150">Haas et al., 2016</xref><break></break>United States</td><td align="left"><list id="lis1205" list-type="simple"><list-item id="lsti3960"><label>•</label><p id="par3960">Healthy participants</p></list-item><list-item id="lsti3965"><label>•</label><p id="par3965">Cases, n = 121(52 M)</p></list-item><list-item id="lsti3970"><label>•</label><p id="par3970">Cases, mean age 21.3 years</p></list-item></list></td><td align="left"><list id="lis1210" list-type="simple"><list-item id="lsti3975"><label>•</label><p id="par3975">Candidate: <italic>OXT</italic> - average <italic>OXT</italic> DNA methylation across nine CpG cites</p></list-item><list-item id="lsti3980"><label>•</label><p id="par3980">Saliva</p></list-item><list-item id="lsti3985"><label>•</label><p id="par3985">Cell type composition: NR</p></list-item><list-item id="lsti3990"><label>•</label><p id="par3990">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1215" list-type="simple"><list-item id="lsti3995"><label>•</label><p id="par3995">3 T</p></list-item><list-item id="lsti4000"><label>•</label><p id="par4000">Structural, T1</p></list-item><list-item id="lsti4005"><label>•</label><p id="par4005">fMRI task: Emotional perspective taking task; Emotion attribution task</p></list-item><list-item id="lsti4010"><label>•</label><p id="par4010">VBM - SPM8</p></list-item></list></td><td align="left"><list id="lis1220" list-type="simple"><list-item id="lsti4015"><label>•</label><p id="par4015">Emotional perspective task: Negative association between <italic>OXT</italic> DNAm and activity in the R superior temporal sulcus during emotional perspective taking;</p></list-item><list-item id="lsti4020"><label>•</label><p id="par4020">Emotion attribution task: negative association in the emotion attribution between <italic>OXT</italic> DNAm and activity in: right STS, right fusiform gyrus/middle occipital gyrus, right inferior frontal gyrus; left fusiform;</p></list-item><list-item id="lsti4025"><label>•</label><p id="par4025">Negative association between <italic>OXT</italic> DNAm and grey matter volume in right fusiform gyrus</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0360">Resmini et al., 2016</xref><break></break>Spain</td><td align="left"><list id="lis1225" list-type="simple"><list-item id="lsti4030"><label>•</label><p id="par4030">Cushing’s syndrome</p></list-item><list-item id="lsti4035"><label>•</label><p id="par4035">Cases, n = 32; controls, n = 32</p></list-item><list-item id="lsti4040"><label>•</label><p id="par4040">Cases: mean age 45 years; controls, mean age 44 years</p></list-item></list></td><td align="left"><list id="lis1230" list-type="simple"><list-item id="lsti4045"><label>•</label><p id="par4045">Candidate: <italic>FKBP5</italic> - intronic regions</p></list-item><list-item id="lsti4050"><label>•</label><p id="par4050">Blood</p></list-item><list-item id="lsti4055"><label>•</label><p id="par4055">Cell type composition: NR</p></list-item><list-item id="lsti4060"><label>•</label><p id="par4060">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis1235" list-type="simple"><list-item id="lsti4065"><label>•</label><p id="par4065">3 T</p></list-item><list-item id="lsti4070"><label>•</label><p id="par4070">Structural, T1</p></list-item><list-item id="lsti4075"><label>•</label><p id="par4075">Hippocampal volume</p></list-item><list-item id="lsti4080"><label>•</label><p id="par4080">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis1240" list-type="simple"><list-item id="lsti4085"><label>•</label><p id="par4085">Cases: positive association between Intron 2 region 2 CpG3 DNAm and bilateral hippocampal volume</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left" rowspan="3" valign="middle"><xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref><break></break>Canada<hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis1245" list-type="simple"><list-item id="lsti4090"><label>•</label><p id="par4090">Healthy participants</p></list-item><list-item id="lsti4095"><label>•</label><p id="par4095">Cases 40(14 M)</p></list-item><list-item id="lsti4100"><label>•</label><p id="par4100">At time of blood sampling: 27</p></list-item><list-item id="lsti4105"><label>•</label><p id="par4105">At time of saliva/buccal sampling: mean 33.7 years</p></list-item></list><hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis1250" list-type="simple"><list-item id="lsti4110"><label>•</label><p id="par4110">Candidate: S<italic>LC6A4</italic> – promoter mean methylation score of 10 CpG sites</p></list-item><list-item id="lsti4115"><label>•</label><p id="par4115">(blood/saliva/buccal)</p></list-item><list-item id="lsti4120"><label>•</label><p id="par4120">Cell type composition: NR</p></list-item><list-item id="lsti4125"><label>•</label><p id="par4125">Consideration of genotype: NR</p></list-item></list><hr/></td><td align="left" rowspan="3" valign="middle"><list id="lis1255" list-type="simple"><list-item id="lsti4130"><label>•</label><p id="par4130">3 T</p></list-item><list-item id="lsti4135"><label>•</label><p id="par4135">fMRI task: Emotional face processing task</p></list-item><list-item id="lsti4140"><label>•</label><p id="par4140">fMRI resting state</p></list-item><list-item id="lsti4145"><label>•</label><p id="par4145">Structural, T1</p></list-item><list-item id="lsti4150"><label>•</label><p id="par4150">WB analysis and 10 ROIs grey matter volumes, functional connectivity</p></list-item><list-item id="lsti4155"><label>•</label><p id="par4155">VBM/SPM12/Conn functional connectivity toolbox</p></list-item></list><hr/></td><td align="left"><list id="lis1260" list-type="simple"><list-item id="lsti4160"><label>•</label><p id="par4160">Positive associations between <italic>SLC6A4</italic> promoter DNAm and grey matter volumes, which varied by tissue type:</p></list-item></list></td></tr><tr><td align="left"><list id="lis1265" list-type="simple"><list-item id="lsti4165"><label>-</label><p id="par4165">Blood: right superior frontal grey matter;</p></list-item><list-item id="lsti4170"><label>-</label><p id="par4170">Saliva: left superior frontal gyrus;</p></list-item><list-item id="lsti4175"><label>-</label><p id="par4175">Buccal cells: left superior frontal gyrus, left inferior frontal gyrus, right ACC.</p></list-item></list></td></tr><tr><td align="left"><list id="lis1270" list-type="simple"><list-item id="lsti4180"><label>•</label><p id="par4180">Positive association between blood <italic>SCL6A4</italic> DNAm and RS connectivity between: RLP and bilateral frontal poles and SFG; RLP and left lateral occipital cortex</p></list-item><list-item id="lsti4185"><label>•</label><p id="par4185">Positive associations between buccal <italic>SLC6A4</italic> promoter DNAm and RS connectivity between the RLP with right lateral occipital cortex and right angular gyrus, ACC, right frontal pole and mPFC</p></list-item><list-item id="lsti4190"><label>•</label><p id="par4190">No significant associations were found for task-based fMRI</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0480">Wiemerslage et al., 2017</xref><break></break>Sweden</td><td align="left"><list id="lis1275" list-type="simple"><list-item id="lsti4195"><label>•</label><p id="par4195">Orexigenia among healthy participants</p></list-item><list-item id="lsti4200"><label>•</label><p id="par4200">Cases, n = 23(all M)</p></list-item><list-item id="lsti4205"><label>•</label><p id="par4205">Cases, mean age 26 years</p></list-item></list></td><td align="left"><list id="lis1280" list-type="simple"><list-item id="lsti4210"><label>•</label><p id="par4210">Candidate: <italic>KLF13</italic> - cg07814318 probe methylation</p></list-item><list-item id="lsti4215"><label>•</label><p id="par4215">Blood</p></list-item><list-item id="lsti4220"><label>•</label><p id="par4220">Cell type composition: yes</p></list-item><list-item id="lsti4225"><label>•</label><p id="par4225">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1285" list-type="simple"><list-item id="lsti4230"><label>•</label><p id="par4230">3 T</p></list-item><list-item id="lsti4235"><label>•</label><p id="par4235">fMRI resting state and task: virtual high or low-calorie food</p></list-item><list-item id="lsti4240"><label>•</label><p id="par4240">WB</p></list-item><list-item id="lsti4245"><label>•</label><p id="par4245">SPM8</p></list-item></list></td><td align="left"><list id="lis1290" list-type="simple"><list-item id="lsti4250"><label>•</label><p id="par4250">Negative associations between <italic>KLF13</italic> DNAm and neural activity in response to images high calorie food in comparison to images of low-calorie foods in: left claustrum and insula, bilateral cingulate gyrus, right precentral gyrus and claustrum, right MFG, SFG and medial FG.</p></list-item><list-item id="lsti4255"><label>•</label><p id="par4255">Positive associations between DNAm and RS activity in the right caudate and putamen, left lingual gyrus and fusiform gyrus.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0210">Ismaylova et al., 2018</xref><break></break>Canada</td><td align="left"><list id="lis1295" list-type="simple"><list-item id="lsti4260"><label>•</label><p id="par4260">Fronto-limbic brain responses to sadness/fear</p></list-item><list-item id="lsti4265"><label>•</label><p id="par4265">Cases, n = 96 monozygotic twins (21 M pairs)</p></list-item><list-item id="lsti4270"><label>•</label><p id="par4270">Cases, mean age 15 years</p></list-item></list></td><td align="left"><list id="lis1300" list-type="simple"><list-item id="lsti4275"><label>•</label><p id="par4275">Candidate: <italic>SLC6A4–</italic> promoter CpG 5-14</p></list-item><list-item id="lsti4280"><label>•</label><p id="par4280">Saliva</p></list-item><list-item id="lsti4285"><label>•</label><p id="par4285">Cell type composition: NR</p></list-item><list-item id="lsti4290"><label>•</label><p id="par4290">Consideration of genotype: NR</p></list-item></list></td><td align="left"><list id="lis1305" list-type="simple"><list-item id="lsti4295"><label>•</label><p id="par4295">3 T</p></list-item><list-item id="lsti4300"><label>•</label><p id="par4300">fMRI task: Emotional face processing task</p></list-item><list-item id="lsti4305"><label>•</label><p id="par4305">ROI functional connectivity</p></list-item><list-item id="lsti4310"><label>•</label><p id="par4310">SPM8/CONN toolbox</p></list-item></list></td><td align="left"><list id="lis1310" list-type="simple"><list-item id="lsti4315"><label>•</label><p id="par4315">Sad condition: Positive association between <italic>SLC6A4</italic> DNAm and OFC activation. Positive association between methylation and functional connectivity between left amygdala and the ACC and the left amygdala and the right OFC</p></list-item><list-item id="lsti4320"><label>•</label><p id="par4320">Fearful condition: positive association between <italic>SLC6A4</italic>methylation and functional connectivity between ACC and both the left amygdala and left insula.</p></list-item></list></td></tr><tr><td colspan="5"><hr/></td></tr><tr><td align="left"><xref ref-type="bibr" rid="bib0115">Freytag et al., 2017</xref><break></break>Germany/<break></break>Switzerland</td><td align="left"><list id="lis1315" list-type="simple"><list-item id="lsti4325"><label>•</label><p id="par4325">Healthy cohort n = 533(222 M) of whom 514 have imaging.</p></list-item><list-item id="lsti4330"><label>•</label><p id="par4330">Mean age at MRI: mean 22.9 years; mean age at blood sampling 23.9 years</p></list-item></list></td><td align="left"><list id="lis1320" list-type="simple"><list-item id="lsti4335"><label>•</label><p id="par4335">Epigenome-wide: Illumina 450 array</p></list-item><list-item id="lsti4340"><label>•</label><p id="par4340">Blood</p></list-item><list-item id="lsti4345"><label>•</label><p id="par4345">Cell type composition: Methylomic profiling sample: yes; Replication cohort: none reported</p></list-item><list-item id="lsti4350"><label>•</label><p id="par4350">Consideration of genotype: yes</p></list-item></list></td><td align="left"><list id="lis1325" list-type="simple"><list-item id="lsti4355"><label>•</label><p id="par4355">1.5 T/3 T</p></list-item><list-item id="lsti4360"><label>•</label><p id="par4360">Structural, T1</p></list-item><list-item id="lsti4365"><label>•</label><p id="par4365">Cortical thickness</p></list-item><list-item id="lsti4370"><label>•</label><p id="par4370">FreeSurfer</p></list-item></list></td><td align="left"><list id="lis1330" list-type="simple"><list-item id="lsti4375"><label>•</label><p id="par4375">Independent component analysis (ICA) applied to decompose methylation profiles.</p></list-item><list-item id="lsti4380"><label>•</label><p id="par4380">Negative association between the second independent component (ICA2) DNAm and cortical thickness. ICA2 DNAm partially mediates the relationship between chronological age and global cortical thickness.</p></list-item><list-item id="lsti4385"><label>•</label><p id="par4385">Negative association between ICA2 and F6 (identified through exploratory factor analysis (EFA) of variation in cortical thicknesses); F6 accounts for 4% of variance in cortical thickness measures - spatial pattern comprising mainly temporal areas (loadings &gt;0.3) with highest loadings in L and R temporal poles and entorhinal cortices.</p></list-item></list></td></tr></tbody></table></table-wrap></p>
<p id="par4900">The three studies that investigated associations with <italic>OXTR</italic> methylation measured DNAm at two different positions: one in exon 3 and the other two at a CpG site -934 base pairs upstream of the TSS which has consistent methylation across blood and brain tissues (<xref ref-type="bibr" rid="bib0215">Jack et al., 2012</xref>; <xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref>; <xref ref-type="bibr" rid="bib0365">Rubin et al., 2016</xref>; <xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>). While these studies all used fMRI, they also used different tasks: social phobia related verbal stimuli, the emotional face matching task, and the social perception task (where objects move in ways to suggest animacy or random movement). One study investigated <italic>OXTR</italic> DNAm in exon 3, which had previously been implicated in social cognition, in a patient population with social anxiety disorder (<xref ref-type="bibr" rid="bib0510">Ziegler et al., 2015</xref>). The other two investigated healthy participants; one of these was in the context of social perception and individual variability in social perception (displays of animacy) (<xref ref-type="bibr" rid="bib0215">Jack et al., 2012</xref>; <xref ref-type="bibr" rid="bib0345">Puglia et al., 2015</xref>).</p>
<p id="par4905">Five papers analysed associations between <italic>SLC6A4</italic> methylation and neuroimaging features. They included fMRI (n = 4) and sMRI (n = 2). fMRI studies used resting state and/or emotional face processing tasks. <xref ref-type="bibr" rid="bib0205">Ismaylova et al. (2017)</xref> estimated DNAm from three different surrogate tissues: blood, saliva, and buccal cells and reported that right lateral parietal area (RLP) resting state connectivity with the lateral occipital cortex and frontal poles has a positive association with <italic>SLC6A4</italic> DNAm (<xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref>). <xref ref-type="bibr" rid="bib0295">Muehlhan et al. (2015)</xref> found positive associations between functional coupling between amygdala and nodes of the salience network with DNAm of the <italic>SLC6A4</italic> promoter in blood (<xref ref-type="bibr" rid="bib0295">Muehlhan et al., 2015</xref>). In the emotional face processing task, two studies report positive association between <italic>SLC6A4</italic> methylation and amygdala reactivity/connectivity in response to threat/fear related faces. Nikolova et al. reported a positive relationship between saliva DNAm at <italic>SLC6A4</italic> and left amygdala reactivity to threat stimuli, while Ismaylova et al. reported that twins with higher saliva DNAm at <italic>SLC6A4</italic> display greater connectivity between ACC and left amygdala (<xref ref-type="bibr" rid="bib0210">Ismaylova et al., 2018</xref>; <xref ref-type="bibr" rid="bib0315">Nikolova et al., 2014</xref>). The two studies that used sMRI both found positive associations between DNAm at <italic>SLC6A4</italic> and grey matter volumes (<xref ref-type="bibr" rid="bib0075">Dannlowski et al., 2014</xref>; <xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref>). However, they did not replicate each other by identifying the same brain regions as being associated even when using the same tissue to estimate DNAm.</p>
</sec>
</sec>
</sec>
<sec id="sec0110">
<label>4</label>
<title>Discussion</title>
<p id="par4910">This systematic review of 60 studies involving approximately 6775 participants suggests that differential DNAm may be associated with MRI features of brain structure and / or function for conditions / diseases within the following categories: neurodevelopment and neurodevelopmental disorders; MDD and suicidality; alcohol use disorder; schizophrenia and psychosis; ageing, stroke, ataxia and neurodegeneration; post-traumatic stress disorder; healthy adults and socio-emotional processing. We found that 10 image features were associated with differential DNAm in two or more of the 60 studies. However, quantitative synthesis of DNAm-MRI associations was not possible due to the lack of consistency in DNAm findings, and / or heterogeneity in image features across studies. While the results presented here could provide new insights into the role of DNAm in health and disease across the life course, caution is required because the clinical and methodological heterogeneity of included studies was large. We identified the following sources of methodological heterogeneity and potential sources of bias: variable inclusion and characterisation of comparator groups in study designs; use of different tissues as a surrogate for brain; variation in methods for estimating DNAm and ascertainment of cell type composition; lack of control for genotype; and variations in image processing methodology and selected MRI features.</p>
<sec id="sec0115">
<label>4.1</label>
<title>Study populations and comparator group validity</title>
<p id="par4915">Twenty-six studies (43 %) did not include a comparator group, and some others recruited cases and controls but combined the groups in DNAm-MRI analysis or restricted DNAm-MRI analysis to one group only. These issues limit inference about disease association. Several aspects of study design that are fundamental to good epidemiology should be adopted in future DNAm-MRI studies to reduce potential sources of bias and enable maximum inference. These include detailed descriptions of participant selection, the population from which they were selected, and the method used to select. Not only is this important for understanding case definition, but also because research participation is influenced by social class, education, and ethnicity, and some of these factors may influence DNAm (<xref ref-type="bibr" rid="bib0430">Stafford et al., 2013</xref>). The same descriptive standards should be applied to comparator groups to ensure clinical validity, and attention should be given to matching comparator groups for ethnicity and age because both affect DNAm (<xref ref-type="bibr" rid="bib0110">Fraser et al., 2012</xref>; <xref ref-type="bibr" rid="bib0180">Heyn et al., 2013</xref>; <xref ref-type="bibr" rid="bib0195">Horvath, 2013</xref>; <xref ref-type="bibr" rid="bib0440">Talens et al., 2010</xref>).</p>
</sec>
<sec id="sec0120">
<label>4.2</label>
<title>Surrogate tissues for brain DNAm and cell composition</title>
<p id="par4920">Surrogate tissues include blood and saliva buccal cell samples. This is important when interpreting data because of tissue and cell heterogeneity in DNAm patterns. Buccal cells, a major cell type found in saliva, have been proposed to have more validity than blood as a surrogate tissue for brain since they have a common embryological cell lineage, both being derived from the ectoderm germ layer (<xref ref-type="bibr" rid="bib0420">Smith et al., 2015</xref>). One study that ascertained DNAm from three sample types (blood, saliva, buccal - buccal cells and saliva samples are collected differently) found that DNAm obtained from non-blood surrogate tissues most strongly associated with brain processes in living humans in the context of fMRI study (<xref ref-type="bibr" rid="bib0205">Ismaylova et al., 2017</xref>). This is consistent with a previous study in postmortem brain tissue in animal models, which found that saliva and brain are more similar in their DNA methylation patterns than are blood and brain (<xref ref-type="bibr" rid="bib0265">Lowe et al., 2013</xref>). Surrogate tissues have heterogeneous cell compositions which can impact the DNAm signature of the sample: blood comprises lymphocytes, neutrophils, basophils, monocytes and eosinophils; and saliva contains predominantly buccal cells but can include leukocytes. Crucially, the compositions of both surrogates are influenced by disease status. Hence, adjustment for cell composition should be considered in DNAm analysis.</p>
</sec>
<sec id="sec0125">
<label>4.3</label>
<title>Candidate gene versus epigenome-wide approaches</title>
<p id="par4925">Forty-three included studies in this review used a candidate gene analysis approach, with candidacy most often rooted in knowledge or hypotheses about the biological underpinnings of the target disease. The majority of candidate gene studies focused on promoter regions, which risks neglect of other important regulatory regions, because it limits research to currently understood genomic elements that have a clear role in gene expression regulation.</p>
<p id="par4930">Although there are inherent sources of bias in the candidate approach, it has been suggested that candidate gene studies can provide a useful starting point for hypothesis construction for example by investigating candidates that have emerged from the GWAS literature (<xref ref-type="bibr" rid="bib0310">Nikolova and Hariri, 2015</xref>). However, we did not find that candidate selection was based on the GWAS literature in the majority of studies. For example, <italic>SLC6A4</italic> was the candidate gene in eleven studies. <italic>SLC6A4</italic> encodes a serotonin transporter responsible for serotonin re-uptake from the synapse, and is one of the targets for the serotonin reuptake inhibitor class of antidepressants. Despite the importance of this gene product in the pharmacology of depression, recent GWAS studies report no association between candidate polymorphisms at <italic>SLC6A4</italic> (or a number of other candidate genes) and major depression (<xref ref-type="bibr" rid="bib0030">Border et al., 2019</xref>). This suggests that candidate genes that encode important pharmacological targets are not necessarily aetiologically significant. This is not to say that the methylation status of these genes is irrelevant: for example, it could be useful for investigating medication response, or as a biomarker. Frodl et al. carried out an DNAm-MRI analysis with medication status as a covariate, and but found that this did not modify their findings regarding <italic>SLC6A4</italic> methylation and brain function in MDD patients and controls, while Booij et al. have reported differential methylation at the <italic>SLC6A4</italic> promoter in association SSRI exposure (<xref ref-type="bibr" rid="bib0025">Booij et al., 2015</xref>; <xref ref-type="bibr" rid="bib0120">Frodl et al., 2015</xref>). In a human population of MDD no difference was found in methylation between medication free subjects and those on medication in a post mortem study (<xref ref-type="bibr" rid="bib0375">Sabunciyan et al., 2012</xref>). These uncertainties suggest that further research into association between medication exposure and DNAm is warranted, and that hypothesis formation around candidate genes should be explicit in terms of theorised mechanism of disease or biomarker development. Further, mechanistic studies are crucial to aid our understanding of the interaction between DNAm and disease or therapy.</p>
<p id="par4935">The rationales given for the selection of candidate genes for DNAm-MRI analysis were varied. Several studies selected candidates based on prior unbiased analyses in relation to phenotype (<xref ref-type="bibr" rid="bib0235">Kim et al., 2017</xref>; <xref ref-type="bibr" rid="bib0370">Ruggeri et al., 2015</xref>; <xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>). For example, both <italic>PP1MG</italic> and <italic>SKA2</italic> were identified in EWAS analyses (<xref ref-type="bibr" rid="bib0370">Ruggeri et al., 2015</xref>; <xref ref-type="bibr" rid="bib0380">Sadeh et al., 2016</xref>), and <italic>CACNA1C</italic> was identified from a hypothesis free Methyl-Seq (<xref ref-type="bibr" rid="bib0235">Kim et al., 2017</xref>). Other candidate genes were chosen because they have a strong genetic link to the patient population being studied, such as <italic>C9orf72</italic> expansion in ALS-clinic patients and <italic>FMR1</italic> in FXTAS patients (<xref ref-type="bibr" rid="bib0280">McMillan et al., 2015</xref>; <xref ref-type="bibr" rid="bib0405">Shelton et al., 2017</xref>, <xref ref-type="bibr" rid="bib0400">2016</xref>). For the most part candidate genes were selected because their gene products are considered key components of a pathway of relevance to a condition or phenotype studied. <italic>NR3C1</italic> and <italic>FKBP5</italic>, the genes that encode the glucocorticoid receptor and FK506 binding protein (which regulates glucocorticoid receptor sensitivity), are both involved in cortisol signalling and were selected in studies investigating stress response or stress related neuropsychiatric conditions such as PTSD or MDD, or in Cushing’s Syndrome where cortisol is known to be dysregulated. <italic>BDNF</italic>, which encodes for brain derived neurotrophic factor, was studied in association to MDD, PTSD and working memory. <italic>COMT</italic> encodes catechol-O-methyltransferase, an enzyme that degrades catecholamines such as dopamine, epinephrine and norepinephrine, was the candidate gene in studies investigating DNAm-MRI in the context of working memory in schizophrenia and in healthy participants. <italic>OXTR</italic> encodes the receptor for oxytocin and was selected in studies that investigated an aspect of emotional or social processing. <italic>SLC6A4</italic> encodes the serotonin reuptake transporter and is a target for the serotonin reuptake inhibitor class of anti-depressants. It was the selected candidate gene in studies of MDD and ADHD patients and emotional processing, and resting state amygdala activity.</p>
<p id="par4940">Seventeen studies used an EWAS approach. There was no overlap between differentially methylated regions identified using this method versus the selected candidate gene approach for any of the phenotypic categories, which highlights the value of epigenome-wide approaches for unbiased investigation of the putative role of DNAm in brain structure and / or function. However, one study which employed an epigenome-wide approach to DNAm analysis identified <italic>COMT</italic> and <italic>SLC6A3</italic> as being negatively associated with right amygdala volume in neonates homozygous for <italic>BDNF</italic> rs6265 Met/Met allele (<xref ref-type="bibr" rid="bib0045">Chen et al., 2015</xref>). Both of these genes were selected as candidates in other studies but associations were reported in different populations with regards to age and clinical background, and with different image features (<xref ref-type="bibr" rid="bib0300">Muench et al., 2018</xref>; <xref ref-type="bibr" rid="bib0450">Ursini et al., 2011</xref>; <xref ref-type="bibr" rid="bib0470">Walton et al., 2014</xref>; <xref ref-type="bibr" rid="bib0485">Wiers et al., 2015</xref>). Many of the studies that utilised epigenome wide methods for measuring DNAm did not go on to report on individual loci. In future studies whole genome-based approaches could play an important role in generating novel candidates and pathways for future research that could provide mechanistic insight into pathogenesis.</p>
</sec>
<sec id="sec0130">
<label>4.4</label>
<title>Interindividual variability, effect of genotype, and temporal stability</title>
<p id="par4945">Sources of variability that are crucial for understanding of how changes in DNAm associate with endophenotypes include interindividual variability which may be stochastic, genetic or environmental in origin, and temporal stability (<xref ref-type="bibr" rid="bib0250">Lancaster et al., 2018</xref>). Twin studies are useful for separating genetic and environmental contributions to variability, and several are included in the DNAm-MRI literature to date (<xref ref-type="bibr" rid="bib0040">Casey et al., 2017</xref>; <xref ref-type="bibr" rid="bib0050">Chen et al., 2018</xref>; <xref ref-type="bibr" rid="bib0210">Ismaylova et al., 2018</xref>). Twenty-four studies controlled for genotypic effects, for example by covarying for single nucleotide polymorphisms (SNPs), or for the first PC of the variance in genome wide genetic data. This is because variation in DNAm may be explained partly by common genetic variation, such as a SNP that removes a methylation site. Therefore, genotyping in DNAm-MRI analyses is necessary for determining whether epigenetic associations with brain structure and function are genotype-specific, or whether associations are independent of genotype.</p>
<p id="par4950">The stability of some epialleles varies over time with dynamic methylation and demethylation at CpG sites occurring in typical development and ageing, and in response to environmental exposures (<xref ref-type="bibr" rid="bib0250">Lancaster et al., 2018</xref>). Only fifteen studies reported the timing of DNAm sampling in respect to MRI acquisition; we suggest that this information is included in future studies because it is required to compare study populations and interpret phenotypic associations. Longitudinal investigation could be used to establish the temporal stability of methylation at a genomic region or site, the impact of medication, and for assessing potential causal relationships.</p>
<p id="par4955">All of the included studies carried out cross-sectional analysis and two additionally carried out longitudinal analysis. Three other studies performed mediation analysis to assess causal relationships (<xref ref-type="bibr" rid="bib0040">Casey et al., 2017</xref>; <xref ref-type="bibr" rid="bib0115">Freytag et al., 2017</xref>; <xref ref-type="bibr" rid="bib0165">Harms et al., 2017</xref>). Studies designed to investigate association or causation should report the magnitude of differential DNAm between groups since the described changes in DNAm are often small and the biological relevance of these remains uncertain. Ultimately however, differential DNAm-MRI data will need to be interpreted in the wider context of mechanistic studies of gene expression in order to make inferences about causality. For example, experiments that demonstrate changes in gene expression associated with the differential methylation patterns reported from DNAm-MRI studies would be an important first step in dissecting causality, although it is important to note that changes in DNAm may actually occur as a consequence of changes in gene expression.</p>
</sec>
<sec id="sec0135">
<label>4.5</label>
<title>Neuroimaging considerations</title>
<p id="par4960">Structural and functional quantitative neuroimaging features have been included in this review, assessed using sMRI, fMRI and dMRI. Others have emphasised the importance of selecting image features that represent a deficient or pathological phenotype when investigating associations between DNAm and MRI (<xref ref-type="bibr" rid="bib0250">Lancaster et al., 2018</xref>). Five DNAm-MRI associations recurred in two or more studies (<italic>SLC6A4</italic> and amygdala reactivity; <italic>OXTR</italic> and amygdala reactivity; <italic>BDNF</italic> and PFC function; <italic>FKBP5</italic> and hippocampal volume; <italic>COMT</italic> and <italic>PFC</italic> function), and a narrative synthesis of these demonstrates that there were mixed directions of associations, which may be explained by the variation in where in a genomic region DNAm was measured and in which tissue, in tasks employed during fMRI and in participant characteristics. A variety of fMRI paradigms have been used to probe brain function in this field, such as resting state and emotional processing, and dMRI studies have used different diffusion gradient encoding schemes and strengths (b-values) to measure the mobility of water molecules in vivo. A further layer of complexity is added in terms of differences in image processing pipelines such as CIVET (<ext-link ext-link-type="uri" id="intr0010" xlink:href="http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET">http://www.bic.mni.mcgill.ca/ServicesSoftware/CIVET</ext-link>), FreeSurfer (<ext-link ext-link-type="uri" id="intr0015" xlink:href="https://surfer.nmr.mgh.harvard.edu">https://surfer.nmr.mgh.harvard.edu</ext-link>) and SPM (<ext-link ext-link-type="uri" id="intr0020" xlink:href="https://www.fil.ion.ucl.ac.uk/spm">https://www.fil.ion.ucl.ac.uk/spm</ext-link>) for sMRI; and voxel based methods e.g. TBSS (<ext-link ext-link-type="uri" id="intr0025" xlink:href="https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/TBSS</ext-link>) or tractography methods e.g. probabilistic neighbourhood tractography (<ext-link ext-link-type="uri" id="intr0030" xlink:href="http://www.tractor-mri.org.uk/tractography">http://www.tractor-mri.org.uk/tractography</ext-link>) for analysis of dMRI (<xref ref-type="bibr" rid="bib0005">Ad-Dab’bagh et al., 2006</xref>; <xref ref-type="bibr" rid="bib0010">Anblagan et al., 2015</xref>; <xref ref-type="bibr" rid="bib0015">Bastin et al., 2010</xref>; <xref ref-type="bibr" rid="bib0070">Clayden et al., 2007</xref>, <xref ref-type="bibr" rid="bib0065">2006</xref>; <xref ref-type="bibr" rid="bib0105">Fischl, 2012</xref>; <xref ref-type="bibr" rid="bib0415">Smith et al., 2006</xref>). In the future, it will be necessary to form consensus and harmonisation about the optimal acquisition protocols and analysis pipelines to allow findings from different groups to be combined more readily. Initiatives such as the ENIGMA consortium which aims to understand brain structure, function and disease using brain imaging and genetic data from groups around the world are an important step in this direction.</p>
</sec>
<sec id="sec0140">
<label>4.6</label>
<title>Strengths and limitations</title>
<p id="par4965">This systematic review has several strengths. It was based on a predefined protocol and followed standard guidelines with rigorous screening of &gt;3,400 articles and without language or publication year restrictions. Our analysis was based on 60 studies examining healthy individuals and a wide range of neurological and psychiatric diseases in more than 6,000 patients across the life course. This provided a detailed overview of a growing body of literature linking DNAm and MRI data types, and enabled us to identify the key sources of methodological variation that should be addressed as standards and conventions in DNAm-MRI analyses become established.</p>
<p id="par4970">Our study also has limitations. First, there was substantial clinical and methodological heterogeneity which prohibited quantitative synthesis for any single phenotype category, or MRI feature. Second, in the absence of validated tools for assessing quality and risk of bias in DNAm-MRI analyses, we were unable to evaluate these issues quantitively.</p>
</sec>
<sec id="sec0145">
<label>4.7</label>
<title>Conclusion</title>
<p id="par4975">There is some evidence of association between differential DNAm and human brain structure and / or function across the life course. However, varied methodologies used to acquire and analyse DNAm-MRI data prevent quantitative synthesis. The development of standards and conventions for studies linking DNAm with MRI data is required, with particular focus on: detailed case and comparator group definition; surrogate tissue type; adjustment for cell composition and common genetic variation; consistent approaches to DNAm estimation using whole genome approaches; and use of image acquisition protocols, analysis pipelines and image feature selection that best support pooled analyses that are likely to be required to achieve statistical power for EWAS-neuroimaging studies. In summary, this review has found that: differential DNAm is associated with image features of brain structure and function in health and disease across the life course using data from over 6,000 individuals; evidence that differential DNAm is associated with specific image features is modest; and it has identified specific sources of sample and methodological heterogeneity in existing DNAm-MRI analyses. We anticipate that identification of these will expedite rational development of analytic methods in this emerging field so that researchers might more rapidly design studies that support causal inference.</p>
</sec>
</sec>
</body>
<back>
<ref-list id="bibl0005">
<title>References</title>
<ref id="bib0005">
<element-citation id="sbref0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ad-Dab’bagh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Einarson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lyttelton</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Muehlboeck</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Mok</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Vincent</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Lepage</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fombonne</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>The CIVET image-processing environment: a fully automated comprehensive pipeline for anatomical neuroimaging research</article-title>
<source/>Proc. 12th Annu. Meet. Organ. Hum. Brain Mapp.
          <year>2006</year>
</element-citation>
</ref>
<ref id="bib0010">
<element-citation id="sbref0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anblagan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bastin</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Sparrow</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Piyasena</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pataky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Serag</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Clayden</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Boardman</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Tract shape modeling detects changes associated with preterm birth and neuroprotective treatment effects</article-title>
<source/>Neuroimage Clin.
          <volume>8</volume>
<year>2015</year>
<fpage>51</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1016/j.nicl.2015.03.021</pub-id>
<pub-id pub-id-type="pmid">26106527</pub-id>
</element-citation>
</ref>
<ref id="bib0015">
<element-citation id="sbref0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bastin</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Munoz Maniega</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Wardlaw</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>MacLullich</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Clayden</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Quantifying the effects of normal ageing on white matter structure using unsupervised tract shape modelling</article-title>
<source/>Neuroimage
          <volume>51</volume>
<year>2010</year>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2010.02.036</pub-id>
<pub-id pub-id-type="pmid">20171285</pub-id>
</element-citation>
</ref>
<ref id="bib0020">
<element-citation id="sbref0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidwell</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Karoly</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Thayer</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Claus</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Bryan</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Weiland</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Yorkwilliams</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hutchison</surname>
<given-names>K.E.</given-names>
</name>
</person-group>
<article-title>DRD2 promoter methylation and measures of alcohol reward : functional activation of reward circuits and clinical severity</article-title>
<source/>Addict. Biol.
          <volume>24</volume>
<year>2018</year>
<fpage>539</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1111/adb.12614</pub-id>
<pub-id pub-id-type="pmid">29464814</pub-id>
</element-citation>
</ref>
<ref id="bib0025">
<element-citation id="sbref0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carballedo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dymov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vaisheva</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fahey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Frodl</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>DNA methylation of the serotonin transporter gene in peripheral cells and stress-related changes in hippocampal volume: a study in depressed patients and healthy controls</article-title>
<source/>PLoS One
          <volume>10</volume>
<year>2015</year>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0119061</pub-id>
</element-citation>
</ref>
<ref id="bib0030">
<element-citation id="sbref0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Border</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Smolen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Berley</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples</article-title>
<source/>Am. J. Psychiatry
          <volume>176</volume>
<year>2019</year>
<fpage>376</fpage>
<lpage>387</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2018.18070881</pub-id>
<pub-id pub-id-type="pmid">30845820</pub-id>
</element-citation>
</ref>
<ref id="bib0035">
<element-citation id="sbref0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao-Lei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Elgbeili</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Laplante</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Pregnant women’s cognitive appraisal of a natural disaster affects DNA methylation in their children 13 years later: project Ice Storm</article-title>
<source/>Transl. Psychiatry
          <volume>5</volume>
<year>2015</year>
<fpage>e515</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.13</pub-id>
<pub-id pub-id-type="pmid">25710121</pub-id>
</element-citation>
</ref>
<ref id="bib0040">
<element-citation id="sbref0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casey</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Levesque</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ismaylova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Verner</surname>
<given-names>M.-P.</given-names>
</name>
<name>
<surname>Suderman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vitaro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brendgen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dionne</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Boivin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Birth weight discordance, DNA methylation, and cortical morphology of adolescent monozygotic twins</article-title>
<source/>Hum. Brain Mapp.
          <volume>38</volume>
<year>2017</year>
<fpage>2037</fpage>
<lpage>2050</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.23503</pub-id>
<pub-id pub-id-type="pmid">28032437</pub-id>
</element-citation>
</ref>
<ref id="bib0045">
<element-citation id="sbref0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tuan</surname>
<given-names>A.N.H.</given-names>
</name>
<name>
<surname>Teh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>MacIsaac</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Mah</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Broekman</surname>
<given-names>B.F.P.</given-names>
</name>
<name>
<surname>Buschdorf</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Kwek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saw</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Gluckman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Fortier</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Rifkin-Graboi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Holbrook</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>The GUSTO Study Group</surname>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism influences the association of the methylome with maternal anxiety and neonatal brain volumes</article-title>
<source/>Dev. Psychopathol.
          <volume>27</volume>
<year>2015</year>
<fpage>137</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1017/S0954579414001357</pub-id>
<pub-id pub-id-type="pmid">25640836</pub-id>
</element-citation>
</ref>
<ref id="bib0050">
<element-citation id="sbref0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Sudre</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Donovan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chandrasekharappa</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Elnitski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Neuroanatomic, epigenetic and genetic differences in monozygotic twins discordant for attention deficit hyperactivity disorder</article-title>
<source/>Mol. Psychiatry
          <volume>23</volume>
<year>2018</year>
<fpage>683</fpage>
<lpage>690</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2017.45</pub-id>
<pub-id pub-id-type="pmid">28322272</pub-id>
</element-citation>
</ref>
<ref id="bib0055">
<element-citation id="sbref0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K.-M.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>B.-J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-S.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>B.-J.</given-names>
</name>
</person-group>
<article-title>Association of brain-derived neurotrophic factor DNA methylation and reduced white matter integrity in the anterior corona radiata in major depression</article-title>
<source/>J. Affect. Disord.
          <volume>172</volume>
<year>2015</year>
<fpage>74</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2014.09.042</pub-id>
<pub-id pub-id-type="pmid">25451398</pub-id>
</element-citation>
</ref>
<ref id="bib0060">
<element-citation id="sbref0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chouliaras</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pishva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Haapakoski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zsoldos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Filippini</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Burrage</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kivima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lunnon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ebmeier</surname>
<given-names>K.P.</given-names>
</name>
</person-group>
<article-title>Peripheral DNA methylation, cognitive decline and brain aging: pilot findings from the Whitehall II imaging study</article-title>
<source/>Epigenomics
          <volume>10</volume>
<year>2018</year>
<fpage>585</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.2217/epi-2017-0132</pub-id>
<pub-id pub-id-type="pmid">29692214</pub-id>
</element-citation>
</ref>
<ref id="bib0065">
<element-citation id="sbref0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clayden</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Bastin</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Storkey</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Improved segmentation reproducibility in group tractography using a quantitative tract similarity measure</article-title>
<source/>Neuroimage
          <volume>33</volume>
<year>2006</year>
<fpage>482</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.07.016</pub-id>
<pub-id pub-id-type="pmid">16956774</pub-id>
</element-citation>
</ref>
<ref id="bib0070">
<element-citation id="sbref0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clayden</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Storkey</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Bastin</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>A probabilistic model-based approach to consistent white matter tract segmentation</article-title>
<source/>IEEE Trans. Med. Imaging
          <volume>26</volume>
<year>2007</year>
<fpage>1555</fpage>
<lpage>1561</lpage>
<pub-id pub-id-type="pmid">18041270</pub-id>
</element-citation>
</ref>
<ref id="bib0075">
<element-citation id="sbref0075" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dannlowski</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Kugel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Redlich</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Halik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Opel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Grotegerd</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schwarte</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schettler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ambree</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rust</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Domschke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Heindel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Baune</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Suslow</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hohoff</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Serotonin transporter gene methylation is associated with hippocampal gray matter volume</article-title>
<source/>Hum. Brain Mapp.
          <volume>35</volume>
<year>2014</year>
<fpage>5356</fpage>
<lpage>5367</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.22555</pub-id>
<pub-id pub-id-type="pmid">24862560</pub-id>
</element-citation>
</ref>
<ref id="bib0080">
<element-citation id="sbref0080" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>E.G.</given-names>
</name>
<name>
<surname>Humphreys</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>McEwen</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Sacchet</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Camacho</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>MacIsaac</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.T.S.</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Gotlib</surname>
<given-names>I.H.</given-names>
</name>
</person-group>
<article-title>Accelerated DNA methylation age in adolescent girls: associations with elevated diurnal cortisol and reduced hippocampal volume</article-title>
<source/>Transl. Psychiatry
          <volume>7</volume>
<year>2017</year>
<fpage>e1223</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2017.188</pub-id>
<pub-id pub-id-type="pmid">28850111</pub-id>
</element-citation>
</ref>
<ref id="bib0085">
<element-citation id="sbref0085" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Poultney</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fromer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kosmicki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shih-Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Aleksic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Biscaldi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Brownfeld</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chahrour</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Chiocchetti</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Guter</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Ionita-Laza</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jimenz Gonzalez</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kilpinen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lehtimaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Ma’ayan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>McInnes</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Parellada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Puura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rajagopalan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rehnstrom</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Reichenberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sachse</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schulte-Ruther</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tammimies</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Valladares</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Voran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li-San</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Study</surname>
<given-names>D.D.D.</given-names>
</name>
<name>
<surname>Homozygosity Mapping Collaborative for, A</surname>
</name>
<name>
<surname>Consortium, U.K</surname>
</name>
<name>
<surname>Cook</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hultman</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Lehner</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Palotie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>State</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Zwick</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Barett</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature
          <volume>515</volume>
<year>2014</year>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="bib0090">
<element-citation id="sbref0090" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Del Blanco</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Barco</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Impact of environmental conditions and chemicals on the neuronal epigenome</article-title>
<source/>Curr. Opin. Behav. Sci.
          <volume>45</volume>
<year>2018</year>
<fpage>157</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1016/j.cbpa.2018.06.003</pub-id>
</element-citation>
</ref>
<ref id="bib0095">
<element-citation id="sbref0095" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Member</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Predicting schizophrenia by fusing networks from SNPs, DNA methylation and fMRI data</article-title>
<source/>Conf. Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. IEEE Eng. Med. Biol. Soc. Annu. Conf.
          <year>2016</year>
<fpage>1447</fpage>
<lpage>1450</lpage>
<pub-id pub-id-type="doi">10.1109/EMBC.2016.7590981</pub-id>
</element-citation>
</ref>
<ref id="bib0100">
<element-citation id="sbref0100" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elliott</surname>
<given-names>L.T.</given-names>
</name>
<name>
<surname>Sharp</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Alfaro-almagro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Douaud</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marchini</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies of brain imaging phenotypes in UK Biobank</article-title>
<source/>Nature
          <volume>562</volume>
<year>2018</year>
<fpage>210</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-018-0571-7</pub-id>
<pub-id pub-id-type="pmid">30305740</pub-id>
</element-citation>
</ref>
<ref id="bib0105">
<element-citation id="sbref0105" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischl</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>FreeSurfer</article-title>
<source/>Neuroimage
          <volume>62</volume>
<year>2012</year>
<fpage>774</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id>
<pub-id pub-id-type="pmid">22248573</pub-id>
</element-citation>
</ref>
<ref id="bib0110">
<element-citation id="sbref0110" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fraser</surname>
<given-names>H.B.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Neumann</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kobor</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Population-specificity of human DNA methylation</article-title>
<source/>Genome Biol.
          <volume>13</volume>
<year>2012</year>
<pub-id pub-id-type="doi">10.1186/gb-2012-13-2-r8</pub-id>
</element-citation>
</ref>
<ref id="bib0115">
<element-citation id="sbref0115" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freytag</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Carrillo-roa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Milnik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Samann</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Vukojevic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Coynel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Demougin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Egli</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gschwind</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jessen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Loos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Riedel-heller</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vogler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Quervain</surname>
<given-names>D.J.De</given-names>
</name>
<name>
<surname>Papassotiropoulos</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>A peripheral epigenetic signature of immune system genes is linked to neocortical thickness and memory</article-title>
<source/>Nat. Commun.
          <volume>8</volume>
<year>2017</year>
<pub-id pub-id-type="doi">10.1038/ncomms15193</pub-id>
</element-citation>
</ref>
<ref id="bib0120">
<element-citation id="sbref0120" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frodl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carballedo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ly</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dymov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vaisheva</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fahey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli</article-title>
<source/>J. Psychiatry Neurosci.
          <volume>40</volume>
<year>2015</year>
<fpage>296</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1503/jpn.140180</pub-id>
<pub-id pub-id-type="pmid">25825812</pub-id>
</element-citation>
</ref>
<ref id="bib0125">
<element-citation id="sbref0125" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gluckman</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Hanson</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Buklijas</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>A conceptual framework for the developmental origins of health and disease</article-title>
<source/>J. Dev. Orig. Health Dis.
          <volume>1</volume>
<year>2010</year>
<fpage>6</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1017/S2040174409990171</pub-id>
<pub-id pub-id-type="pmid">25142928</pub-id>
</element-citation>
</ref>
<ref id="bib0130">
<element-citation id="sbref0130" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gouin</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.Q.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boivin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cote</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Hebert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ouellet-Morin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vitaro</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Associations among oxytocin receptor gene (OXTR) DNA methylation in adulthood, exposure to early life adversity, and childhood trajectories of anxiousness</article-title>
<source/>Sci. Rep.
          <volume>7</volume>
<year>2017</year>
<fpage>7446</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-07950-x</pub-id>
<pub-id pub-id-type="pmid">28785027</pub-id>
</element-citation>
</ref>
<ref id="bib0135">
<element-citation id="sbref0135" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grayson</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Guidotti</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The dynamics of DNA methylation in schizophrenia and related psychiatric disorders</article-title>
<source/>Neuropsychopharmacology
          <volume>38</volume>
<year>2013</year>
<fpage>138</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2012.125</pub-id>
<pub-id pub-id-type="pmid">22948975</pub-id>
</element-citation>
</ref>
<ref id="bib0140">
<element-citation id="sbref0140" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregory</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Towers</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Biscocho</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Markunas</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Lintas</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Langford</surname>
<given-names>C.F.</given-names>
</name>
<name>
<surname>Worley</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Delong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Cuccaro</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pericak-Vance</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Genomic and epigenetic evidence for oxytocin receptor deficiency in autism</article-title>
<source/>BMC Med.
          <volume>7</volume>
<year>2009</year>
<pub-id pub-id-type="doi">10.1186/1741-7015-7-62</pub-id>
</element-citation>
</ref>
<ref id="bib0145">
<element-citation id="sbref0145" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillaume</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Poh</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>P.F.</given-names>
</name>
<name>
<surname>Karnani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Improving mass-univariate analysis of neuroimaging data by modelling important unknown covariates: application to Epigenome-Wide Association Studies</article-title>
<source/>Neuroimage
          <volume>173</volume>
<year>2018</year>
<fpage>57</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.01.073</pub-id>
<pub-id pub-id-type="pmid">29448075</pub-id>
</element-citation>
</ref>
<ref id="bib0150">
<element-citation id="sbref0150" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haas</surname>
<given-names>B.W.</given-names>
</name>
<name>
<surname>Filkowski</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Cochran</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Denison</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ishak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nishitani</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Epigenetic modification of OXT and human sociability</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>113</volume>
<year>2016</year>
<pub-id pub-id-type="doi">10.1073/pnas.1602809113</pub-id>
</element-citation>
</ref>
<ref id="bib0155">
<element-citation id="sbref0155" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Joe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tae</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1038/srep42621</pub-id>
<pub-id pub-id-type="pmid">28127051</pub-id>
</element-citation>
</ref>
<ref id="bib0160">
<element-citation id="sbref0160" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Tae</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>TESC gene-regulating genetic variant (rs7294919) affects hippocampal subfield volumes and parahippocampal cingulum white matter integrity in major depressive disorder</article-title>
<source/>J. Psychiatr. Res.
          <volume>93</volume>
<year>2017</year>
<fpage>20</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2017.05.010</pub-id>
<pub-id pub-id-type="pmid">28575645</pub-id>
</element-citation>
</ref>
<ref id="bib0165">
<element-citation id="sbref0165" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harms</surname>
<given-names>M.B.</given-names>
</name>
<name>
<surname>Birn</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Provencal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wiechmann</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Early life stress, FK506 binding protein 5 gene (FKBP5) methylation, and inhibition-related prefrontal function: a prospective longitudinal study</article-title>
<source/>Dev. Psychopathol.
          <volume>29</volume>
<year>2017</year>
<fpage>1895</fpage>
<lpage>1903</lpage>
<pub-id pub-id-type="doi">10.1017/S095457941700147X</pub-id>
<pub-id pub-id-type="pmid">29162190</pub-id>
</element-citation>
</ref>
<ref id="bib0170">
<element-citation id="sbref0170" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hass</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beyer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smolka</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Roessner</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sponheim</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Gollub</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Associations between DNA methylation and schizophrenia-related intermediate phenotypes — a gene set enrichment analysis</article-title>
<source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
          <volume>59</volume>
<year>2015</year>
<fpage>31</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2015.01.006</pub-id>
<pub-id pub-id-type="pmid">25598502</pub-id>
</element-citation>
</ref>
<ref id="bib0175">
<element-citation id="sbref0175" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Blauw</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Susser</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Lumey</surname>
<given-names>L.H.</given-names>
</name>
</person-group>
<article-title>Persistent epigenetic differences associated with prenatal exposure to famine in humans</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>105</volume>
<year>2008</year>
<fpage>17046</fpage>
<lpage>17049</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0806560105</pub-id>
<pub-id pub-id-type="pmid">18955703</pub-id>
</element-citation>
</ref>
<ref id="bib0180">
<element-citation id="sbref0180" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heyn</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hernando-Herraez</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sayols</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sandoval</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Monk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marques-Bonet</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>DNA methylation contributes to natural human variation</article-title>
<source/>Genome Res.
          <volume>23</volume>
<year>2013</year>
<fpage>1363</fpage>
<lpage>1372</lpage>
<pub-id pub-id-type="doi">10.1101/gr.154187.112</pub-id>
<pub-id pub-id-type="pmid">23908385</pub-id>
</element-citation>
</ref>
<ref id="bib0185">
<element-citation id="sbref0185" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodgson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Carless</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Sprooten</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Mathias</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goring</surname>
<given-names>H.H.H.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Olvera</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Almasy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Duggirala</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blangero</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Glahn</surname>
<given-names>D.C.</given-names>
</name>
</person-group>
<article-title>Epigenetic age acceleration assessed with human white-matter images</article-title>
<source/>J. Neurosci.
          <volume>37</volume>
<year>2017</year>
<fpage>4735</fpage>
<lpage>4743</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0177-17.2017</pub-id>
<pub-id pub-id-type="pmid">28385874</pub-id>
</element-citation>
</ref>
<ref id="bib0190">
<element-citation id="sbref0190" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sportelli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ziller</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Spengler</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Epigenomics of major depressive disorders and schizophrenia: early life decides</article-title>
<source/>Int. J. Mol. Sci.
          <volume>18</volume>
<year>2017</year>
<fpage>1</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.3390/ijms18081711</pub-id>
</element-citation>
</ref>
<ref id="bib0195">
<element-citation id="sbref0195" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horvath</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>DNA methylation age of human tissues and cell types</article-title>
<source/>Genome Biol.
          <volume>14</volume>
<year>2013</year>
<pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id>
</element-citation>
</ref>
<ref id="bib0200">
<element-citation id="sbref0200" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Member</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Adaptive sparse multiple canonical correlation analysis with application to imaging (Epi)Genomics study of schizophrenia</article-title>
<source/>IEEE Trans. Biomed. Eng.
          <volume>65</volume>
<year>2018</year>
<fpage>390</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1109/TBME.2017.2771483</pub-id>
<pub-id pub-id-type="pmid">29364120</pub-id>
</element-citation>
</ref>
<ref id="bib0205">
<element-citation id="sbref0205" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismaylova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Di Sante</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nemoda</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Pomares</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gobbi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Vitaro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Serotonin transporter gene promoter methylation in peripheral cells in healthy adults: neural correlates and tissue specificity</article-title>
<source/>Eur. Neuropsychopharmacol.
          <volume>27</volume>
<year>2017</year>
<fpage>1032</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="doi">10.1016/j.euroneuro.2017.07.005</pub-id>
<pub-id pub-id-type="pmid">28774705</pub-id>
</element-citation>
</ref>
<ref id="bib0210">
<element-citation id="sbref0210" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismaylova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lévesque</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Pomares</surname>
<given-names>F.B.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fahim</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vitaro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Brendgen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dionne</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Boivin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Booij</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Serotonin transporter promoter methylation in peripheral cells and neural responses to negative stimuli : a study of adolescent monozygotic twins</article-title>
<source/>Transl. Psychiatry
          <volume>8</volume>
<year>2018</year>
<pub-id pub-id-type="doi">10.1038/s41398-018-0195-6</pub-id>
</element-citation>
</ref>
<ref id="bib0215">
<element-citation id="sbref0215" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jack</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>DNA methylation of the oxytocin receptor gene predicts neural response to ambiguous social stimuli</article-title>
<source/>Front. Hum. Neurosci.
          <volume>6</volume>
<year>2012</year>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2012.00280</pub-id>
<pub-id pub-id-type="pmid">22279433</pub-id>
</element-citation>
</ref>
<ref id="bib0220">
<element-citation id="sbref0220" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joehanes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Just</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Pilling</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Mandaviya</surname>
<given-names>P.R.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Elks</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Aslibekyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Moreno-Macias</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Brody</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Dhingra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yousefi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pankow</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Kunze</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>McRae</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Lohman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sha</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Absher</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Ferrucci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Demerath</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Bressler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Huan</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mendelson</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kiel</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang-Sattler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Visscher</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>N.R.</given-names>
</name>
<name>
<surname>Starr</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Wareham</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Irvin</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Zhi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Barrdahl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vineis</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ambatipudi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uitterlinden</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Colicino</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vokonas</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Bandinelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Ware</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Klengel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Psaty</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Gharib</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Swenson</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Demeo</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>O’Connor</surname>
<given-names>G.T.</given-names>
</name>
<name>
<surname>Herceg</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Conneely</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Sotoodehnia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kardia</surname>
<given-names>S.L.R.</given-names>
</name>
<name>
<surname>Melzer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Van Meurs</surname>
<given-names>J.B.J.</given-names>
</name>
<name>
<surname>Romieu</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Arnett</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>K.K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Waldenberger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Deary</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Fornage</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>London</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Epigenetic signatures of cigarette smoking</article-title>
<source/>Circ. Cardiovasc. Genet.
          <volume>9</volume>
<year>2016</year>
<fpage>436</fpage>
<lpage>447</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCGENETICS.116.001506</pub-id>
<pub-id pub-id-type="pmid">27651444</pub-id>
</element-citation>
</ref>
<ref id="bib0225">
<element-citation id="sbref0225" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Functions of DNA methylation: islands, start sites, gene bodies and beyond</article-title>
<source/>Nat. Rev. Genet.
          <volume>13</volume>
<year>2012</year>
<fpage>484</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3230</pub-id>
<pub-id pub-id-type="pmid">22641018</pub-id>
</element-citation>
</ref>
<ref id="bib0230">
<element-citation id="sbref0230" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ad-Dab’bagh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification</article-title>
<source/>Neuroimage
          <volume>27</volume>
<year>2005</year>
<fpage>210</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2005.03.036</pub-id>
<pub-id pub-id-type="pmid">15896981</pub-id>
</element-citation>
</ref>
<ref id="bib0235">
<element-citation id="sbref0235" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Jahng</surname>
<given-names>G.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.K.</given-names>
</name>
</person-group>
<article-title>A pilot study of differential brain activation to suicidal means and DNA methylation of CACNA1C gene in suicidal attempt patients</article-title>
<source/>Psychiatry Res.
          <volume>255</volume>
<year>2017</year>
<fpage>42</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2017.03.058</pub-id>
<pub-id pub-id-type="pmid">28521147</pub-id>
</element-citation>
</ref>
<ref id="bib0240">
<element-citation id="sbref0240" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klengel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Anacker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rex-Haffner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pruessner</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Pariante</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>T.W.W.</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Mayberg</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nemeroff</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heim</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Rein</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions</article-title>
<source/>Nat. Neurosci.
          <volume>16</volume>
<year>2013</year>
<fpage>33</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3275</pub-id>
<pub-id pub-id-type="pmid">23201972</pub-id>
</element-citation>
</ref>
<ref id="bib0245">
<element-citation id="sbref0245" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klengel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>The role of DNA methylation in stress-related psychiatric disorders</article-title>
<source/>Neuropharmacology
          <volume>80</volume>
<year>2014</year>
<fpage>115</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.01.013</pub-id>
<pub-id pub-id-type="pmid">24452011</pub-id>
</element-citation>
</ref>
<ref id="bib0250">
<element-citation id="sbref0250" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lancaster</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Neuroimaging epigenetics: challenges and recommendations for best practices</article-title>
<source/>Neuroscience
          <volume>370</volume>
<year>2018</year>
<fpage>88</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.08.004</pub-id>
<pub-id pub-id-type="pmid">28801185</pub-id>
</element-citation>
</ref>
<ref id="bib0255">
<element-citation id="sbref0255" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Julnes</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Walton</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
</person-group>
<article-title>The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients</article-title>
<source/>Schizophr. Res.
          <volume>169</volume>
<year>2015</year>
<fpage>447</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1016/j.schres.2015.08.035.The</pub-id>
<pub-id pub-id-type="pmid">26381449</pub-id>
</element-citation>
</ref>
<ref id="bib0260">
<element-citation id="sbref0260" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Long</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.-X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Blood DNA methylation pattern is altered in mesial temporal lobe epilepsy</article-title>
<source/>Sci. Rep.
          <volume>7</volume>
<year>2017</year>
<pub-id pub-id-type="doi">10.1038/srep43810</pub-id>
</element-citation>
</ref>
<ref id="bib0265">
<element-citation id="sbref0265" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gemma</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Beyan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hawa</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Bazeos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Montpetit</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vardhman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rakyan</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Ramagopalan</surname>
<given-names>S.V.</given-names>
</name>
</person-group>
<article-title>Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies</article-title>
<source/>Epigenetics
          <volume>8</volume>
<year>2013</year>
<pub-id pub-id-type="doi">10.4161/epi.24362</pub-id>
</element-citation>
</ref>
<ref id="bib0270">
<element-citation id="sbref0270" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lyst</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Rett syndrome: a complex disorder with simple roots</article-title>
<source/>Nat. Rev. Genet.
          <volume>16</volume>
<year>2015</year>
<pub-id pub-id-type="doi">10.1038/nrg3897</pub-id>
</element-citation>
</ref>
<ref id="bib0275">
<element-citation id="sbref0275" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGowan</surname>
<given-names>P.O.</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>D’Alessio</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Dymov</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Labonte</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Turecki</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Meaney</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse</article-title>
<source/>Nat. Neurosci.
          <volume>12</volume>
<year>2009</year>
<fpage>342</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2270</pub-id>
<pub-id pub-id-type="pmid">19234457</pub-id>
</element-citation>
</ref>
<ref id="bib0280">
<element-citation id="sbref0280" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMillan</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Russ</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Grossman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>McCluskey</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Van Deerlin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>C9orf72 promoter hypermethylation is neuroprotective</article-title>
<source/>Am. Acad. Neurol.
          <volume>84</volume>
<year>2015</year>
<fpage>1622</fpage>
<lpage>1630</lpage>
</element-citation>
</ref>
<ref id="bib0285">
<element-citation id="sbref0285" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McNerney</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nechvatal</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Lyons</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hara</surname>
<given-names>R.O.</given-names>
</name>
<name>
<surname>Hallmayer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ashford</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Yesavage</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adamson</surname>
<given-names>M.M.</given-names>
</name>
</person-group>
<article-title>Integration of neural and epigenetic contributions to posttraumatic stress symptoms: the role of hippocampal volume and glucocorticoid receptor gene methylation</article-title>
<source/>PLoS One
          <volume>13</volume>
<year>2018</year>
<object-id pub-id-type="publisher-id">e0192222</object-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0192222</pub-id>
</element-citation>
</ref>
<ref id="bib0290">
<element-citation id="sbref0290" publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Paoloni-giacobino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stenz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Adouan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rusconi-serpa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ansermet</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dayer</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<chapter-title>BDNF Methylation and Maternal Brain Activity in a Violence-Related Sample</chapter-title>
<year>2015</year>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0143427</pub-id>
</element-citation>
</ref>
<ref id="bib0295">
<element-citation id="sbref0295" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muehlhan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kirschbaum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wittchen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Epigenetic variation in the serotonin transporter gene predicts resting state functional connectivity strength within the salience-network</article-title>
<source/>Hum. Brain Mapp.
          <volume>36</volume>
<year>2015</year>
<fpage>4361</fpage>
<lpage>4371</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.22923</pub-id>
<pub-id pub-id-type="pmid">26303978</pub-id>
</element-citation>
</ref>
<ref id="bib0300">
<element-citation id="sbref0300" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muench</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wiers</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Cortes</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Momenan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lohoff</surname>
<given-names>F.W.</given-names>
</name>
</person-group>
<article-title>Dopamine transporter gene methylation is associated with nucleus accumbens activation during reward processing in healthy but not alcohol-dependent individuals</article-title>
<source/>Alcohol. Clin. Exp. Res.
          <volume>42</volume>
<year>2018</year>
<fpage>21</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1111/acer.13526</pub-id>
<pub-id pub-id-type="pmid">29030974</pub-id>
</element-citation>
</ref>
<ref id="bib0305">
<element-citation id="sbref0305" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Na</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Tae</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Joe</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>B.J.</given-names>
</name>
</person-group>
<article-title>Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder</article-title>
<source/>Sci. Rep.
          <volume>6</volume>
<year>2016</year>
<fpage>21089</fpage>
<pub-id pub-id-type="doi">10.1038/srep21089</pub-id>
<pub-id pub-id-type="pmid">26876488</pub-id>
</element-citation>
</ref>
<ref id="bib0310">
<element-citation id="sbref0310" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolova</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Hariri</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Can we observe epigenetic effects on human brain function?</article-title>
<source/>Trends Cogn. Sci.
          <volume>19</volume>
<year>2015</year>
<fpage>366</fpage>
<lpage>373</lpage>
<pub-id pub-id-type="doi">10.1016/j.tics.2015.05.003</pub-id>
<pub-id pub-id-type="pmid">26051383</pub-id>
</element-citation>
</ref>
<ref id="bib0315">
<element-citation id="sbref0315" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolova</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Koenen</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Galea</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Seney</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Sibille</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Hariri</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Beyond genotype: serotonin transporter epigenetic modification predicts human brain function</article-title>
<source/>Nat. Neurosci.
          <volume>17</volume>
<year>2014</year>
<fpage>1153</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="doi">10.1038/nn.3778</pub-id>
<pub-id pub-id-type="pmid">25086606</pub-id>
</element-citation>
</ref>
<ref id="bib0320">
<element-citation id="sbref0320" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oberlander</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Weinberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Papsdorf</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grunau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Misri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses</article-title>
<source/>Epigenetics
          <volume>3</volume>
<year>2008</year>
<fpage>97</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.4161/epi.3.2.6034</pub-id>
<pub-id pub-id-type="pmid">18536531</pub-id>
</element-citation>
</ref>
<ref id="bib0325">
<element-citation id="sbref0325" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palumbo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mariotti</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Iofrida</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pellegrini</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Genes and aggressive behavior: epigenetic mechanisms underlying individual susceptibility to aversive environments</article-title>
<source/>Front. Behav. Neurosci.
          <volume>12</volume>
<year>2018</year>
<fpage>117</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2018.00117</pub-id>
<pub-id pub-id-type="pmid">29950977</pub-id>
</element-citation>
</ref>
<ref id="bib0330">
<element-citation id="sbref0330" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Cheong</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Associations between serotonin transporter gene (SLC6A4) methylation and clinical characteristics and cortical thickness in children with ADHD</article-title>
<source/>Psychol. Med.
          <volume>45</volume>
<year>2015</year>
<fpage>3009</fpage>
<lpage>3017</lpage>
<pub-id pub-id-type="doi">10.1017/S003329171500094X</pub-id>
<pub-id pub-id-type="pmid">26017091</pub-id>
</element-citation>
</ref>
<ref id="bib0335">
<element-citation id="sbref0335" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Provenzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guida</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Montirosso</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Preterm behavioral epigenetics: a systematic review</article-title>
<source/>Neurosci. Biobehav. Rev.
          <volume>84</volume>
<year>2018</year>
<fpage>262</fpage>
<lpage>271</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.08.020</pub-id>
<pub-id pub-id-type="pmid">28867654</pub-id>
</element-citation>
</ref>
<ref id="bib0340">
<element-citation id="sbref0340" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pruessner</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Serles</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pruessner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Kabani</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lupien</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>Volumetry of Hippocampus and Amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories</article-title>
<source/>Cereb. Cortex
          <volume>10</volume>
<year>2000</year>
<fpage>433</fpage>
<lpage>442</lpage>
<pub-id pub-id-type="pmid">10769253</pub-id>
</element-citation>
</ref>
<ref id="bib0345">
<element-citation id="sbref0345" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puglia</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Lillard</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Epigenetic modification of the oxytocin receptor gene influences the perception of anger and fear in the human brain</article-title>
<source/>Proc. Natl. Acad. Sci. U. S. A.
          <volume>112</volume>
<year>2015</year>
<fpage>3308</fpage>
<lpage>3313</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1422096112</pub-id>
<pub-id pub-id-type="pmid">25675509</pub-id>
</element-citation>
</ref>
<ref id="bib0350">
<element-citation id="sbref0350" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Bressler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gottesman</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pankow</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Boerwinkle</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mosley</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Fornage</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Cerebral white matter hyperintensities on MRI and acceleration of epigenetic aging: the atherosclerosis risk in communities study</article-title>
<source/>Clin. Epigenetics
          <volume>9</volume>
<year>2017</year>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1186/s13148-016-0302-6</pub-id>
<pub-id pub-id-type="pmid">28149329</pub-id>
</element-citation>
</ref>
<ref id="bib0355">
<element-citation id="sbref0355" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rangasamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D’Mello</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Epigenetics, autism Spectrum, and neurodevelopmental disorders</article-title>
<source/>Neurotherapeutics
          <volume>10</volume>
<year>2013</year>
<fpage>742</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="doi">10.1007/s13311-013-0227-0</pub-id>
<pub-id pub-id-type="pmid">24104594</pub-id>
</element-citation>
</ref>
<ref id="bib0360">
<element-citation id="sbref0360" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Resmini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aulinas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Vives-Gilabert</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wand</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Reduced DNA methylation of FKBP5 in Cushing’s syndrome</article-title>
<source/>Endocrine
          <volume>54</volume>
<year>2016</year>
<fpage>768</fpage>
<lpage>777</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-016-1083-6</pub-id>
<pub-id pub-id-type="pmid">27664120</pub-id>
</element-citation>
</ref>
<ref id="bib0365">
<element-citation id="sbref0365" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubin</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Connelly</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Drogos</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Pournaja</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ruocco</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Keedy</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Matthew</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tandon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pearlson</surname>
<given-names>G.D.</given-names>
</name>
<name>
<surname>Clementz</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Tamminga</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Gershon</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Keshavan</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>Sex and diagnosis-specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders</article-title>
<source/>Biol. Psychiatry
          <volume>1</volume>
<year>2016</year>
<fpage>141</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1016/j.bpsc.2015.10.003</pub-id>
</element-citation>
</ref>
<ref id="bib0370">
<element-citation id="sbref0370" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruggeri</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nymberg</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vuoksimaa</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lourdusamy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>F.M.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cattrell</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Macare</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Bokde</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Bromberg</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Buchel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Conrod</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Fauth-Buhler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Flor</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Frouin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gallinat</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Garavan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gowland</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Heinz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ittermann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Martinot</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Nees</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Pausova</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Paus</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rietschel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Smolka</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Spanagel</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bakalkin</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Aliev</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dick</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaprio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Desrivieres</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>IMAGEN Consortium</surname>
</name>
</person-group>
<article-title>Association of Protein Phosphatase PPM1G With Alcohol Use Disorder and Brain Activity During Behavioral Control in a Genome-Wide Methylation Analysis</article-title>
<source/>Am. J. Psychiatry
          <volume>172</volume>
<year>2015</year>
<fpage>543</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2014.14030382</pub-id>
<pub-id pub-id-type="pmid">25982659</pub-id>
</element-citation>
</ref>
<ref id="bib0375">
<element-citation id="sbref0375" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabunciyan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aryee</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Irizarry</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Rongione</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lessard</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yolken</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Feinberg</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Potash</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>GenRED Consortium</surname>
</name>
</person-group>
<article-title>Genome-wide DNA methylation scan in major depressive disorder</article-title>
<source/>PLoS One
          <volume>7</volume>
<year>2012</year>
<object-id pub-id-type="publisher-id">e34451</object-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0034451</pub-id>
</element-citation>
</ref>
<ref id="bib0380">
<element-citation id="sbref0380" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadeh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Spielberg</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Logue</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Lusk</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Sperbeck</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Milberg</surname>
<given-names>W.P.</given-names>
</name>
<name>
<surname>Mcglinchey</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>SKA2 methylation is associated with decreased prefrontal cortical thickness and greater PTSD severity among trauma-exposed veterans</article-title>
<source/>Mol. Psychiatry
          <volume>21</volume>
<year>2016</year>
<fpage>357</fpage>
<lpage>363</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.134</pub-id>
<pub-id pub-id-type="pmid">26324104</pub-id>
</element-citation>
</ref>
<ref id="bib0385">
<element-citation id="sbref0385" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schechter</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Paoloni-Giacobino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stenz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gex-Fabry</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Adouan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cordero</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Suardi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Manini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sancho Rossignol</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Merminod</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ansermet</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dayer</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Rusconi-Serpa</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Methylation of NR3C1 is related to maternal PTSD, parenting stress and maternal medial prefrontal cortical activity in response to child separation among mothers with histories of violence exposure</article-title>
<source/>Front. Psychiatry
          <volume>6</volume>
<year>2015</year>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.3389/fpsyg.2015.00690</pub-id>
<pub-id pub-id-type="pmid">25653621</pub-id>
</element-citation>
</ref>
<ref id="bib0390">
<element-citation id="sbref0390" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schechter</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Moser</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Pointet</surname>
<given-names>V.C.</given-names>
</name>
<name>
<surname>Aue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Stenz</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Paoloni-giacobino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adouan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Manini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suardi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Vital</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sancho</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cordero</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Rothenberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dayer</surname>
<given-names>A.G.</given-names>
</name>
</person-group>
<article-title>The association of serotonin receptor 3A methylation with maternal violence exposure, neural activity, and child aggression</article-title>
<source/>Behav. Brain Res.
          <volume>325</volume>
<year>2017</year>
<fpage>268</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2016.10.009</pub-id>
<pub-id pub-id-type="pmid">27720744</pub-id>
</element-citation>
</ref>
<ref id="bib0395">
<element-citation id="sbref0395" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schneider</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kugel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Redlich</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Grotegerd</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Burger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Burkner</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Opel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Dohm</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zaremba</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Meinert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schroder</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Strassburg</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Schwarte</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schettler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ambree</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Rust</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Domschke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Heindel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Baune</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dannlowski</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Hohoff</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Association of serotonin transporter gene AluJb methylation with major depression, amygdala responsiveness, 5-HTTLPR/rs25531 polymorphism, and stress</article-title>
<source/>Neuropsychopharmacology
          <volume>43</volume>
<year>2018</year>
<fpage>1308</fpage>
<lpage>1316</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2017.273</pub-id>
<pub-id pub-id-type="pmid">29114103</pub-id>
</element-citation>
</ref>
<ref id="bib0400">
<element-citation id="sbref0400" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shelton</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Cornish</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Kolbe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Clough</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Slater</surname>
<given-names>H.R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kraan</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>Q.M.</given-names>
</name>
<name>
<surname>Godler</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Fielding</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females</article-title>
<source/>Transl. Psychiatry
          <volume>6</volume>
<year>2016</year>
<pub-id pub-id-type="doi">10.1038/tp.2016.250</pub-id>
</element-citation>
</ref>
<ref id="bib0405">
<element-citation id="sbref0405" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shelton</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Cornish</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Godler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bui</surname>
<given-names>Q.M.</given-names>
</name>
<name>
<surname>Kolbe</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fielding</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>White matter microstructure, cognition, and molecular markers in fragile X premutation females</article-title>
<source/>Neurology
          <volume>88</volume>
<year>2017</year>
<fpage>2070</fpage>
<lpage>2088</lpage>
<pub-id pub-id-type="pmid">28476761</pub-id>
</element-citation>
</ref>
<ref id="bib0410">
<element-citation id="sbref0410" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinagawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kusaka</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Neuroscience Letters DNA methylation in the NCAPH2 / LMF2 promoter region is associated with hippocampal atrophy in Alzheimer’ s disease and amnesic mild cognitive impairment patients</article-title>
<source/>Neurosci. Lett.
          <volume>629</volume>
<year>2016</year>
<fpage>33</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2016.06.055</pub-id>
<pub-id pub-id-type="pmid">27356276</pub-id>
</element-citation>
</ref>
<ref id="bib0415">
<element-citation id="sbref0415" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Jenkinson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Johansen-berg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Rueckert</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>T.E.</given-names>
</name>
<name>
<surname>Mackay</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Ciccarelli</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Cader</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Matthews</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Behrens</surname>
<given-names>T.E.J.</given-names>
</name>
</person-group>
<article-title>Tract-based spatial statistics : voxelwise analysis of multi-subject diffusion data</article-title>
<source/>Neuroimage
          <volume>31</volume>
<year>2006</year>
<fpage>1487</fpage>
<lpage>1505</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.02.024</pub-id>
<pub-id pub-id-type="pmid">16624579</pub-id>
</element-citation>
</ref>
<ref id="bib0420">
<element-citation id="sbref0420" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Kilaru</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Klengel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mercer</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Conneely</surname>
<given-names>K.N.</given-names>
</name>
<name>
<surname>Ressler</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>E.B.</given-names>
</name>
</person-group>
<article-title>DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain</article-title>
<source/>Am. J. Med. Genet. Part B Neuropsychiatr. Genet.
          <volume>168</volume>
<year>2015</year>
<fpage>36</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32278</pub-id>
</element-citation>
</ref>
<ref id="bib0425">
<element-citation id="sbref0425" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sparrow</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Manning</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Cartier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anblagan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bastin</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Piyasena</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pataky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Semple</surname>
<given-names>S.I.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Drake</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Boardman</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural function</article-title>
<source/>Transl. Psychiatry
          <volume>6</volume>
<year>2016</year>
<fpage>e716</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.210</pub-id>
<pub-id pub-id-type="pmid">26784970</pub-id>
</element-citation>
</ref>
<ref id="bib0430">
<element-citation id="sbref0430" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stafford</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuh</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development</article-title>
<source/>Eur. J. Ageing
          <volume>10</volume>
<year>2013</year>
<fpage>145</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1007/s10433-013-0258-8</pub-id>
<pub-id pub-id-type="pmid">23637643</pub-id>
</element-citation>
</ref>
<ref id="bib0435">
<element-citation id="sbref0435" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swartz</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Hariri</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>D.E.</given-names>
</name>
</person-group>
<article-title>An epigenetic mechanism links socioeconomic status to changes in depression-related brain function in high-risk adolescents</article-title>
<source/>Mol. Psychiatry
          <volume>22</volume>
<year>2017</year>
<fpage>209</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.82</pub-id>
<pub-id pub-id-type="pmid">27217150</pub-id>
</element-citation>
</ref>
<ref id="bib0440">
<element-citation id="sbref0440" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talens</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Boomsma</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Tobi</surname>
<given-names>E.W.</given-names>
</name>
<name>
<surname>Kremer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jukema</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Putter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Slagboom</surname>
<given-names>P.E.</given-names>
</name>
<name>
<surname>Heijmans</surname>
<given-names>B.T.</given-names>
</name>
</person-group>
<article-title>Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology</article-title>
<source/>FASEB J. Res. Commun.
          <volume>24</volume>
<year>2010</year>
<fpage>3135</fpage>
<lpage>3144</lpage>
<pub-id pub-id-type="doi">10.1096/fj.09-150490</pub-id>
</element-citation>
</ref>
<ref id="bib0445">
<element-citation id="sbref0445" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Unternaehrer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Luers</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dempster</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Staehli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lieb</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hellhammer</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Meinlschmidt</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Dynamic changes in DNA methylation of stress-associated genes (OXTR, BDNF) after acute psychosocial stress</article-title>
<source/>Transl. Psychiatry
          <volume>2</volume>
<year>2012</year>
<pub-id pub-id-type="doi">10.1038/tp.2012.77</pub-id>
</element-citation>
</ref>
<ref id="bib0450">
<element-citation id="sbref0450" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ursini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bollati</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Fazio</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Porcelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iacovelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Catalani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sinibaldi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gelao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rampino</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taurisano</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giorgio</surname>
<given-names>A.Di</given-names>
</name>
<name>
<surname>Popolizio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Baccarelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blasi</surname>
<given-names>A.De</given-names>
</name>
<name>
<surname>Blasi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bertolino</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Stress-related methylation of the catechol- O -Methyltransferase val 158 allele predicts human prefrontal cognition and activity</article-title>
<source/>J. Neurosci.
          <volume>31</volume>
<year>2011</year>
<fpage>6692</fpage>
<lpage>6698</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.6631-10.2011</pub-id>
<pub-id pub-id-type="pmid">21543598</pub-id>
</element-citation>
</ref>
<ref id="bib0455">
<element-citation id="sbref0455" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ursini</surname>
<given-names>A.G.</given-names>
</name>
<name>
<surname>Cavalleri</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fazio</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>BDNF rs6265 methylation and genotype interact on risk for schizophrenia</article-title>
<source/>Epigenetics
          <volume>11</volume>
<year>2016</year>
<fpage>11</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1080/15592294.2015.1117736</pub-id>
<pub-id pub-id-type="pmid">26889735</pub-id>
</element-citation>
</ref>
<ref id="bib0460">
<element-citation id="sbref0460" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Neelon</surname>
<given-names>S.E.B.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tuli</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Fuemmeler</surname>
<given-names>B.F.</given-names>
</name>
<name>
<surname>Hoyo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Schildkraut</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Overcash</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kurtzberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jirtle</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Iversen</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Maternal stress, preterm birth, and DNA methylation at imprint regulatory sequences in humans</article-title>
<source/>Genet. Epigenetics
          <volume>6</volume>
<year>2014</year>
<fpage>37</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.4137/GEG.S18067</pub-id>
<pub-id pub-id-type="pmid">25512713</pub-id>
</element-citation>
</ref>
<ref id="bib0465">
<element-citation id="sbref0465" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vukojevic</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kolassa</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fastenrath</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gschwind</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spalek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Milnik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heck</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vogler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wilker</surname>
<given-names>X.S.</given-names>
</name>
<name>
<surname>Demougin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Atucha</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Stetak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Roozendaal</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elbert</surname>
<given-names>X.T.</given-names>
</name>
<name>
<surname>Papassotiropoulos</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Quervain</surname>
<given-names>D.J.De</given-names>
</name>
</person-group>
<article-title>Epigenetic modification of the glucocorticoid receptor gene is linked to traumatic memory and post-traumatic stress disorder risk in genocide survivors</article-title>
<source/>J. Neurosci.
          <volume>34</volume>
<year>2014</year>
<fpage>10274</fpage>
<lpage>10284</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1526-14.2014</pub-id>
<pub-id pub-id-type="pmid">25080589</pub-id>
</element-citation>
</ref>
<ref id="bib0470">
<element-citation id="sbref0470" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walton</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hass</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Roessner</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gollub</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Ehrlich</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls</article-title>
<source/>Epigenetics
          <volume>9</volume>
<year>2014</year>
<fpage>1101</fpage>
<lpage>1107</lpage>
<pub-id pub-id-type="doi">10.4161/epi.29223</pub-id>
<pub-id pub-id-type="pmid">24837210</pub-id>
</element-citation>
</ref>
<ref id="bib0475">
<element-citation id="sbref0475" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Calhoun</surname>
<given-names>V.D.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Integration of multiple genomic imaging data for the study of Schizophrenia using joint nonnegative matrix factorization</article-title>
<source/>IEEE Trans. Biomed. Eng.
          <year>2017</year>
<fpage>1083</fpage>
<lpage>1087</lpage>
</element-citation>
</ref>
<ref id="bib0480">
<element-citation id="sbref0480" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiemerslage</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Van Der Kamp</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Olivo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ence-Eriksson</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Castillo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Bandstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dahlberg</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Perland</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gustavsson</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schürmann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Rask-Andersen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Benedict</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schiöth</surname>
<given-names>H.B.</given-names>
</name>
</person-group>
<article-title>A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels</article-title>
<source/>Int. J. Obes.
          <volume>41</volume>
<year>2017</year>
<fpage>990</fpage>
<lpage>994</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2017.43</pub-id>
</element-citation>
</ref>
<ref id="bib0485">
<element-citation id="sbref0485" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiers</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Shumay</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Volkow</surname>
<given-names>N.D.</given-names>
</name>
<name>
<surname>Frieling</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kotsiari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lindenmeyer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bermpohl</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Effects of depressive symptoms and peripheral DAT methylation on neural reactivity to alcohol cues in alcoholism</article-title>
<source/>Transl. Psychiatry
          <volume>5</volume>
<year>2015</year>
<fpage>e648</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.141</pub-id>
<pub-id pub-id-type="pmid">26418276</pub-id>
</element-citation>
</ref>
<ref id="bib0490">
<element-citation id="sbref0490" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wijetunge</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Chattarji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wyllie</surname>
<given-names>D.J.A.</given-names>
</name>
<name>
<surname>Kind</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>Fragile X syndrome: from targets to treatments</article-title>
<source/>Neuropharmacology
          <volume>68</volume>
<year>2013</year>
<fpage>83</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.11.028</pub-id>
<pub-id pub-id-type="pmid">23257237</pub-id>
</element-citation>
</ref>
<ref id="bib0495">
<element-citation id="sbref0495" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Logue</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Sadeh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Schichman</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salat</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Milberg</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>McGlinchey</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Accelerated DNA methylation age: associations with PTSD and neural integrity</article-title>
<source/>Psychoneuroendocrinology
          <volume>63</volume>
<year>2016</year>
<fpage>155</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.09.020</pub-id>
<pub-id pub-id-type="pmid">26447678</pub-id>
</element-citation>
</ref>
<ref id="bib0500">
<element-citation id="sbref0500" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>K.-M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.S.</given-names>
</name>
<name>
<surname>Tae</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Son</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Joe</surname>
<given-names>S.-H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-S.</given-names>
</name>
<name>
<surname>Ham</surname>
<given-names>B.-J.</given-names>
</name>
</person-group>
<article-title>Association between reduced white matter integrity in the corpus callosum and serotonin transporter gene DNA methylation in medication-naive patients with major depressive disorder</article-title>
<source/>Transl. Psychiatry
          <volume>6</volume>
<year>2016</year>
<fpage>e866</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.137</pub-id>
<pub-id pub-id-type="pmid">27505229</pub-id>
</element-citation>
</ref>
<ref id="bib0505">
<element-citation id="sbref0505" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Association of extracellular superoxide dismutase gene methylation with cerebral infarction</article-title>
<source/>Chinese J. Med. Genet.
          <volume>33</volume>
<year>2016</year>
<fpage>378</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.3760/cma.j.issn.1003-9406.2016.03.023</pub-id>
</element-citation>
</ref>
<ref id="bib0510">
<element-citation id="sbref0510" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ziegler</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dannlowski</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Brauer</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laeger</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Wittmann</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kugel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dobel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hurleman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>K.-P.</given-names>
</name>
<name>
<surname>Heindel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kirschbaum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Arolt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gwerlach</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Hoyer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deckert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zwanzger</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Domschke</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Oxytocin receptor gene methylation : converging multilevel evidence for a role in social anxiety</article-title>
<source/>Neuropsychopharmacology
          <volume>40</volume>
<year>2015</year>
<fpage>1528</fpage>
<lpage>1538</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2015.2</pub-id>
<pub-id pub-id-type="pmid">25563749</pub-id>
</element-citation>
</ref>
</ref-list>
<sec id="sec0155" sec-type="supplementary-material">
<label>Appendix A</label>
<title>Supplementary data</title>
<p id="par4990">The following are Supplementary data to this article:<supplementary-material content-type="local-data" id="upi0005"><media xlink:href="mmc1.zip"></media></supplementary-material><supplementary-material content-type="local-data" id="upi0010"><media xlink:href="mmc2.docx"></media></supplementary-material></p>
</sec>
<ack id="ack0005">
<title>Acknowledgements</title>
<p>ENWW is supported by the <funding-source id="gs0005">Wellcome Trust Translational Neuroscience</funding-source> PhD fellowship programme at the University of Edinburgh (203769/Z/16/A). The work was undertaken in the MRC Centre for Reproductive Health, which is funded by <funding-source id="gs0010">MRC Centre Grant</funding-source> (MRC G1002033). DQS is supported by a fellowship from Theirworld (<ext-link ext-link-type="uri" id="intr0035" xlink:href="https://theirworld.org/">https://theirworld.org/</ext-link>). The authors declare no conflicts of interest.</p>
</ack>
<fn-group>
<fn fn-type="supplementary-material" id="sec0150">
<label>Appendix A</label>
<p id="par4985">Supplementary material related to this article can be found, in the online version, at doi:<ext-link ext-link-type="uri" id="intr0040" xlink:href="https://doi.org/10.1016/j.neubiorev.2020.03.007">https://doi.org/10.1016/j.neubiorev.2020.03.007</ext-link>.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>